Disease on EC 3.4.17.19 - Carboxypeptidase Taq
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abortion, Spontaneous
Logistic regression with a continuous exposure measured in pools and subject to errors.
Abscess
Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V.
Acidosis
Acidic environment activates inflammatory programs in fibroblasts via a cAMP-MAPK pathway.
Acidosis
Acidosis differently modulates the inflammatory program in monocytes and macrophages.
Acidosis
Effect of acidosis on IL-8 and MCP-1 during hypoxia and reoxygenation in human NT2-N neurons.
Acidosis
Extracellular Acidosis Regulates the Expression of Inflammatory Mediators in Rat Epithelial Cells.
Acidosis
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Acidosis
Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
Acquired Immunodeficiency Syndrome
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.
Acquired Immunodeficiency Syndrome
Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia.
Acquired Immunodeficiency Syndrome
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Acquired Immunodeficiency Syndrome
Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
Acquired Immunodeficiency Syndrome
MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.
Acquired Immunodeficiency Syndrome
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Acquired Immunodeficiency Syndrome
Reduction in monocyte chemoattractant protein-1 mRNA expression in peripheral blood mononuclear cells of diamorphine addicts.
Acquired Immunodeficiency Syndrome
Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells.
Acquired Immunodeficiency Syndrome
[Chemokines as mediators for intercellular communication in the brain]
Acquired Immunodeficiency Syndrome
[Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients]
Acute Coronary Syndrome
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Acute Coronary Syndrome
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Acute Coronary Syndrome
Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome.
Acute Coronary Syndrome
MCP-1 found to predict prognosis in acute and chronic phases after acute coronary syndrome.
Acute Coronary Syndrome
Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
Acute Coronary Syndrome
Monocyte chemoattractant protein-1 in acute coronary syndromes: Complex vicious interaction.
Acute Coronary Syndrome
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes.
Acute Coronary Syndrome
The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
Acute Coronary Syndrome
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Acute Coronary Syndrome
[Change of serum MCP-1 level and CCR2 protein expression in isolated monocytes in patients with acute coronary syndrome.]
Acute Kidney Injury
A polymeric nanomedicine diminishes inflammatory events in renal tubular cells.
Acute Kidney Injury
Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.
Acute Kidney Injury
Exosomal ATF3 RNA Attenuates Pro-inflammatory Gene MCP-1 Transcription in Renal Ischemia-Reperfusion.
Acute Kidney Injury
Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
Acute Kidney Injury
Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney.
Acute Kidney Injury
Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations.
Acute Kidney Injury
Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.
Acute Lung Injury
Chemokine regulation of ozone-induced neutrophil and monocyte inflammation.
Acute Lung Injury
Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.
Acute Lung Injury
IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid metabolism in a murine model.
Acute Lung Injury
IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
Acute Lung Injury
IL-33-mediated IL-13 secretion by ST2+ Treg controls inflammation after lung injury.
Acute Lung Injury
Involvement of multiple transcription factors in regulation of IL-?-induced MCP-1 expression in alveolar type II epithelial cells.
Acute Lung Injury
[Effect of aging on pulmonary ICAM-1 and MCP-1 expressions in rats with lipopolysaccharide- induced acute lung injury.]
Acute-On-Chronic Liver Failure
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
Adenocarcinoma
Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model.
Adenocarcinoma
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Adenocarcinoma
MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells.
Adenocarcinoma
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas.
Adenocarcinoma
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Adenocarcinoma
Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages.
Adenocarcinoma of Lung
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Adenocarcinoma of Lung
Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma.
Adenoma
Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
Adenoma
Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism.
Adenoma
Vitamin E delta-tocotrienol and metabolite 13'-carboxychromanol inhibit colitis-associated colon tumorigenesis and modulate gut microbiota in mice.
Adenomyosis
Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis.
Adenomyosis
Cytokine Profiling in the Eutopic Endometrium of Adenomyosis During the Implantation Window After Ovarian Stimulation.
Adenomyosis
Impaired decidualization of human endometrial stromal cells from women with adenomyosis.
Aggressive Periodontitis
Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment.
Aggressive Periodontitis
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Aggressive Periodontitis
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in patients with aggressive periodontitis.
Airway Obstruction
The role of the beta chemokines in experimental obliterative bronchiolitis.
Albuminuria
2,3,5,4'-Tetrahydroxystilbene-2-O-?-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin.
Albuminuria
Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats.
Albuminuria
Albuminuria, expression of nicotinamide adenine dinucleotide phosphate oxidase and monocyte chemoattractant protein-1 in the renal tubules of hypertensive Dahl salt-sensitive rats.
Albuminuria
Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
Albuminuria
B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
Albuminuria
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Albuminuria
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Albuminuria
Effects of Tumor Necrosis Factor-? on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy.
Albuminuria
Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?
Albuminuria
Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.
Albuminuria
Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population.
Albuminuria
Haploinsufficiency of the Transcription Factor Ets-1 Is Renoprotective in Dahl Salt-Sensitive Rats.
Albuminuria
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
Albuminuria
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Albuminuria
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Albuminuria
Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF-?B.
Albuminuria
Monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-{beta}, increases podocyte motility and albumin permeability.
Albuminuria
Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation.
Albuminuria
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Albuminuria
Oral administration of powdered dried rhizomes of Curcuma longa L. (turmeric, Zingiberaceae) is effective in the treatment of doxorubicin-induced kidney injury in rats.
Albuminuria
Oral cholecalciferol decreases albuminuria and urinary TGF-?1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.
Albuminuria
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
Albuminuria
RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Albuminuria
Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Albuminuria
Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion.
Albuminuria
Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.
Albuminuria
[Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus]
Alcoholic Neuropathy
Impact of cytokines on the pathomechanism of diabetic and alcoholic neuropathies.
Alopecia Areata
Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in korean patients with alopecia areata.
Alveolar Bone Loss
Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.
Alveolitis, Extrinsic Allergic
Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.
Alveolitis, Extrinsic Allergic
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Alzheimer Disease
Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly.
Alzheimer Disease
Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer's disease.
Alzheimer Disease
Elevated Plasma MCP-1 Concentration Following Traumatic Brain Injury as a Potential "Predisposition" Factor Associated with an Increased Risk for Subsequent Development of Alzheimer's Disease.
Alzheimer Disease
Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease.
Alzheimer Disease
MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes.
Alzheimer Disease
MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
Alzheimer Disease
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
Alzheimer Disease
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study.
Alzheimer Disease
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
Alzheimer Disease
The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: A case-control study.
Amyloidosis
MCP-1 as an Effector of IL-31 Signaling in Familial Primary Cutaneous Amyloidosis.
Amyotrophic Lateral Sclerosis
Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Amyotrophic Lateral Sclerosis
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Amyotrophic Lateral Sclerosis
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Anaphylaxis
Dehydroandrographolide inhibits IgE-mediated anaphylactic reactions via calcium signaling pathway.
Anemia
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.
Anemia
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib.
Anemia
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease.
Anemia
Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.
Anemia
Fermented goat milk consumption improves cardiovascular health during anemia recovery.
Anemia
Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma.
Aneurysm
Altered patterns of gene expression distinguishing unruptured abdominal aortic aneurysms from ruptured ones: comprehensive analysis of inflammatory factors.
Aneurysm
Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence.
Aneurysm
Deficiency of ??T cells protects against abdominal aortic aneurysms by regulating phosphoinositide 3-kinase/AKT signaling.
Aneurysm
Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice.
Aneurysm
Effects of stenting the parent artery on aneurysm filling and gene expression of various potential factors involved in healing of experimental aneurysms.
Aneurysm
Local Delivery Is Critical for Monocyte Chemotactic Protein-1 Mediated Site-Specific Murine Aneurysm Healing.
Aneurysm
Monocyte Chemotactic Protein-1-Interleukin-6-Osteopontin Pathway of Intra-Aneurysmal Tissue Healing.
Aneurysm, Ruptured
Expression of Pro-Inflammatory Cytokines and the Risk of Intracranial Aneurysm.
Angina Pectoris
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
Angina Pectoris
[Effect of compound paeonol dripping pill on levels of plasma inflammatory mediators in patients with unstable angina]
Angina, Stable
Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X?
Angina, Stable
Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina.
Angina, Stable
Immunomediated and ischemia-independent inflammation of coronary microvessels in unstable angina.
Angina, Stable
Increased levels of monocyte-related cytokines in patients with unstable angina.
Angina, Stable
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Angina, Stable
Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.
Angina, Stable
The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
Angina, Unstable
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Angina, Unstable
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T.
Angina, Unstable
Increased levels of monocyte-related cytokines in patients with unstable angina.
Angina, Unstable
Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.
Angina, Unstable
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Angina, Unstable
The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.
Angina, Unstable
[Markers of inflammation--monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein--in blood of patients with unstable angina pectoris and stable effort angina]
Anthracosis
MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis.
Anti-Glomerular Basement Membrane Disease
Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Antiphospholipid Syndrome
Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells.
Aortic Aneurysm
A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury.
Aortic Aneurysm
Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.
Aortic Aneurysm
High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model.
Aortic Aneurysm
MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats.
Aortic Aneurysm
Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.
Aortic Aneurysm, Abdominal
Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Interleukin-10 promotes proliferation of vascular smooth muscle cells by inhibiting inflammation in rabbit abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm.
Appendicitis
Evaluation of a Possible Inflammatory Response after Appendectomy for Non-Perforated Appendicitis in Children.
Arterial Occlusive Diseases
Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery--a pilot study.
Arterial Occlusive Diseases
Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Arteriosclerosis
Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis.
Arteriosclerosis
Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.
Arteriosclerosis
Effects of a healthy life exercise program on arteriosclerosis adhesion molecules in elderly obese women.
Arteriosclerosis
Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
Arteriosclerosis
Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.
Arteriosclerosis
Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression.
Arteriosclerosis
Histamine receptors expressed in circulating progenitor cells have reciprocal actions in ligation-induced arteriosclerosis.
Arteriosclerosis
Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.
Arteriovenous Fistula
Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.
Arthralgia
Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
Arthralgia
Proinflammatory Cytokines and Chemokines as Biomarkers of Persistent Arthralgia and Severe Disease After Chikungunya Virus Infection: A 5-Year Follow-Up Study in Southern Thailand.
Arthralgia
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
Arthritis
A subcytotoxic dose of subtilase cytotoxin prevents lipopolysaccharide-induced inflammatory responses, depending on its capacity to induce the unfolded protein response.
Arthritis
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Arthritis
An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model.
Arthritis
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Arthritis
IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel Fc?RIIB-deficient rheumatoid arthritis mouse model.
Arthritis
Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1.
Arthritis
Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis.
Arthritis
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Arthritis
Novel Compound Q-1 Alleviates Type II Collagen-Induced Arthritis in Rats through the NF-?B Pathway.
Arthritis
Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8.
Arthritis
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
Arthritis
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
Arthritis
Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls.
Arthritis
Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1.
Arthritis
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
Arthritis
The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese.
Arthritis
The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis.
Arthritis
The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats.
Arthritis, Experimental
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Arthritis, Experimental
Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1.
Arthritis, Experimental
[Effect of tongbiling on the expression of MCP-1 mRNA of synovial cells in rats with adjuvant arthritis]
Arthritis, Gouty
N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.
Arthritis, Gouty
Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation.
Arthritis, Juvenile
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis.
Arthritis, Rheumatoid
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Arthritis, Rheumatoid
Anti-arthritogenic effect of Saponin-1 by alteration of Th1/Th2 cytokine paradigm in arthritic mice.
Arthritis, Rheumatoid
Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
Arthritis, Rheumatoid
Blockade of IL-6 and TNF-? inhibited oxLDL-induced production of MCP-1 via scavenger receptor induction.
Arthritis, Rheumatoid
Development of protein microarray technology to monitor biomarkers of rheumatoid arthritis disease.
Arthritis, Rheumatoid
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice.
Arthritis, Rheumatoid
Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis.
Arthritis, Rheumatoid
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis.
Arthritis, Rheumatoid
Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production.
Arthritis, Rheumatoid
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Arthritis, Rheumatoid
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.
Arthritis, Rheumatoid
MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis.
Arthritis, Rheumatoid
miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Arthritis, Rheumatoid
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4.
Arthritis, Rheumatoid
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
Arthritis, Rheumatoid
RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis.
Arthritis, Rheumatoid
Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides.
Arthritis, Rheumatoid
SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
Arthritis, Rheumatoid
Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8.
Arthritis, Rheumatoid
The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.
Arthritis, Rheumatoid
Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.
Arthritis, Rheumatoid
[Effect of tongbiling on the expression of MCP-1 mRNA of synovial cells in rats with adjuvant arthritis]
Arthritis, Rheumatoid
[Expression of monocyte chemoattractant protein-1 and lupus nephritis]
Aspergillosis
Quantification of mRNA encoding cytokines and chemokines in nasal biopsies from dogs with sino-nasal aspergillosis.
Asthma
A shotgun proteomic approach reveals novel potential salivary protein biomarkers for asthma.
Asthma
Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2.
Asthma
Association between MCP-1 -2518A>G polymorphism and asthma susceptibility: a meta-analysis.
Asthma
Biflavonoid-rich fraction from Daphne pseudomezereum var. koreana Hamaya exerts anti-inflammatory effect in an experimental animal model of allergic asthma.
Asthma
Bulleyaconitine A Effectively Relieves Allergic Lung Inflammation in a Murine Asthmatic Model.
Asthma
Ciclesonide Inhibits TNF? and IL-1? Induced Monocyte Chemotactic Protein-1 (MCP-1/ CCL2) Secretion from Human Airway Smooth Muscle Cells.
Asthma
Differential association of plasma monocyte chemoattractant protein-1 with systemic inflammatory and airway remodeling biomarkers in type-2 diabetic patients with and without asthma.
Asthma
Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
Asthma
Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma.
Asthma
Expression of adhesion molecules on granulocytes and monocytes from patients with asthma stimulated in vitro with interleukin-8 and monocyte chemotactic protein-1.
Asthma
Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.
Asthma
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Asthma
Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma.
Asthma
Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects.
Asthma
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Asthma
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.
Asthma
Intelectin is required for IL-13-induced monocyte chemotactic protein-1 and -3 expression in lung epithelial cells and promotes allergic airway inflammation.
Asthma
Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
Asthma
MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma.
Asthma
Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Asthma
Nasal lavage VEGF and TNF-? levels during a natural cold predict asthma exacerbations.
Asthma
Pediatric asthmatic patients have low serum levels of monocyte chemoattractant protein-1.
Asthma
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity.
Asthma
Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors.
Asthma
Recruited Alveolar Macrophages, in Response to Airway Epithelial-derived MCP-1/CCL2, Regulate Airway Inflammation and Remodeling in Allergic Asthma.
Asthma
Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge.
Asthma
Sequential evaluation of serum monocyte chemotactic protein 1 among asymptomatic state and acute exacerbation and remission of asthma in children.
Asthma
Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma.
Asthma
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.
Asthma
Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
Asthma
Zinc Suppressed the Airway Inflammation in Asthmatic Rats: Effects of Zinc on Generation of Eotaxin, MCP-1, IL-8, IL-4, and IFN-?
Asthma
[Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease]
Astrocytoma
CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells.
Astrocytoma
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
Astrocytoma
MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo.
Astrocytoma
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Astrocytoma
Suppression of methylmercury-induced IL-6 and MCP-1 expressions by N-acetylcysteine in U-87MG human astrocytoma cells.
Astrocytoma
The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP.
Asymptomatic Infections
In situ cytokines (IL-4, IL-10, IL-12, IFN-?) and chemokines (MCP-1, MIP-1?) gene expression in human Leishmania (Leishmania) Mexicana infection.
Atherosclerosis
17beta-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells.
Atherosclerosis
3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells.
Atherosclerosis
A Causal Relationship between Shear Stress and Atherosclerotic Lesions in Apolipoprotein-E Knockout Mice Assessed by Ultrasound Biomicroscopy.
Atherosclerosis
A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?
Atherosclerosis
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
Atherosclerosis
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.
Atherosclerosis
ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages.
Atherosclerosis
Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis.
Atherosclerosis
Acute-Phase Inflammatory Response to Single-Bout HIIT and Endurance Training: A Comparative Study.
Atherosclerosis
Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells.
Atherosclerosis
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.
Atherosclerosis
Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.
Atherosclerosis
Anti-atherogenic effect of San-Huang-Xie-Xin-Tang, a traditional Chinese medicine, in cultured human aortic smooth muscle cells.
Atherosclerosis
Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
Atherosclerosis
Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Atherosclerosis
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Atherosclerosis
Arctium lappa root extract containing L-arginine prevents TNF-?-induced early atherosclerosis in vitro and in vivo.
Atherosclerosis
Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines.
Atherosclerosis
Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells.
Atherosclerosis
Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells.
Atherosclerosis
Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese.
Atherosclerosis
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Atherosclerosis
Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Atherosclerosis
Association between monocyte chemoattractant protein-1 and blood pressure in smokers.
Atherosclerosis
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Atherosclerosis
Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration.
Atherosclerosis
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Atherosclerosis
Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
Atherosclerosis
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Atherosclerosis
Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits.
Atherosclerosis
c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells.
Atherosclerosis
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Atherosclerosis
Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells.
Atherosclerosis
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys.
Atherosclerosis
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
Atherosclerosis
Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.
Atherosclerosis
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
Atherosclerosis
Characterization of Monocyte Chemoattractant Proteins and CC Chemokine Receptor 2 Expression During Atherogenesis in Apolipoprotein E-null Mice.
Atherosclerosis
Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells.
Atherosclerosis
Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Atherosclerosis
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Atherosclerosis
Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction.
Atherosclerosis
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Atherosclerosis
Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction.
Atherosclerosis
Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation.
Atherosclerosis
Corosolic Acid Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Regulating the Nuclear Factor-?B Signaling Pathway and Inhibiting Monocyte Chemoattractant Protein-1 Expression.
Atherosclerosis
Curcumin incorporated titanium dioxide nanoparticles as MRI contrasting agent for early diagnosis of atherosclerosis- rat model.
Atherosclerosis
Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling.
Atherosclerosis
Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells.
Atherosclerosis
Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients.
Atherosclerosis
Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1.
Atherosclerosis
D-Psicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs.
Atherosclerosis
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Atherosclerosis
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
Atherosclerosis
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia.
Atherosclerosis
Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study.
Atherosclerosis
Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression.
Atherosclerosis
Disparity of MCP-1 mRNA and protein expressions between the carotid artery and the aorta in WHHL rabbits: one aspect involved in the regional difference in atherosclerosis.
Atherosclerosis
Effect of olmesartan medoxomil on atherosclerosis: clinical implications of the emerging evidence.
Atherosclerosis
Effect of PKC-? Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs).
Atherosclerosis
Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis.
Atherosclerosis
Effects of antiatherosclerosis in carotid artery by RNAi-mediated silencing of MCP-1 expression.
Atherosclerosis
Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice.
Atherosclerosis
Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits.
Atherosclerosis
Effects of simvastatin on NF-kappaB-DNA binding activity and monocyte chemoattractant protein-1 expression in a rabbit model of atherosclerosis.
Atherosclerosis
Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys.
Atherosclerosis
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
Atherosclerosis
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.
Atherosclerosis
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.
Atherosclerosis
Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-ox-LDL antibody, MCP-1, and RANTES levels in early onset occlusive carotid artery disease.
Atherosclerosis
ERK is integral to the IFN-?-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages.
Atherosclerosis
Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells.
Atherosclerosis
Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect.
Atherosclerosis
Estradiol suppresses MCP-1 expression In vivo : implications for atherosclerosis.
Atherosclerosis
Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cells.
Atherosclerosis
Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.
Atherosclerosis
Expression of monocyte chemoattractant protein-1 by nonenzymatically glycated albumin (Amadori adducts) in vascular smooth muscle cells.
Atherosclerosis
Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis.
Atherosclerosis
Expression of monocyte chemoattractant protein-1 in monocytes and effects of native and oxidized very low density lipoproteins.
Atherosclerosis
Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty.
Atherosclerosis
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein.
Atherosclerosis
Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Atherosclerosis
Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating Lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades.
Atherosclerosis
High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population.
Atherosclerosis
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1.
Atherosclerosis
Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.
Atherosclerosis
Housefly Maggots (Musca domestica) Protein-enriched Fraction/ extracts (PE) Inhibit Lipopolysaccharide-induced Atherosclerosis Pro-inflammatory Responses.
Atherosclerosis
Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-?B/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice.
Atherosclerosis
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Atherosclerosis
IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.
Atherosclerosis
Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Atherosclerosis
Induction of heme oxygenase-1 in monocytes suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2: role of bilirubin and carbon monoxide generated by the enzyme.
Atherosclerosis
Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells.
Atherosclerosis
Inflammation and enhanced atherogenesis in the carotid artery with altered blood flow in an atherosclerosis-resistant mouse strain.
Atherosclerosis
Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.
Atherosclerosis
Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
Atherosclerosis
Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells.
Atherosclerosis
Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells.
Atherosclerosis
Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins.
Atherosclerosis
Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production.
Atherosclerosis
Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma.
Atherosclerosis
Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Atherosclerosis
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
Atherosclerosis
Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.
Atherosclerosis
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
Atherosclerosis
Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4.
Atherosclerosis
Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse.
Atherosclerosis
Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes.
Atherosclerosis
Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
Atherosclerosis
Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
Atherosclerosis
Macrophage Adipose Triglyceride Lipase Deficiency Attenuates Atherosclerotic Lesion Development in Low-Density Lipoprotein Receptor Knockout Mice.
Atherosclerosis
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease.
Atherosclerosis
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma.
Atherosclerosis
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.
Atherosclerosis
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
Atherosclerosis
Metabolic Syndrome Is Associated with Increased Plasma Levels of Monocyte Chemoattractant Protein in Dialysis Patients.
Atherosclerosis
Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.
Atherosclerosis
Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
Atherosclerosis
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Atherosclerosis
Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
Atherosclerosis
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.
Atherosclerosis
Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions.
Atherosclerosis
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis.
Atherosclerosis
Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats.
Atherosclerosis
Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
Atherosclerosis
Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages.
Atherosclerosis
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Atherosclerosis
Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells.
Atherosclerosis
Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice.
Atherosclerosis
Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes.
Atherosclerosis
Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome.
Atherosclerosis
Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits.
Atherosclerosis
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
Atherosclerosis
Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis.
Atherosclerosis
Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice.
Atherosclerosis
New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.
Atherosclerosis
No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls.
Atherosclerosis
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Atherosclerosis
Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
Atherosclerosis
Nutrient intake and serum level of gamma-glutamyltransferase, MCP-1 and homocysteine in early stages of heart failure.
Atherosclerosis
Overexpressed miR-335-5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome.
Atherosclerosis
Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages.
Atherosclerosis
p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-?B p65 in human vascular smooth muscle cells.
Atherosclerosis
p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Atherosclerosis
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells.
Atherosclerosis
Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice.
Atherosclerosis
Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Atherosclerosis
Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.
Atherosclerosis
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
Atherosclerosis
Platelet-derived growth factor-specific regulation of the JE promoter in rat aortic smooth muscle cells.
Atherosclerosis
Polymeric Vector-Mediated Targeted Delivery of Anti-PAK1 siRNA to Macrophages for Efficient Atherosclerosis Treatment.
Atherosclerosis
Predicting carotid restenosis by comparison of plaque MCP-1 mRNA expression and serum levels.
Atherosclerosis
Predictive Markers of Blood Cytokine and Chemokine in Recurrent Brain Infarction.
Atherosclerosis
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Atherosclerosis
Quercetin attenuates Monocyte Chemoattractant Protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1.
Atherosclerosis
Radiolabeled Monocyte Chemotactic Protein 1 for the detection of inflammation in experimental atherosclerosis.
Atherosclerosis
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Atherosclerosis
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.
Atherosclerosis
Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages.
Atherosclerosis
Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Atherosclerosis
Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
Atherosclerosis
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
Atherosclerosis
Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
Atherosclerosis
Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis.
Atherosclerosis
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Atherosclerosis
Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.
Atherosclerosis
Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.
Atherosclerosis
Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.
Atherosclerosis
The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients.
Atherosclerosis
The effect of n-3 fatty acids on coronary atherosclerosis: results from SCIMO, an angiographic study, background and implications.
Atherosclerosis
The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway.
Atherosclerosis
The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis.
Atherosclerosis
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.
Atherosclerosis
Thioredoxin 1 downregulates MCP-1 secretion and expression in human endothelial cells by suppressing nuclear translocation of activator protein 1 and redox factor-1.
Atherosclerosis
Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-?B signaling pathway activation in vascular endothelial cells.
Atherosclerosis
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.
Atherosclerosis
TLR4/NF-?B signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.
Atherosclerosis
Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis.
Atherosclerosis
Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice.
Atherosclerosis
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages.
Atherosclerosis
Ultravist Induces the Expression of MCP-1 and VCAM-1 in IL-4-Stimulated HUVECs.
Atherosclerosis
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.
Atherosclerosis
Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice.
Atherosclerosis
Whitmania Pigra Whitman Extracts Inhibit Lipopolysaccharide Induced Rat Vascular Smooth Muscle Cells Migration and their Adhesion Ability to THP-1 and RAW 264.7 Cells.
Atherosclerosis
[Aortic expression of monocyte chemotactic protein-1 (MCP-1) gene in rabbits with experimental atherosclerosis]
Atherosclerosis
[Contribution of monocyte chemoattractant protein-1 and c-fms/macrophage colony-stimulating factor receptor to coronary artery disease: analysis of human coronary atherectomy specimens]
Atherosclerosis
[Effect and mechanism of gypenosides on the inflammatory molecular expression in high-fat induced atherosclerosis rats]
Atherosclerosis
[Effect of selenium on expression of P38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 in diabetic endothelial cells.]
Atherosclerosis
[Effects of IL-1beta, TNF-alpha and lipopolysaccharide on the expression of MCP-1 in human umbilical vein endothelial cells]
Atherosclerosis
[Effects of oxidatively modified low density lipoprotein and very low density lipoprotein on the expression of MCP-1 in macrophages]
Atherosclerosis
[Expression of monocyte chemoattractant protein-1 in aorta of early hypertensive rats]
Atherosclerosis
[Inhibition of monocytes adhesion to the intima of arterial wall by local expression of antisense monocyte chemotactic protein-1]
Atherosclerosis
[Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes]
Atrial Fibrillation
Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation.
Atrial Fibrillation
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Atrial Fibrillation
Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
Autoimmune Diseases
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Autoimmune Diseases
Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia.
Autoimmune Diseases
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
Autoimmune Diseases
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice.
Autoimmune Diseases
Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.
Azotemia
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease.
Azotemia
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
Azotemia
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Azotemia
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
Bacteremia
Transcriptional regulation of alpha5beta1 integrin, fibronectin, VCAM-1, MCSF-1/c-fms, and MCP-1 in atrioventricular valves after valvular surgery and Staphylococcus aureus bacteremia.
Bacterial Infections
Cytokines and chemokines as biomarkers of community-acquired bacterial infection.
Bacterial Infections
Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling.
Bacterial Infections
Monocyte chemoattractant protein-1 expression by osteoblasts following infection with Staphylococcus aureus or Salmonella.
Bacterial Infections
TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection.
Bacterial Infections
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Behcet Syndrome
The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients.
Biliary Atresia
Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
Blister
Impaired monocyte CD11b expression in interstitial inflammation in hemodialysis patients.
Blister
Inhibition of Monocyte Chemoattractant Protein 1 Prevents Conjunctival Fibrosis in an Experimental Model of Glaucoma Filtration Surgery.
Blister
Leukocyte CD11b and CD62l expression in response to interstitial inflammation in CAPD patients.
Blister
Monocyte adhesion molecule expression in interstitial inflammation in patients with renal failure.
Blister
Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1.
Blister
Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production.
Bone Diseases
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Bone Diseases
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease.
Bone Diseases, Metabolic
MCP-1 and CCR2 Gene Variants and the Risk for Osteoporosis and Osteopenia.
Bone Neoplasms
Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats.
Bone Neoplasms
Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain.
Bone Resorption
Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone.
Bone Resorption
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Bone Resorption
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
Bone Resorption
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Bone Resorption
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
Bone Resorption
p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.
Bone Resorption
Smoking Dependent Alterations in Bone Formation and Inflammation Represent Major Risk Factors for Complications Following Total Joint Arthroplasty.
Borna Disease
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Brain Abscess
Association of ICAM-1 (K469E) and MCP-1 -2518 A>G gene polymorphism with brain abscess.
Brain Death
Brain death in combination with warm ischemic stress during isolation procedures induces the expression of crucial inflammatory mediators in the isolated islets.
Brain Death
Donor Brain Death Predisposes Human Kidney Grafts to a Proinflammatory Reaction after Transplantation.
Brain Death
Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death.
Brain Diseases
Blood Biomarkers and 6- to 7-Year Childhood Outcomes Following Neonatal Encephalopathy.
Brain Diseases
MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Brain Diseases
Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice.
Brain Diseases
The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1.
Brain Edema
Experimental studies of erythropoietin protection following traumatic brain injury in rats.
Brain Infarction
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Brain Infarction
Predictive Markers of Blood Cytokine and Chemokine in Recurrent Brain Infarction.
Brain Injuries
Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain.
Brain Injuries
Albumin stimulates monocyte chemotactic protein-1 expression in rat embryonic mixed brain cells.
Brain Injuries
Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme.
Brain Injuries
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain.
Brain Injuries
Chemokines direct neural progenitor cell migration following striatal cell loss.
Brain Injuries
IL-5; a diffuse biomarker associated with brain inflammation after blast exposure.
Brain Injuries
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.
Brain Injuries
Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.
Brain Injuries, Traumatic
BpV(pic) confers neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury.
Brain Injuries, Traumatic
Chemokine inhibition in rat stab wound brain injury using antisense oligodeoxynucleotides.
Brain Injuries, Traumatic
Elevated Plasma MCP-1 Concentration Following Traumatic Brain Injury as a Potential "Predisposition" Factor Associated with an Increased Risk for Subsequent Development of Alzheimer's Disease.
Brain Injuries, Traumatic
Experimental studies of erythropoietin protection following traumatic brain injury in rats.
Brain Injuries, Traumatic
Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques.
Brain Injuries, Traumatic
Serum IL-8 and MCP-1 concentration do not identify patients with enlarging contusions after traumatic brain injury.
Brain Injuries, Traumatic
The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat.
Brain Ischemia
Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats.
Brain Ischemia
Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats.
Brain Ischemia
Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice.
Brain Ischemia
Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat.
Brain Ischemia
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.
Brain Ischemia
MCP-1 mediated activation of microglia promotes white matter lesions and cognitive deficits by chronic cerebral hypoperfusion in mice.
Brain Ischemia
Monocyte chemoattractant protein-1-deficiency results in altered blood-brain barrier breakdown after experimental stroke.
Brain Ischemia
Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression.
Brain Ischemia
Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia.
Brain Ischemia
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia.
Brain Ischemia
[Angiogenesis mechanisms in the formation of structural changes of brain tissue in patients with progressive cerebrovascular disease].
Brain Ischemia
[Influence of JDTL injection on inflammatory factors in rat experimental cerebral ischemia]
Brain Neoplasms
Experimental gliosarcoma induces chemokine receptor expression in rat brain.
Brain Neoplasms
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Brain Neoplasms
Primary central nervous system lymphoma secretes monocyte chemoattractant protein 1.
Breast Diseases
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Breast Neoplasms
A systematic review and meta-analysis of the effects of general anesthesia combined with continuous paravertebral block in breast cancer surgery and postoperative analgesia.
Breast Neoplasms
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Breast Neoplasms
Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West India.
Breast Neoplasms
Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.
Breast Neoplasms
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1.
Breast Neoplasms
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.
Breast Neoplasms
CD16(+) monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.
Breast Neoplasms
Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.
Breast Neoplasms
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Breast Neoplasms
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
Breast Neoplasms
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Breast Neoplasms
Effects of protein kinase Cdelta and phospholipase C-gamma1 on monocyte chemoattractant protein-1 expression in taxol-induced breast cancer cell death.
Breast Neoplasms
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Breast Neoplasms
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Breast Neoplasms
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.
Breast Neoplasms
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.
Breast Neoplasms
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Breast Neoplasms
Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinoma.
Breast Neoplasms
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.
Breast Neoplasms
Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization.
Breast Neoplasms
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Breast Neoplasms
Lymph cytokines as markers oncogenesis and effective treatment of experimental breast cancer Wistar rat.
Breast Neoplasms
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
Breast Neoplasms
MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.
Breast Neoplasms
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
Breast Neoplasms
MCP-1-induced ERK/GSK-3?/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Breast Neoplasms
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Breast Neoplasms
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Breast Neoplasms
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
Breast Neoplasms
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.
Breast Neoplasms
Non-tumorigenic epithelial cells secrete MCP-1 and other cytokines that promote cell division in breast cancer cells by activating ER? via PI3K/Akt/mTOR signaling.
Breast Neoplasms
Opposing effects of pro- and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women: a pilot study.
Breast Neoplasms
Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Breast Neoplasms
Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-?1.
Breast Neoplasms
PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells.
Breast Neoplasms
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Breast Neoplasms
Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
Breast Neoplasms
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Breast Neoplasms
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Breast Neoplasms
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma.
Breast Neoplasms
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Breast Neoplasms
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
Breast Neoplasms
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones.
Breast Neoplasms
Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells.
Bronchiolitis
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Bronchitis, Chronic
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Bronchitis, Chronic
Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics.
Bronchitis, Chronic
Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Bronchopneumonia
Deoxynivalenol exacerbates viral bronchopneumonia induced by respiratory reovirus infection.
Brucellosis
Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems.
Candidemia
Integrating GWAS with bulk and single-cell RNA-sequencing reveals a role for LY86 in the anti-Candida host response.
carboxypeptidase taq deficiency
Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation.
carboxypeptidase taq deficiency
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
carboxypeptidase taq deficiency
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
carboxypeptidase taq deficiency
Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism.
carboxypeptidase taq deficiency
Diminished induction of skin fibrosis in mice with MCP-1 deficiency.
carboxypeptidase taq deficiency
Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA.
carboxypeptidase taq deficiency
Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet.
carboxypeptidase taq deficiency
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
carboxypeptidase taq deficiency
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
carboxypeptidase taq deficiency
Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.
carboxypeptidase taq deficiency
MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration.
carboxypeptidase taq deficiency
MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.
carboxypeptidase taq deficiency
MCP-1 deficiency enhances browning of adipose tissue via increased M2 polarization.
carboxypeptidase taq deficiency
MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury.
carboxypeptidase taq deficiency
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.
carboxypeptidase taq deficiency
MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model.
carboxypeptidase taq deficiency
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
carboxypeptidase taq deficiency
Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.
carboxypeptidase taq deficiency
Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset.
carboxypeptidase taq deficiency
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
carboxypeptidase taq deficiency
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis.
carboxypeptidase taq deficiency
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
carboxypeptidase taq deficiency
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
carboxypeptidase taq deficiency
Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain.
Carcinogenesis
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Carcinogenesis
Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
Carcinogenesis
Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1? and VEGF.
Carcinogenesis
Dihydroxystilbenes prevent azoxymethane/dextran sulfate sodium-induced colon cancer by inhibiting colon cytokines, a chemokine, and programmed cell death-1 in C57BL/6J mice.
Carcinogenesis
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Carcinogenesis
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Carcinogenesis
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Carcinogenesis
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
Carcinogenesis
MCP-1-induced ERK/GSK-3?/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Carcinogenesis
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Carcinogenesis
Whole body microwave irradiation for improved dacarbazine therapeutical action in cutaneous melanoma mouse model.
Carcinoma
Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells.
Carcinoma
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.
Carcinoma
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Carcinoma
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Carcinoma
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Carcinoma
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Carcinoma
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Carcinoma
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.
Carcinoma
Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
Carcinoma
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Carcinoma
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Carcinoma
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors.
Carcinoma
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Carcinoma
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Carcinoma
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
Carcinoma
MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
Carcinoma
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
Carcinoma
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas.
Carcinoma
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Carcinoma
Monocyte chemoattractant protein-1 is generated via TGF-beta by myofibroblasts in gastric intestinal metaplasia and carcinoma without H. pylori infection.
Carcinoma
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Carcinoma
Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Carcinoma
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Carcinoma
Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas.
Carcinoma
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Carcinoma
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Carcinoma
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Carcinoma
Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma.
Carcinoma
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
Carcinoma
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.
Carcinoma
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Carcinoma
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Carcinoma
Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Carcinoma
Studies on the Bioactive Flavonoids Isolated from Pithecellobium clypearia Benth.
Carcinoma
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Carcinoma
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Carcinoma
Tumor-driven matrix invasion by infiltrating lymphocytes: involvement of the alpha1 integrin I-domain.
Carcinoma
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
Carcinoma in Situ
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.
Carcinoma in Situ
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Carcinoma, Basal Cell
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Carcinoma, Basal Cell
Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Carcinoma, Ductal
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Carcinoma, Ductal
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.
Carcinoma, Ductal
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Carcinoma, Hepatocellular
Cachexia--induced cerebellar degeneration: involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease.
Carcinoma, Hepatocellular
Expression patterns of cytokines and chemokines genes in human hepatoma cells.
Carcinoma, Hepatocellular
Hepatocyte-specific hypoxia-inducible factor-1? is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
Carcinoma, Hepatocellular
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.
Carcinoma, Hepatocellular
Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Carcinoma, Hepatocellular
Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Oxidative products from alcohol metabolism differentially modulate pro-inflammatory cytokine expression in Kupffer cells and hepatocytes.
Carcinoma, Hepatocellular
Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.
Carcinoma, Intraductal, Noninfiltrating
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Carcinoma, Intraductal, Noninfiltrating
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Carcinoma, Lewis Lung
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Carcinoma, Lewis Lung
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Carcinoma, Non-Small-Cell Lung
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Carcinoma, Ovarian Epithelial
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.
Carcinoma, Ovarian Epithelial
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Carcinoma, Renal Cell
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Carcinoma, Renal Cell
Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Carcinoma, Renal Cell
Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma.
Carcinoma, Renal Cell
Tumor-driven matrix invasion by infiltrating lymphocytes: involvement of the alpha1 integrin I-domain.
Carcinoma, Renal Cell
[Polymorphisms in inflammatory response genes in metastatic renal cancer]
Carcinoma, Squamous Cell
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Carcinoma, Squamous Cell
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Carcinoma, Squamous Cell
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.
Carcinoma, Squamous Cell
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Carcinoma, Squamous Cell
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Carcinoma, Squamous Cell
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Carcinoma, Squamous Cell
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
Cardiomegaly
Angiotensin ? Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
Cardiomegaly
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Cardiomegaly
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Cardiomegaly
Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
Cardiomegaly
Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage.
Cardiomegaly
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Cardiomyopathies
Abrogation of cardiomyopathy in diabetic rats by escin - possible role of NF-?? and MCP-1.
Cardiomyopathies
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Cardiomyopathies
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Cardiomyopathies
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
Cardiomyopathies
Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemia.
Cardiomyopathies
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Cardiomyopathies
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Cardiomyopathies
Pegfilgrastim and linagliptin potentiate chemoattraction of Ccr2 and Cd44 stem cells accompanied by alterations of cardiac Hgf, Igf-1 and Mcp-1 in daunorubicin cardiomyopathy.
Cardiomyopathy, Dilated
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.
Cardiotoxicity
Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats.
Cardiovascular Diseases
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-{kappa}B-dependent pathway in rat preadipocytes.
Cardiovascular Diseases
Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.
Cardiovascular Diseases
Association between monocyte chemoattractant protein-1 and blood pressure in smokers.
Cardiovascular Diseases
Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration.
Cardiovascular Diseases
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Cardiovascular Diseases
Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Cardiovascular Diseases
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Cardiovascular Diseases
Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: Role of nitric oxide mediating pleiotropic effects.
Cardiovascular Diseases
Effects of intermittent exercise on biomarkers of cardiovascular risk in night shift workers.
Cardiovascular Diseases
Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Cardiovascular Diseases
Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Cardiovascular Diseases
Femoral artery diameter and arteriogenic cytokines in healthy women.
Cardiovascular Diseases
High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
Cardiovascular Diseases
Impact of chronic wounds of various etiology on systemic profiles of key inflammatory cytokines, chemokines, and growth factors and their interplay.
Cardiovascular Diseases
Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol.
Cardiovascular Diseases
MCP-1-induced protein promotes endothelial-like and angiogenic properties in human bone marrow monocytic cells.
Cardiovascular Diseases
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.
Cardiovascular Diseases
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.
Cardiovascular Diseases
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
Cardiovascular Diseases
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
Cardiovascular Diseases
Serum levels of cytokines and chemokines associated with cardiovascular disease in Brazilian patients treated with statins for dyslipidemia.
Cardiovascular Diseases
Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
Cardiovascular Diseases
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Cardiovascular Diseases
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness.
Cardiovascular Diseases
Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
Cardiovascular Diseases
[Prospects of buccal epithelium application for noninvasive diagnosis of coronary heart disease in people of different age.]
Cardiovascular Diseases
[The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases]
Carotid Artery Diseases
Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-ox-LDL antibody, MCP-1, and RANTES levels in early onset occlusive carotid artery disease.
Carotid Artery Diseases
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
Carotid Artery Diseases
Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness.
Carotid Artery Diseases
Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan.
Carotid Artery Diseases
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Carotid Stenosis
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation.
Carotid Stenosis
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Cataract
Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery.
Cataract
Aqueous humor levels of asymmetric dimethylarginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis.
Cataract
Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
Cataract
Characteristic Profiles of Inflammatory Cytokines in the Aqueous Humor of Glaucomatous Eyes.
Cataract
Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent uveitic cataracts.
Cataract
Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients.
Cataract
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Cataract
Dynamic monocyte chemoattractant protein-1 level as predictors of perceived pain during first and second phacoemulsification eye surgeries in patients with bilateral cataract.
Cataract
Elevation of preoperative recipient aqueous cytokine levels in eyes with primary graft failure after corneal transplantation.
Cataract
Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification.
Cataract
Molecular Inflammation in the Contralateral Eye After Cataract Surgery in the First Eye.
Cataract
Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis.
Cataract
Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.
Cataract
The high expression of the pain-related inflammatory factors in the eyes of cataract patients infected with hepatitis B virus.
cathepsin e deficiency
Differential regulation of the nature and functions of dendritic cells and macrophages by cathepsin e.
Central Nervous System Diseases
Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
Central Nervous System Diseases
Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.
Central Nervous System Infections
Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.
Central Nervous System Infections
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
ceramidase deficiency
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
Cerebral Hemorrhage
Gene silencing of MCP-1 prevents microglial activation and inflammatory injury after intracerebral hemorrhage.
Cerebral Hemorrhage
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Cerebral Infarction
Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction.
Cerebral Infarction
Correlations of MCP-1 -2518A>G Polymorphism and Serum Levels with Cerebral Infarction Risk: A Meta-Analysis.
Cerebral Infarction
IL-27 Protects the Brain from Ischemia-Reperfusion Injury via the gp130/STAT3 Signaling Pathway.
Cerebral Infarction
The Neurovascular Protective Effect of S14G-Humanin in a Murine MCAO Model and Brain Endothelial Cells.
Cerebrovascular Disorders
Effect of dietary ? carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E(-/-) mice.
Cerebrovascular Disorders
High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
Cervical Intraepithelial Neoplasia
In situ increased chemokine expression in human cervical intraepithelial neoplasia.
Chagas Disease
alpha 4 Integrins and sialyl Lewis x modulation in chronic Chagas disease: further evidence of persistent immune activation.
Chikungunya Fever
High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand.
Chikungunya Fever
Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells.
Cholangitis
Ascending cholangitis provokes IL-8 and MCP-1 expression and promotes inflammatory cell infiltration in the cholestatic rat liver.
Cholangitis
Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats.
Cholangitis, Sclerosing
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Cholera
Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.
Cholera
Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes.
Cholera
Transcriptional upregulation of inflammatory cytokines in human intestinal epithelial cells following Vibrio cholerae infection.
Cholestasis
Glucocorticoid treatment down-regulates chemokine expression of bacterial cholangitis in cholestatic rats.
Cholestasis
The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.
Chorioamnionitis
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
Chorioamnionitis
Pulmonary and systemic expression of monocyte chemotactic proteins in preterm sheep fetuses exposed to lipopolysaccharide-induced chorioamnionitis.
Chorioamnionitis
Pulmonary and Systemic Expression of Monocyte Chemotactic Proteins in Preterm Sheep Fetuses Exposed to LPS Induced Chorioamnionitis.
Choroidal Neovascularization
Magnetic nanoparticles conjugated with "RPE cell -MCP-1 antibody -VEGF antibody" compounds for the targeted therapy of age-related macular degeneration: a hypothesis.
Choroidal Neovascularization
The Role of Mitochondria-Associated Reactive Oxygen Species in the Amyloid ? Induced Production of Angiogenic Factors b y ARPE-19 Cells.
Chronic Periodontitis
Association between Monocyte Chemoattractant Protein-1 -2518 (A/G) Single Nucleotide Polymorphism and Chronic Periodontitis in End-stage Renal Disease Patients - A Case-control Study.
Chronic Periodontitis
Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment.
Chronic Periodontitis
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Chronic Periodontitis
Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases.
Chronic Periodontitis
Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease.
Chronic Periodontitis
[Infiltration of monocytes/macrophages and expression of monocyte chemoattractant protein-1 in gingival tissues from patients with rapidly progressive periodontitis]
Chronic Periodontitis
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Chronic Urticaria
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
Coinfection
Events associated with susceptibility to invasive Salmonella enterica serovar Typhi in BALB/c mice previously infected with Plasmodium berghei ANKA.
Coinfection
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
Coinfection
Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment.
Coinfection
Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response.
Coinfection
The Expression of IL-6, TNF-?, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Colitis
CD40 Receptor Knockout Protects against Microcystin-LR (MC-LR) Prolongation and Exacerbation of Dextran Sulfate Sodium (DSS)-Induced Colitis.
Colitis
Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells.
Colitis
Chrysin Ameliorates Chemically Induced Colitis in the Mouse Through Modulation of a PXR/NF-?B Signaling Pathway.
Colitis
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells.
Colitis
Dietary Nondigestible Polysaccharides Ameliorate Colitis by Improving Gut Microbiota and CD4+ Differentiation, as Well as Facilitating M2 Macrophage Polarization.
Colitis
Early detection of renal injury using urinary vanin-1 in rats with experimental colitis.
Colitis
Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis.
Colitis
Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset.
Colitis
Monocyte chemotactic protein-1 in a randomized placebo controlled study of canine plasmacytic-lymphocytic colitis.
Colitis
Sacral nerve stimulation improves colonic inflammation mediated by autonomic-inflammatory cytokine mechanism in rats.
Colitis
Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species.
Colitis
Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1? expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice.
Colitis
TGR5 Protects Against Colitis in Mice, but Vertical Sleeve Gastrectomy Increases Colitis Severity.
Colitis
The anti-inflammatory activity of peptides from simulated gastrointestinal digestion of preserved egg white in DSS-induced mouse colitis.
Colitis
The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis.
Colitis
The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats.
Colitis
Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
Colitis, Microscopic
Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers.
Colitis, Ulcerative
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.
Colitis, Ulcerative
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa.
Colitis, Ulcerative
The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease.
Colitis, Ulcerative
The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
Colitis, Ulcerative
[rCsHscB derived from Clonorchis sinensis has therapeutic effect on dextran sodium sulfate-induced chronic ulcerative colitis in mice].
Colitis-Associated Neoplasms
Vitamin E delta-tocotrienol and metabolite 13'-carboxychromanol inhibit colitis-associated colon tumorigenesis and modulate gut microbiota in mice.
Colonic Neoplasms
Differential Expression of mRNA in Human Monocytes following Interaction with Human Colon Cancer Cells.
Colonic Neoplasms
Expression of chemotaxis- and angiogenesis-related factors in human monocytes following interaction with colon cancer cells is suppressed by low-dose lipopolysaccharide.
Colonic Neoplasms
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Colonic Neoplasms
Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
Colonic Neoplasms
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
Colorectal Neoplasms
An association of the MCP-1 and CCR2 single nucleotide polymorphisms with colorectal cancer prevalence.
Colorectal Neoplasms
Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines.
Colorectal Neoplasms
Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.
Colorectal Neoplasms
Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells.
Colorectal Neoplasms
Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
Coma
Serum Levels of Monocyte Chemoattractant Protein-1 Correlate with Poor Clinical Grades in Cerebral Aneurysms.
Communicable Diseases
Reduction in monocyte chemoattractant protein-1 mRNA expression in peripheral blood mononuclear cells of diamorphine addicts.
Communicable Diseases
Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden.
Conjunctivitis, Allergic
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments.
Conjunctivitis, Allergic
Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1 /CCR2.
Conjunctivitis, Allergic
MCP-1, CCR2 and CCR5 Polymorphisms in Tunisian Patients with Atopic Asthma.
Contracture
FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice.
Contracture
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Corneal Dystrophies, Hereditary
Preoperative Aqueous Cytokine Levels are Associated With Endothelial Cell Loss After Descemet's Stripping Automated Endothelial Keratoplasty.
Corneal Neovascularization
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Corneal Neovascularization
Involvement of macrophage chemotactic protein-1 and interleukin-1beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea.
Coronary Aneurysm
Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease.
Coronary Artery Disease
A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation.
Coronary Artery Disease
A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population.
Coronary Artery Disease
Adiponectin incompletely prevent MCP-1-dependent restenosis after percutaneous coronary intervension in patients with coronary artery disease.
Coronary Artery Disease
Association between Plasma Monocyte Chemoattractant Protein-1 Levels and the Extent of Atherosclerotic Peripheral Artery Disease.
Coronary Artery Disease
Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients.
Coronary Artery Disease
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Coronary Artery Disease
Circulating monocyte chemoattractant protein-1 in women with gestational diabetes.
Coronary Artery Disease
Correlation between IL-7 and MCP-1 in diabetic chronic non healing ulcer patients at higher risk of coronary artery disease.
Coronary Artery Disease
Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease.
Coronary Artery Disease
Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-?B, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial.
Coronary Artery Disease
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial.
Coronary Artery Disease
Elevated circulating levels of C-C chemokines in patients with congestive heart failure.
Coronary Artery Disease
Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: A meta-analysis.
Coronary Artery Disease
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Coronary Artery Disease
IL-17 contributes to the development of chronic rejection in a murine heart transplant model.
Coronary Artery Disease
Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.
Coronary Artery Disease
Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis - Influence on IP-10, TNF-? and MCP-1.
Coronary Artery Disease
Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Coronary Artery Disease
Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.
Coronary Artery Disease
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
Coronary Artery Disease
MCP-1 and soluble TWEAK levels are independently associated with coronary artery disease severity in patients with chronic kidney disease.
Coronary Artery Disease
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Coronary Artery Disease
Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study.
Coronary Artery Disease
Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome.
Coronary Artery Disease
Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease.
Coronary Artery Disease
Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians.
Coronary Artery Disease
Relation between serum monocyte chemoattractant protein-1 and coronary collateral development.
Coronary Artery Disease
Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression.
Coronary Artery Disease
Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females.
Coronary Artery Disease
Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography.
Coronary Artery Disease
Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
Coronary Artery Disease
Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction.
Coronary Artery Disease
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Coronary Artery Disease
The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population.
Coronary Artery Disease
The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts.
Coronary Artery Disease
The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease.
Coronary Artery Disease
Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1.
Coronary Artery Disease
[Expression of monocyte chemotactic protein-1 and its receptor in sudden coronary death].
Coronary Artery Disease
[Monocyte chemotactic protein-1 expression in coronary atherosclerosis plaque of sudden coronary death patients]
Coronary Disease
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
Coronary Disease
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Coronary Disease
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Coronary Disease
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Coronary Disease
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Coronary Disease
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Coronary Disease
Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
Coronary Disease
Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.
Coronary Disease
Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects.
Coronary Disease
Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.
Coronary Disease
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
Coronary Disease
[Randomized controlled study on effects of the needling method for regulating spleen-stomach on coronary heart disease complicated by type 2 diabetes mellitus complicated]
Coronary Occlusion
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Costello Syndrome
Tropoelastin regulates chemokine expression in fibroblasts in Costello syndrome.
COVID-19
Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
COVID-19
Changes of serum IL-10, IL-1?, IL-6, MCP-1, TNF-?, IP-10 and IL-4 in COVID-19 patients.
COVID-19
COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
COVID-19
Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
COVID-19
Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
COVID-19
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
COVID-19
High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
COVID-19
Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.
COVID-19
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
COVID-19
Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
COVID-19
Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.
COVID-19
Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19.
COVID-19
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
COVID-19
Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
COVID-19
Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.
Crohn Disease
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
Crohn Disease
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa.
Crohn Disease
SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
Crohn Disease
The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease.
Cryptococcosis
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.
Cryptococcosis
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.
Cryptogenic Organizing Pneumonia
Cytokine profile of broncho-alveolar lavage in BOOP and UIP.
Cystic Fibrosis
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system.
Cystic Fibrosis
Effects of treatment in the levels of circulating cytokines and growth factors in cystic fibrosis and dialyzed patients by multi-analytical determination with a biochip array platform.
Cystic Fibrosis
Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays.
Cysts
Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
Cysts
Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Cysts
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial.
Cysts
Expression of adhesion molecules, chemokines and matrix metallo- proteinases (MMPs) in viable and degenerating stage of Taenia solium metacestode in swine neurocysticercosis.
Cysts
Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis.
Cysts
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Cysts
Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
Cytomegalovirus Infections
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.
Cytomegalovirus Infections
Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice.
Delirium
Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients.
Delirium
Dexmedetomidine Attenuates Lipopolysaccharide Induced MCP-1 Expression in Primary Astrocyte.
Delirium
Elevated Monocyte Chemoattractant Protein-1 as the Independent Risk Factor of Delirium after Cardiac Surgery. A Prospective Cohort Study.
Delirium
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients.
Dementia
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
Dementia
Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
Dementia
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.
Dementia
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment.
Dementia
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Dementia
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Dementia
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.
Dementia
Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia.
Dementia
MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes.
Dementia
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Dementia
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies.
Demyelinating Diseases
Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Demyelinating Diseases
Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing-remitting EAE in H-2b/s mice.
Demyelinating Diseases
Expression of chemokine genes in rat glial cells: the effect of myelin basic protein-reactive encephalitogenic T cells.
Demyelinating Diseases
Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease.
Demyelinating Diseases
Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression.
Demyelinating Diseases
MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling.
Demyelinating Diseases
Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve.
Demyelinating Diseases
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons.
Dengue
Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease.
Dengue
MCP-1 and MIP-1alpha expression in a model resembling early immune response to dengue.
Dengue
MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells.
Dengue
Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue.
Dermatitis
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
Dermatitis
Glucocorticoid insensitivity by staphylococcal enterotoxin B in keratinocytes of allergic dermatitis is associated with impaired nuclear translocation of the Glucocorticoid Receptor ?.
Dermatitis
Inhibitory Effect of Metalloproteinase Inhibitors on Skin Cell Inflammation Induced by Jellyfish Nemopilema nomurai Nematocyst Venom.
Dermatitis
Tumor necrosis factor-?, monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 increase during the development of a 2,4-dinitrofluorobenzene-induced immediate-type dermatitis in rats.
Dermatitis, Allergic Contact
MCP-1 produced by keratinocytes is associated with leucocyte recruitment during elicitation of nickel-induced occupational allergic contact dermatitis.
Dermatitis, Atopic
Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.
Dermatitis, Contact
Anti-inflammatory Effects of Brassica oleracea Var. capitata L. (Cabbage) Methanol Extract in Mice with Contact Dermatitis.
Dermatitis, Contact
Chemokine expression in trinitrochlorobenzene-mediated contact hypersensitivity.
Dermatitis, Contact
Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.
Dermatitis, Contact
Enhanced contact hypersensitivity in human monocyte chemoattractant protein-1 transgenic mouse.
Dermatitis, Contact
Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.
Dermatitis, Contact
MCP-1 Priming Enhanced the Therapeutic Effects of Human Mesenchymal Stromal Cells on Contact Hypersensitivity Mice by Activating the COX2-PGE2/STAT3 Pathway.
Dermatitis, Contact
[Analysis of contact hypersensitivity response in human monocyte chemoattractant protein (MCP)-1 transgenic mice]
Dermatomyositis
In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction.
Dermatomyositis
Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage.
Diabetes Complications
Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
Diabetes Complications
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis.
Diabetes Complications
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Diabetes Mellitus
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets.
Diabetes Mellitus
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Diabetes Mellitus
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
Diabetes Mellitus
Association of monocyte chemoattractant protein-1 gene 2518A/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis.
Diabetes Mellitus
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Diabetes Mellitus
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism.
Diabetes Mellitus
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Diabetes Mellitus
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Diabetes Mellitus
D-Psicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs.
Diabetes Mellitus
Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover.
Diabetes Mellitus
Enhancement of lens extraction-induced MCP-1 upregulation and microglia response in long-term diabetes via c-jun, stat1 and ERK.
Diabetes Mellitus
Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg.
Diabetes Mellitus
Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.
Diabetes Mellitus
Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus.
Diabetes Mellitus
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
Diabetes Mellitus
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Diabetes Mellitus
Maternal serum leptin, adiponectin, resistin and monocyte chemoattractant protein-1 levels in different types of diabetes mellitus.
Diabetes Mellitus
Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes.
Diabetes Mellitus
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Diabetes Mellitus
Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice.
Diabetes Mellitus
Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.
Diabetes Mellitus
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Diabetes Mellitus
The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Diabetes Mellitus
Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Diabetes Mellitus
[Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy].
Diabetes Mellitus
[Randomized controlled study on effects of the needling method for regulating spleen-stomach on coronary heart disease complicated by type 2 diabetes mellitus complicated]
Diabetes Mellitus, Experimental
Comparative Effect Of Curcumin Versus Liposomal Curcumin On Systemic Pro-Inflammatory Cytokines Profile, MCP-1 And RANTES In Experimental Diabetes Mellitus.
Diabetes Mellitus, Type 1
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets.
Diabetes Mellitus, Type 1
Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion.
Diabetes Mellitus, Type 1
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Diabetes Mellitus, Type 1
Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.
Diabetes Mellitus, Type 1
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes.
Diabetes Mellitus, Type 1
Gene expression analysis of human islets in a subject at onset of type 1 diabetes.
Diabetes Mellitus, Type 1
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.
Diabetes Mellitus, Type 1
Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes.
Diabetes Mellitus, Type 1
Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1? in Patients With Type 1 Diabetes.
Diabetes Mellitus, Type 1
Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice.
Diabetes Mellitus, Type 1
Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.
Diabetes Mellitus, Type 1
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes.
Diabetes Mellitus, Type 2
Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
Diabetes Mellitus, Type 2
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.
Diabetes Mellitus, Type 2
Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Diabetes Mellitus, Type 2
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.
Diabetes Mellitus, Type 2
Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
Diabetes Mellitus, Type 2
Association of monocyte chemoattractant protein-1 gene 2518A/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis.
Diabetes Mellitus, Type 2
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Diabetes Mellitus, Type 2
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism.
Diabetes Mellitus, Type 2
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Diabetes Mellitus, Type 2
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.
Diabetes Mellitus, Type 2
Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis.
Diabetes Mellitus, Type 2
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Circulating monocyte chemoattractant protein-1 in women with gestational diabetes.
Diabetes Mellitus, Type 2
Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1?, and TNF? levels in type 2 diabetes and insulin resistance.
Diabetes Mellitus, Type 2
Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover.
Diabetes Mellitus, Type 2
Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes.
Diabetes Mellitus, Type 2
Effects of Liraglutide Combined with Insulin on Oxidative Stress and Serum MCP-1 and NF-kB Levels in Type 2 Diabetes.
Diabetes Mellitus, Type 2
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial.
Diabetes Mellitus, Type 2
Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.
Diabetes Mellitus, Type 2
Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg.
Diabetes Mellitus, Type 2
Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro.
Diabetes Mellitus, Type 2
Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1 release in mature 3T3-L1 adipocytes: Possible regulatory mechanism through endogenous ER stress and AMPK-related pathways.
Diabetes Mellitus, Type 2
Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
Diabetes Mellitus, Type 2
MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
Diabetes Mellitus, Type 2
Methylation Status of CpG Sites in the MCP-1 Promoter is Correlated to Serum MCP-1 in type 2 Diabetes.
Diabetes Mellitus, Type 2
Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population.
Diabetes Mellitus, Type 2
Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy.
Diabetes Mellitus, Type 2
Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Diabetes Mellitus, Type 2
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Diabetes Mellitus, Type 2
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Diabetes Mellitus, Type 2
Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians.
Diabetes Mellitus, Type 2
Podocyte as a potential target of inflammation: role of pioglitazone hydrochloride in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Diabetes Mellitus, Type 2
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
Diabetes Mellitus, Type 2
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Diabetes Mellitus, Type 2
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Diabetes Mellitus, Type 2
The DNA methylation of TNF-aplha, MCP-1, and adiponectin in visceral adipose tissue is related to type 2 diabetes in Xinjiang Uygur population.
Diabetes Mellitus, Type 2
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Diabetes Mellitus, Type 2
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Diabetes Mellitus, Type 2
Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
Diabetes Mellitus, Type 2
[Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy].
Diabetes Mellitus, Type 2
[Randomized controlled study on effects of the needling method for regulating spleen-stomach on coronary heart disease complicated by type 2 diabetes mellitus complicated]
Diabetes, Gestational
Circulating levels of MCP-1 are increased in women with gestational diabetes.
Diabetes, Gestational
Circulating monocyte chemoattractant protein-1 in women with gestational diabetes.
Diabetic Angiopathies
Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.
Diabetic Foot
Correlation between IL-7 and MCP-1 in diabetic chronic non healing ulcer patients at higher risk of coronary artery disease.
Diabetic Foot
Silencing TNF? with lipidoid nanoparticles downregulates both TNF? and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
Diabetic Foot
The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer.
Diabetic Nephropathies
A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells.
Diabetic Nephropathies
A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?
Diabetic Nephropathies
ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.
Diabetic Nephropathies
Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
Diabetic Nephropathies
Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.
Diabetic Nephropathies
Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Diabetic Nephropathies
Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.
Diabetic Nephropathies
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Diabetic Nephropathies
Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Diabetic Nephropathies
Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Diabetic Nephropathies
Colchicine Attenuates Inflammatory Cells Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy.
Diabetic Nephropathies
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Diabetic Nephropathies
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Diabetic Nephropathies
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Diabetic Nephropathies
Effects of mycophenolate mofetil on the expression of monocyte chemoattractant protein-1 and fibronectin in high glucose cultured human mesangial cells.
Diabetic Nephropathies
Effects of Tumor Necrosis Factor-? on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy.
Diabetic Nephropathies
Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats.
Diabetic Nephropathies
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Diabetic Nephropathies
Ergosterol ameliorates renal inflammatory responses in mice model of diabetic nephropathy.
Diabetic Nephropathies
Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse.
Diabetic Nephropathies
Full composition granules of Huanglian (Rhizoma Coptidis) decrease the serum monocyte chemotactic protein-1 and connective tissue growth factor levels and inhibit kidney nuclear factor-?B expression in rats with high-fat diet-induced diabete.
Diabetic Nephropathies
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Diabetic Nephropathies
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.
Diabetic Nephropathies
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy.
Diabetic Nephropathies
Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
Diabetic Nephropathies
Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-?B Signaling Pathway.
Diabetic Nephropathies
Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats.
Diabetic Nephropathies
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
Diabetic Nephropathies
MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
Diabetic Nephropathies
Metformin inhibits TGF-beta 1-induced MCP-1 expression through BAMBI-mediated suppression of MEK/ERK1/2 signaling.
Diabetic Nephropathies
Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy.
Diabetic Nephropathies
miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression.
Diabetic Nephropathies
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.
Diabetic Nephropathies
Monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-{beta}, increases podocyte motility and albumin permeability.
Diabetic Nephropathies
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
Diabetic Nephropathies
NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
Diabetic Nephropathies
Nifedipine, a calcium-channel blocker, inhibits advanced glycation end-product-induced expression of monocyte chemoattractant protein-1 in human cultured mesangial cells.
Diabetic Nephropathies
Nuclear NF-?B p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.
Diabetic Nephropathies
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
Diabetic Nephropathies
Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy.
Diabetic Nephropathies
Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats.
Diabetic Nephropathies
Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.
Diabetic Nephropathies
Rosiglitazone ameliorates diabetic nephropathy by inhibiting reactive oxygen species and its downstream-signaling pathways.
Diabetic Nephropathies
Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.
Diabetic Nephropathies
Suppressor of Cytokine Signaling-1 Ameliorates Expression of MCP-1 in Diabetic Nephropathy.
Diabetic Nephropathies
Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Diabetic Nephropathies
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
Diabetic Nephropathies
TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1.
Diabetic Nephropathies
TRB3: an oxidant stress-induced pseudokinase with a potential to negatively modulate MCP-1 cytokine in diabetic nephropathy.
Diabetic Nephropathies
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.
Diabetic Nephropathies
Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Diabetic Nephropathies
Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.
Diabetic Nephropathies
Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
Diabetic Nephropathies
[Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy]
Diabetic Nephropathies
[Randomized and controlled study on needling method of harmonizing spleen-stomach for early intervention of diabetic nephropathies and the mechanism of protecting kidney]
Diabetic Retinopathy
Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Diabetic Retinopathy
Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Diabetic Retinopathy
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.
Diabetic Retinopathy
Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
Diabetic Retinopathy
ATF4 is a novel regulator of MCP-1 in microvascular endothelial cells.
Diabetic Retinopathy
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Diabetic Retinopathy
Effect of metformin and insulin combination on monocyte chemoattractant protein-1 and cathepsin-D in type 2 diabetes mellitus.
Diabetic Retinopathy
Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy.
Diabetic Retinopathy
Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Diabetic Retinopathy
Elevated serum monocyte chemoattractant protein-1 levels and its genetic polymorphism is associated with diabetic retinopathy in Chinese patients with Type 2 diabetes.
Diabetic Retinopathy
Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema.
Diabetic Retinopathy
Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism.
Diabetic Retinopathy
Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.
Diabetic Retinopathy
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Diabetic Retinopathy
Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro.
Dry Eye Syndromes
Corneal regeneration by conditioned medium of human uterine cervical stem cells is mediated by TIMP-1 and TIMP-2.
Dyslipidemias
Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia.
Dyslipidemias
Aging and Hyperglycemia Intensify Dyslipidemia-Induced Oxidative Stress and Inflammation in Rats: Assessment of Restorative Potentials of ALA and EPA + DHA.
Dyslipidemias
Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
Dyslipidemias
Dyslipidemia and Intraperitoneal Inflammation Axis in Peritoneal Dialysis Patients: A Cross-Sectional Pilot Study.
Dyslipidemias
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
Dyslipidemias
Obese Mexican American children have elevated MCP-1, TNF-?, monocyte concentration, and dyslipidemia.
Echinococcosis
Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region.
Eczema
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models.
Encephalitis
A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease.
Encephalitis
Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis.
Encephalitis
Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis.
Encephalitis
Correlations of cytokine levels in cerebrospinal fluid and peripheral blood with outcome of HHV-6B encephalitis after hematopoietic stem cell transplantation.
Encephalitis
Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation.
Encephalitis
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.
Encephalitis
Expression Kinetics of RANTES and MCP-1 in the Brain of Deer Mice (Peromyscus maniculatus) Infected with Vesicular Stomatitis New Jersey Virus.
Encephalitis
Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.
Encephalitis
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression.
Encephalitis
MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult.
Encephalitis
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Encephalitis
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Encephalitis
Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
Encephalitis
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Encephalitis
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Encephalitis
[Tick-borne encephalitis virus (TBEV) enhances the expression of MCP-1, CD68 and NF-?B in infected mouse brain tissue].
Encephalitis, Herpes Simplex
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Encephalitis, Japanese
Association of ICAM-1 (K469E) and MCP-1-2518 A?>?G polymorphism with risk of Japanese encephalitis in North Indian population.
Encephalitis, Tick-Borne
[Evaluation of soluble platelet cell adhesion molecule sPECAM-1 and chemokine MCP-1 (CCL2) concentration in CSF of patients with tick-borne encephalitis]
Encephalomyelitis
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Encephalomyelitis
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease.
Encephalomyelitis
Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.
Encephalomyelitis
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
Encephalomyelitis
MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation.
Encephalomyelitis
Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.
Encephalomyelitis
Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis.
Encephalomyelitis
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
Encephalomyelitis
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Encephalomyelitis, Autoimmune, Experimental
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1 alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats.
Encephalomyelitis, Autoimmune, Experimental
Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.
Encephalomyelitis, Autoimmune, Experimental
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
Encephalomyelitis, Autoimmune, Experimental
Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.
Encephalomyelitis, Autoimmune, Experimental
Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis.
Encephalomyelitis, Autoimmune, Experimental
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
Encephalomyelitis, Autoimmune, Experimental
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Endometrial Neoplasms
Expression of monocyte chemotactic protein-1 in human endometrial cancer cells and the effect of treatment with tamoxifen or buserelin.
Endometriosis
Addition of MCP-1 and MIP-3? to the IL-8 appraisal in peritoneal fluid enhances the probability of identifying women with endometriosis.
Endometriosis
Analysis of cytokines in the peritoneal fluid of endometriosis patients as a function of the menstrual cycle stage using the Bio-Plex® platform.
Endometriosis
Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis.
Endometriosis
Correlation between decreased type-II interleukin-1 receptor and increased monocyte chemotactic protein-1 expression in the endometrium of women with endometriosis.
Endometriosis
Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis.
Endometriosis
Differential flow cytometric detection of intracellular cytokines in peripheral and peritoneal mononuclear cells of women with endometriosis.
Endometriosis
Effect of IL-1 beta and TNF-alpha on the expression of monocyte chemotactic protein-1 in endometriotic cells.
Endometriosis
Effect of monocyte chemoattractant protein-1 and estradiol on the secretion of vascular endothelial growth factor in endometrial stromal cells in vitro.
Endometriosis
Effect of oxytocin treatment on explant size, plasma and peritoneal levels of MCP-1, VEGF, TNF-? and histopathological parameters in a rat endometriosis model.
Endometriosis
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial.
Endometriosis
Effects of 17?-estradiol on the release of monocyte chemotactic protein-1 and MAPK activity in monocytes stimulated with peritoneal fluid from endometriosis patients.
Endometriosis
Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis.
Endometriosis
Elevated Levels of Monocyte Chemotactic Protein-1 in the Follicular Fluid Reveals Different Populations among Women with Severe Endometriosis.
Endometriosis
Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.
Endometriosis
Endometrial stromal cells treated by tumor necrosis factor-? stimulate macrophages polarized toward M2 via interleukin-6 and monocyte chemoattractant protein-1.
Endometriosis
Endometriosis-associated changes in serum levels of interferons and chemokines.
Endometriosis
Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis.
Endometriosis
Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis.
Endometriosis
Expression of monocyte chemoattractant protein-1 in peritoneal endometriotic cells.
Endometriosis
Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis.
Endometriosis
Focal Adhesion Kinase-Mediated Sequences, Including Cell Adhesion, Inflammatory Response, and Fibrosis, as a Therapeutic Target in Endometriosis.
Endometriosis
Functional changes of immune cells: signal of immune tolerance of the ectopic lesions in endometriosis?
Endometriosis
Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis.
Endometriosis
Induction of monocyte chemotactic protein-1 in peritoneal mesothelial and endometrial cells by oxidized low-density lipoprotein and peritoneal fluid from women with endometriosis.
Endometriosis
Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility.
Endometriosis
Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization.
Endometriosis
Regulation of monocyte chemotactic protein-1 expression in human endometrial endothelial cells by sex steroids: a potential mechanism for leukocyte recruitment in endometriosis.
Endometriosis
Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis. Le groupe d'investigation en gynécologie.
Endometriosis
Serum tumor necrosis factor-?, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility.
Endometriosis
Soluble interleukin-1 receptor type II blocks monocyte chemotactic protein-1 secretion by U937 cells in response to peripheral blood serum of women with endometriosis.
Endometriosis
Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis.
Endometriosis
The G(-2518)A polymorphism of monocyte chemotactic protein-1 (MCP-1) and its serum and peritoneal fluid levels in Korean women with endometriosis.
Endometriosis
The Peritoneal Leptin, MCP-1 and TNF-? in the Pathogenesis of Endometriosis-Associated Infertility.
Endometriosis
The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation.
Endometriosis
TSLP induced by estrogen stimulates secretion of MCP-1 and IL-8 and growth of human endometrial stromal cells through JNK and NF-?B signal pathways.
Endometriosis
[Determination of monocyte chemotactic protein-1 in cultured endometriotic cells]
Endometriosis
[Expression of monocyte chemotacticp protein-1 in the eutopic endometrium of women with endometriosis]
Endophthalmitis
Elevated cytokine levels in vitreous as biomarkers of disease severity in infectious endophthalmitis.
Endophthalmitis
Intraocular Cytokine Levels in Post-Cataract Endophthalmitis and their Association with Visual Outcome.
Endotoxemia
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Endotoxemia
Acute alcohol intoxication and gadolinium chloride attenuate endotoxin-induced release of CC chemokines in the rat.
Endotoxemia
ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression.
Endotoxemia
Canscora lucidissima, a Chinese folk medicine, exerts anti-inflammatory activities by inhibiting the phosphorylation of ERK1/2 in LPS-activated macrophages.
Endotoxemia
Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta in chimpanzees.
Endotoxemia
Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia.
Endotoxemia
Impact of insulin on the intestinal microcirculation in a model of sepsis-related hyperglycemia.
Endotoxemia
MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult.
Endotoxemia
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.
Enteritis
Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
Enteritis
Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis.
Eosinophilia
Increased epithelial galectin-13 expression associates with eosinophilic airway inflammation in asthma.
Eosinophilia
Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks.
Eosinophilia
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.
Eosinophilia
[Clinical Symptoms and Mediators in the Allergic Early and Late Phase Reaction.]
Epilepsy
Cellular injury and neuroinflammation in children with chronic intractable epilepsy.
Epilepsy
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Epilepsy
Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
Epilepsy
Pyrrolidine dithiocarbamate (PDTC) inhibits the overexpression of MCP-1 and attenuates microglial activation in the hippocampus of a pilocarpine-induced status epilepticus rat model.
Epiretinal Membrane
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Epiretinal Membrane
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Epiretinal Membrane
Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Epiretinal Membrane
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Epiretinal Membrane
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Epstein-Barr Virus Infections
Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2.
Erythema
A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats.
Escherichia coli Infections
Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli.
Escherichia coli Infections
Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection.
Esophageal Achalasia
Multiplex immunoassays reveal increased serum cytokines and chemokines associated with the subtypes of achalasia.
Esophageal Squamous Cell Carcinoma
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Esophagitis
Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease?
Esophagitis, Peptic
Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease?
Essential Hypertension
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
Essential Hypertension
Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension.
Essential Hypertension
Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.
Familial Primary Pulmonary Hypertension
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Farber Lipogranulomatosis
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
Fatty Liver
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Fatty Liver
Chlorella Protein Hydrolysate Attenuates Glucose Metabolic Disorder and Fatty Liver in High-fat Diet-induced Obese Mice.
Fatty Liver
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Fatty Liver
Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
Fatty Liver
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Fatty Liver
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
Fatty Liver
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.
Fatty Liver
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet.
Fatty Liver
Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.
Fatty Liver
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Fatty Liver
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Fatty Liver
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Fatty Liver
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Fatty Liver
[Effects and mechanisms of punicosides on acute alcoholic liver damage in mice].
Fatty Liver, Alcoholic
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Fibromyalgia
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
Fibromyalgia
High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia.
Foot Ulcer
Silencing TNF? with lipidoid nanoparticles downregulates both TNF? and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
Foot Ulcer
The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer.
Frontotemporal Lobar Degeneration
MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.
Fuchs' Endothelial Dystrophy
Preoperative Aqueous Cytokine Levels are Associated With Endothelial Cell Loss After Descemet's Stripping Automated Endothelial Keratoplasty.
Gastritis
Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells.
Gastritis
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Gastritis
Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1? expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice.
Gastroenteritis
Monocyte Chemoattractant Protein (MCP)-1 in Rotavirus-Associated White Matter Injury in Newborns.
Giant Cell Arteritis
MCP-1 gene haplotype association in biopsy proven giant cell arteritis.
Giant Cell Arteritis
Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.
Gingivitis
Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Gingivitis
Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases.
Gingivitis
Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease.
Glaucoma
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
Glaucoma
Monocyte Chemotactic Protein-1 Level in the Aqueous Humor as a Prognostic Factor for the Outcome of Trabeculectomy.
Glaucoma
Tear Cytokine Profile in Medicated Glaucoma Patients Effect of Monocyte Chemoattractant Protein 1 on Early Posttrabeculectomy Outcome.
Glaucoma, Neovascular
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Glioblastoma
A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
Glioblastoma
Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology.
Glioblastoma
Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells.
Glioblastoma
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
Glioblastoma
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro.
Glioblastoma
Interleukin-8 and monocyte chemotactic protein-1 production by a human glioblastoma cell line, T98G in coculture with monocytes: involvement of monocyte-derived interleukin-1alpha.
Glioblastoma
MCP-1 and MIP-3? Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
Glioblastoma
Role of Cysteine-rich 61 Protein (CCN1) in Macrophage-mediated Oncolytic Herpes Simplex Virus Clearance.
Glioblastoma
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen.
Glioma
A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
Glioma
ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.
Glioma
Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma.
Glioma
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: Involvement of ATP and P2X(7) receptor.
Glioma
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X? receptor.
Glioma
Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Glioma
Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium.
Glioma
Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE.
Glioma
Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form.
Glioma
Increased monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha can mediate macrophage infiltration in gliomas.
Glioma
Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.
Glioma
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.
Glioma
Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells.
Glioma
Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells.
Glioma
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Glioma
Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells.
Glioma
The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme.
Glioma
Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.
Glioma
Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor.
Gliosarcoma
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Glomerulonephritis
A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats.
Glomerulonephritis
AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis.
Glomerulonephritis
CCAAT/enhancer-binding protein-delta is induced in mesangial area during the early stages of anti-Thy1.1 glomerulonephritis and regulates cell proliferation and inflammatory gene expression in cultured rat mesangial cells.
Glomerulonephritis
Cell to cell interaction between mesangial cells and macrophages induces the expression of monocyte chemoattractant protein-1 through nuclear factor-kappaB activation.
Glomerulonephritis
Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection.
Glomerulonephritis
Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis.
Glomerulonephritis
Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
Glomerulonephritis
Efficacy of antisense monocyte chemoattractant protein-1 (MCP-1) in a rat model of mesangial proliferative glomerulonephritis.
Glomerulonephritis
Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.
Glomerulonephritis
IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells.
Glomerulonephritis
Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Glomerulonephritis
Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice.
Glomerulonephritis
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Glomerulonephritis
KLF6 Acetylation Promotes Sublytic C5b-9-Induced Production of MCP-1 and RANTES in Experimental Mesangial Proliferative Glomerulonephritis.
Glomerulonephritis
MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis.
Glomerulonephritis
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
Glomerulonephritis
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
Glomerulonephritis
Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis.
Glomerulonephritis
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment.
Glomerulonephritis
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1.
Glomerulonephritis
Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Glomerulonephritis
Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells.
Glomerulonephritis
Production of monocyte chemoattractant protein-1 by cultured glomerular epithelial cells: inhibition by dexamethasone.
Glomerulonephritis
Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury.
Glomerulonephritis
Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides.
Glomerulonephritis
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
Glomerulonephritis
The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
Glomerulonephritis
Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study.
Glomerulonephritis
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Glomerulonephritis
Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
Glomerulonephritis
[Expression of monocyte chemoattractant protein-1 in experimental rat glomerulonephritis is mediated by NF-kappaB/IkappaB signal pathway]
Glomerulonephritis, IGA
Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
Glomerulonephritis, IGA
Enhanced expression of C chemokine lymphotactin in IgA nephropathy.
Glomerulonephritis, IGA
Evaluation of TGF-?1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
Glomerulonephritis, IGA
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Glomerulonephritis, IGA
Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis.
Glomerulonephritis, IGA
No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy.
Glomerulonephritis, IGA
Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Glomerulonephritis, IGA
Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Glomerulonephritis, IGA
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Glomerulonephritis, IGA
Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis.
Glomerulonephritis, IGA
Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy.
Glomerulonephritis, IGA
Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor ?1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Glomerulonephritis, IGA
[Effects of Artesunate on MCP-1 and MCP-1 mRNA expression of renal tissue in the rat IgA nephropathy model]
Glomerulonephritis, IGA
[Effects of astragalus on renal tubulointerestitial lesions and expression of NF-kappaB and MCP-1 in renal tissues in rat experimental IgA nephropathy]
Glomerulonephritis, IGA
[Expression of MCP-1 in renal tissues of patients with IgA nephropathy]
Glomerulonephritis, Membranous
Effects of sodium houttuyfonate on expression of NF-kappaB and MCP-1 in membranous glomerulonephritis.
Glomerulonephritis, Membranous
Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis.
Glomerulonephritis, Membranous
Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.
Glomerulonephritis, Membranous
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Glomerulosclerosis, Focal Segmental
Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor ?1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Glucose Intolerance
Adverse Effects of Methylglyoxal on Transcriptome and Metabolic Changes in Visceral Adipose Tissue in a Prediabetic Rat Model.
Glucose Intolerance
Early Onset Inflammation in Pre-Insulin-Resistant Diet-Induced Obese Rats Does Not Affect the Vasoreactivity of Isolated Small Mesenteric Arteries.
Glucose Intolerance
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Glucose Intolerance
Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.
Glucose Intolerance
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Glucose Intolerance
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Glucose Intolerance
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Glucose Intolerance
The Effects of High-Protein Diet and Resistance Training on Glucose Control and Inflammatory Profile of Visceral Adipose Tissue in Rats.
Glucose Intolerance
The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity.
Gout
Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL/6 mice.
Gout
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Gout
Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients.
Gram-Positive Bacterial Infections
Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.
Gram-Positive Bacterial Infections
Enhanced wound-healing performance of a phyto-polysaccharide-enriched dressing - a preclinical small and large animal study.
Granuloma
A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-?B signaling in mice.
Granuloma
Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo.
Granuloma
Augmentation of monocyte chemotactic protein-1 and mRNA transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo.
Granuloma
Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.
Granuloma
Detection of Experimentally Induced Pulmonary Granuloma Inflammation in Monocyte Chemoattractant Protein-1 Reporter Mice.
Granuloma
Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Granuloma
Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.
Granuloma
Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits.
Granuloma
Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.
Granuloma
Hesperidin methyl chalcone alleviates spinal tuberculosis in New Zealand white rabbits by suppressing immune responses.
Granuloma
Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis.
Granuloma
Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model.
Granuloma
Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells.
Granuloma
Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis.
Granuloma
Monocyte chemotactic protein-1 gene expression and translation in formed granulomatous calcified tissue in vivo.
Granuloma
Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks.
Granuloma
Neutrophils and reactive oxygen intermediates mediate glucan-induced pulmonary granuloma formation through the local induction of monocyte chemoattractant protein-1.
Granuloma
Nitric oxide interaction with IL-10, MIP-1alpha, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis.
Granuloma
Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis.
Granuloma
Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression.
Granuloma
Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts.
Granuloma
Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1.
Granuloma
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.
Granuloma
Role of monocyte chemoattractant protein-1 in Propionibacterium acnes-induced pulmonary granulomatosis.
Graves Ophthalmopathy
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
Graves Ophthalmopathy
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
Hamman-Rich Syndrome
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Hand, Foot and Mouth Disease
Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.
Head and Neck Neoplasms
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Hearing Loss
Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.
Heart Arrest
Minimal changes of TNF-alpha and MCP-1 expression in blood serum of rats subjected to experimental cardiac arrest.
Heart Diseases
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Heart Diseases
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.
Heart Diseases
Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: a family-based investigation.
Heart Diseases
MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP.
Heart Diseases
MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Heart Failure
Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling.
Heart Failure
Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells.
Heart Failure
Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.
Heart Failure
Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-? Signaling.
Heart Failure
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Heart Failure
Dobutamine inhibits monocyte chemoattractant protein-1 production and chemotaxis in human monocytes.
Heart Failure
Elevated circulating levels of C-C chemokines in patients with congestive heart failure.
Heart Failure
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.
Heart Failure
Galectin-3 Is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes.
Heart Failure
Induction of early biomarkers in a thrombus-induced sheep model of ischemic heart failure.
Heart Failure
MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP.
Heart Failure
Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction.
Heart Failure
Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure.
Heart Failure
Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy.
Heart Failure
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
Heart Failure
Nutrient intake and serum level of gamma-glutamyltransferase, MCP-1 and homocysteine in early stages of heart failure.
Heart Failure
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure.
Heart Failure
Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure.
Heart Failure
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
Heart Failure
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Heart Failure
Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.
Heart Failure
The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.
Heart Failure
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Heart Rupture
Improved survival rate after myocardial infarction using an inducible cholesterol efflux (iCE) peptide: FAMP.
Hemangioendothelioma
Nox-4 Dependent Nuclear H2O2 Drives DNA Oxidation Resulting in 8-OHdG as Urinary Biomarker and Hemangioendothelioma Formation.
Hemangioma
Berry anthocyanins as novel antioxidants in human health and disease prevention.
Hemangioma
Hemangioma model for in vivo angiogenesis: inducible oxidative stress and MCP-1 expression in EOMA cells.
Hemangioma
Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations.
Hemangioma
Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.
Hemangioma
Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Hemarthrosis
Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model.
Hemochromatosis
Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Hemophilia A
IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis.
Hemophilia A
Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model.
Hemorrhagic Fever, Crimean
Association of MCP-1 promotor polymorphism with disease severity of Crimean-Congo hemorrhagic fever.
Hemorrhagic Stroke
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
Henipavirus Infections
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatic Encephalopathy
Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
Hepatitis
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Hepatitis
Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10.
Hepatitis
Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration.
Hepatitis
Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.
Hepatitis B
RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
Hepatitis B, Chronic
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.
Hepatitis B, Chronic
Relationship among MIF, MCP-1, viral loads, and HBs Ag levels in chronic hepatitis B patients.
Hepatitis B, Chronic
[Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease].
Hepatitis C
Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES.
Hepatitis C
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Hepatitis C
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Hepatitis C
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatitis C
[TLR9 expression and its relationship with MCP-1 and TNF-? in HCV-stimulated BV2 cells].
Hepatitis C, Chronic
Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C.
Hepatitis C, Chronic
Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C.
Hepatitis C, Chronic
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Hepatitis C, Chronic
Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.
Hepatitis C, Chronic
Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Hepatitis C, Chronic
The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection.
Hepatitis C, Chronic
[Chronic HCV-infection and expression of mRNA of CC-chemokines and their receptors]
Hepatitis, Alcoholic
Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
Hepatitis, Chronic
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Hepatitis, Chronic
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
Hepatomegaly
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Hepatopulmonary Syndrome
Mcp-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes in hepatopulmonary syndrome.
Herpes Simplex
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.
HIV Infections
Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
HIV Infections
Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells.
HIV Infections
Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells.
HIV Infections
Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.
HIV Infections
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression.
HIV Infections
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
HIV Infections
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.
HIV Infections
Potential gingival crevicular fluid and serum biomarkers by stage of HIV infection.
HIV Infections
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
HIV Infections
Upregulation of MHC class II, interferon-alpha and interferon-gamma receptor protein expression in HIV-associated nephropathy.
Hodgkin Disease
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Homozygous Familial Hypercholesterolemia
Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.
HTLV-I Infections
Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
Huntington Disease
Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction.
Hydronephrosis
Diagnostic value of urinary RBP, ALB and AQP2 in neonatal hydronephrosis and the relationship with expression of MCP-1 in the prenatal maternal peripheral blood.
Hydronephrosis
Urinary biomarkers can identify the need for pyeloplasty in presence of supranormal differential renal function in antenatally diagnosed unilateral hydronephrosis.
Hydronephrosis
Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.
Hydronephrosis
Urinary IP-10, MCP-1, NGAL, Cystatin-C, and KIM-1 Levels in Prenatally Diagnosed Unilateral Hydronephrosis: The Search for an Ideal Biomarker.
Hyperalgesia
ATP-sensitive potassium channels alleviate postoperative pain through JNK-dependent MCP-1 expression in spinal cord.
Hyperalgesia
Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican.
Hyperalgesia
Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain.
Hyperalgesia
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Hyperalgesia
Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1.
Hyperalgesia
Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats.
Hyperalgesia
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
Hyperalgesia
miR-125a-5p in astrocytes attenuates peripheral neuropathy in type 2 diabetic mice through targeting TRAF6.
Hyperalgesia
Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain.
Hyperalgesia
Monocyte chemoattractant protein-1-induced excitation and sensitization to mechanical stimulation of mechanosensitive C-fiber afferents in rat skin.
Hyperalgesia
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.
Hyperalgesia
PI3K/Akt Signaling Pathway may be involved in MCP-1-induced P2X4R Expression in cultured microglia and Cancer-induced Bone Pain Rats.
Hyperalgesia
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat.
Hyperalgesia
Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats.
Hyperalgesia
Spinal injection of TNF-?-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.
Hyperalgesia
Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis.
Hyperandrogenism
Does oral contraceptive pill increase plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1 and Tumor Necrosis Factor-? levels in women with Polycystic Ovary Syndrome (PCOS): A pilot study.
Hypercholesterolemia
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Hypercholesterolemia
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
Hypercholesterolemia
Chronic exercise reduces adhesion molecules/iNOS expression and partially reverses vascular responsiveness in hypercholesterolemic rabbit aortae.
Hypercholesterolemia
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.
Hypercholesterolemia
Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats.
Hypercholesterolemia
Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
Hypercholesterolemia
Probucol plus cilostazol attenuate hypercholesterolemia?induced exacerbationin ischemic brain injury via anti-inflammatory effects.
Hypercholesterolemia
[Increase of choroidal and scleral MCP-1 expression in hypercholesterolemia experimental model].
Hyperemia
Vascular effects of simvastatin combined with ramipril in hypercholesterolemic patients with coronary artery disease, compared with simvastatin alone: a randomized, double-blind, placebo-controlled, crossover study.
Hypereosinophilic Syndrome
The roles of MCP-1 and protein kinase Cdelta activation in human eosinophilic leukemia EoL-1 cells.
Hyperglycemia
Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.
Hyperglycemia
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Hyperglycemia
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes.
Hyperglycemia
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Hyperglycemia
Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats.
Hyperglycemia
Effect of short-term hyperglycemia on adipose tissue fluxes of selected cytokines in vivo during multiple phases of diet-induced weight loss in obese women.
Hyperglycemia
Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
Hyperglycemia
High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells.
Hyperglycemia
Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK/PI3K/AKT-mediated oxidative stress.
Hyperglycemia
Hyperglycemia induces NF-?B activation and MCP-1 expression via downregulating GLP-1R expression in rat mesangial cells: inhibition by metformin.
Hyperglycemia
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Hyperglycemia
Monocyte Chemoattractant Protein 1 Is Correlated With Glycemic Control and Peripheral Arterial Disease in Type 2 Diabetic Patients With Metabolic Syndrome.
Hyperglycemia
Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.
Hyperglycemia
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Hyperglycemia
Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice.
Hyperglycemia
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Hyperglycemia
The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.
Hyperhomocysteinemia
Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems.
Hyperhomocysteinemia
Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation.
Hyperhomocysteinemia
Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation.
Hyperhomocysteinemia
Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-?B/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice.
Hyperhomocysteinemia
Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules.
Hyperhomocysteinemia
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Hyperhomocysteinemia
Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages.
Hyperhomocysteinemia
[Folate reduces monocyte chemoattractant protein-1 expression in rats with hyperhomocysteinemia]
Hyperinsulinism
Effect of Ursolic Acid on Insulin Resistance and Hyperinsulinemia in Rats with Diet-Induced Obesity: Role of Adipokines Expression.
Hyperinsulinism
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Hyperinsulinism
Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin.
Hyperinsulinism
Moringa oleifera Lam. leaf extracts reverse metabolic syndrome in Sprague Dawley rats fed high-fructose high fat diet for 60-days.
Hyperinsulinism
[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]
Hyperlipidemias
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Hyperlipidemias
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Hyperlipidemias
Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.
Hyperlipidemias
Evidence on n-3 Fatty Acids and Oleic Acid Role in Retinal Inflammation and Microvascular Integrity: Insight from a Hyperlipidemic Rat Model.
Hyperlipidemias
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
Hyperlipidemias
Possible involvement of PI3K-dependent pathways in the increased VEGF120 release from osteoblastic cells preloaded with palmitate in vitro.
Hyperlipidemias
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
Hyperlipidemias
Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
Hyperlipidemias
The expression of monocyte chemoattractant protein-1 and C-C chemokine receptor 2 in post-kidney transplant patients and the influence of simvastatin treatment.
Hyperlipidemias
[Effect of electroacupuncture stimulation of "Fenglong" (ST 40) on expression of inflammatory cytokines of celiac macrophages in hyperlipidemia rats].
Hyperlipoproteinemias
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.
Hyperlipoproteinemias
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb.
Hyperoxaluria
Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice.
Hypersensitivity
Anti-Inflammatory and Immunomodulatory Effects of Bortezomib in Various in vivo Models.
Hypersensitivity
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments.
Hypersensitivity
Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1 /CCR2.
Hypersensitivity
Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects.
Hypersensitivity
Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy induced peripheral neuropathy.
Hypersensitivity
Effect of roasted peanut allergen Ara h 3 protein on the sensitization of Caco-2 cells.
Hypersensitivity
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
Hypersensitivity
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Hypersensitivity
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
Hypersensitivity
Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1.
Hypersensitivity
Ligustilide attenuates inflammatory pain via inhibition of NF?B-mediated chemokines production in spinal astrocytes.
Hypersensitivity
Monocyte chemoattractant peptide-1 expression during cutaneous allergic reactions in mice is mast cell dependent and largely mediates the monocyte recruitment response.
Hypersensitivity
Monocyte Chemoattractant Protein 1 Expression in Synovial Fluid of Patients With Total Hip Arthroplasty.
Hypersensitivity
Role of quercetin (a natural herbal compound) in allergy and inflammation.
Hypersensitivity
Transgenic Mice Expressing MCP-1 by the Urothelium Demonstrate Bladder Hypersensitivity, Pelvic Pain and Voiding Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
Hypersensitivity, Delayed
Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1.
Hypersensitivity, Immediate
Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1 /CCR2.
Hypertension
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Hypertension
Adrenomedullin inhibits pressure-induced mesangial MCP-1 expression through activation of protein kinase A.
Hypertension
Angiotensin ? Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
Hypertension
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.
Hypertension
Anti-inflammatory Effects of ?-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II-Dependent Hypertension.
Hypertension
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Hypertension
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Hypertension
Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients.
Hypertension
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
Hypertension
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study.
Hypertension
Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.
Hypertension
Co-Inheritance of Autosomal Dominant Polycystic Kidney Disease and Naevoid Basal Cell Carcinoma Syndrome: Effects on Renal Progression.
Hypertension
Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
Hypertension
Decreased effectiveness of ischemic heart preconditioning in the state of chronic inflammation.
Hypertension
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Hypertension
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Hypertension
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease.
Hypertension
Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney.
Hypertension
Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure.
Hypertension
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
Hypertension
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Hypertension
Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Hypertension
Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
Hypertension
MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects.
Hypertension
MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant Hypertension.
Hypertension
Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone.
Hypertension
Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats.
Hypertension
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Hypertension
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Hypertension
Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
Hypertension
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
Hypertension
Peroxisome Proliferator Activated Receptor-? Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.
Hypertension
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
Hypertension
Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase.
Hypertension
Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD.
Hypertension
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Hypertension
Role of aortic stiffness and inflammation in the etiology of young-onset hypertension
Hypertension
Sang-qi Granula Reduces Blood Pressure and Myocardial Fibrosis by Suppressing Inflammatory Responses Associated with the Peroxisome Proliferator-Activated Receptors and Nuclear Factor ? B Protein in Spontaneously Hypertensive Rats.
Hypertension
Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
Hypertension
Sex-, Age-, and Metabolic Disorder-Dependent Distributions of Selected Inflammatory Biomarkers among Community-Dwelling Adults.
Hypertension
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.
Hypertension
Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms.
Hypertension
Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
Hypertension
[Expression of monocyte chemoattractant protein-1 in aorta of early hypertensive rats]
Hypertension
[Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes]
Hypertension
[The role of monocyte chemotactic peptide (MCP-1) in chronic renal allograft rejection]
Hypertension, Portal
Does hepatic vagus nerve modulate the progression of biliary fibrosis in rats?
Hypertension, Portal
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
Hypertension, Pregnancy-Induced
Characterization of maternal plasma biomarkers associated with delivery of small and large for gestational age infants in the MIREC study cohort.
Hypertension, Pulmonary
Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1.
Hypertension, Pulmonary
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Hypertension, Pulmonary
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension.
Hypertension, Pulmonary
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
Hyperthyroidism
Increased susceptibility of hyperthyroid rats to ozone: early events and mechanisms.
Hyperthyroidism
Influence of hyperthyroidism on rat lung cytokine production and nuclear factor-kappaB activation following ozone exposure.
Hypertriglyceridemia
Association between serum cytokine concentrations and the presence of hypertriglyceridemia.
Hypertriglyceridemia
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Hypertriglyceridemia
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Hypertrophy, Left Ventricular
MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant Hypertension.
Hypertrophy, Left Ventricular
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Hypertrophy, Left Ventricular
Thiazide diuretics, endothelial function, and vascular oxidative stress.
Hypertrophy, Right Ventricular
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats.
Hypotension
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
Hypothyroidism
Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis.
Hypoxia-Ischemia, Brain
Blood Biomarkers and 6- to 7-Year Childhood Outcomes Following Neonatal Encephalopathy.
Idiopathic Interstitial Pneumonias
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Idiopathic Pulmonary Fibrosis
Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Idiopathic Pulmonary Fibrosis
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
IgA Vasculitis
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Ileitis
Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice.
Immune Complex Diseases
Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.
Immune Complex Diseases
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
Immune System Diseases
[Effect of intravenous lornoxicam at different doses on the immune function in patients undergoing total abdominal hysterectomy.]
Immunoglobulin G4-Related Disease
Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.
Infarction, Middle Cerebral Artery
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment.
Infarction, Middle Cerebral Artery
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.
Infarction, Middle Cerebral Artery
Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats.
Infarction, Middle Cerebral Artery
MIP-1alpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke.
Infarction, Middle Cerebral Artery
Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.
Infarction, Middle Cerebral Artery
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Infarction, Middle Cerebral Artery
Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.
Infarction, Middle Cerebral Artery
Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression.
Infarction, Middle Cerebral Artery
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Infarction, Middle Cerebral Artery
The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
Infarction, Middle Cerebral Artery
The Neurovascular Protective Effect of S14G-Humanin in a Murine MCAO Model and Brain Endothelial Cells.
Infections
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Infections
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
Infections
A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.
Infections
A MyD88-dependent IFN?R-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge.
Infections
A novel CCR-2/TLR-2 triggered signaling in murine peritoneal macrophages intensifies bacterial (Staphylococcus aureus) killing by reactive oxygen species through TNF-R1.
Infections
A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease.
Infections
Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice.
Infections
Activating transcription factor 4 (ATF4) is upregulated by human herpesvirus 8 infection, increases virus replication and promotes proangiogenic properties.
Infections
Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm.
Infections
Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice.
Infections
Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-? and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors.
Infections
Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells.
Infections
Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection.
Infections
Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo.
Infections
Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation.
Infections
Adrenal Steroids Modulate Fibroblast-Like Synoviocytes Response During B. abortus Infection.
Infections
Aging Reduces the Expression of Lung CINC and MCP-1 mRNA in a P. aeruginosa Rat Model of Infection.
Infections
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections.
Infections
An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities.
Infections
An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions.
Infections
Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection.
Infections
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.
Infections
Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion.
Infections
Arcobacter butzleri Induce Colonic, Extra-Intestinal and Systemic Inflammatory Responses in Gnotobiotic IL-10 Deficient Mice in a Strain-Dependent Manner.
Infections
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
Infections
Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections.
Infections
Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function.
Infections
Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.
Infections
Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.
Infections
Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.
Infections
Breast Milk from Tanzanian Women Has Divergent Effects on Cell-Free and Cell-Associated HIV-1 Infection In Vitro.
Infections
Brucella abortus Proliferates in Decidualized and Non-Decidualized Human Endometrial Cells Inducing a Proinflammatory Response.
Infections
Brucella invasion of human intestinal epithelial cells elicits a weak proinflammatory response but a significant CCL20 secretion.
Infections
CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.
Infections
CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.
Infections
CCR5, MCP-1 and VDR Gene Polymorphisms Are Associated with the Susceptibility to HBV Infection.
Infections
Central Nervous System Inflammation and Infection During Early, Non-Accelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
Infections
Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells.
Infections
Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection.
Infections
Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment with the Synthetic Immunomodulatory Peptide IDR-1002.
Infections
Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.
Infections
Chemokine induction and leukocyte trafficking to the lungs during murine gammaherpesvirus 68 (MHV-68) infection.
Infections
Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus.
Infections
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.
Infections
Chlamydia trachomatis infection modulates trophoblast cytokine/chemokine production.
Infections
Chronic Exercise Reduces Illness Severity, Decreases Viral Load, and Results in Greater Anti-Inflammatory Effects than Acute Exercise during Influenza Infection.
Infections
Circulating cytokine portraits can differentiate between allograft rejection and pulmonary infection in cardiac transplant rats.
Infections
Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
Infections
Circulating cytokines, chemokines, and stress hormones are increased in patients with organ dysfunction following liver resection.
Infections
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.
Infections
Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1.
Infections
Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models.
Infections
Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
Infections
Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children.
Infections
Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection.
Infections
Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.
Infections
Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis.
Infections
Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus: obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment.
Infections
Cytokine profile and cytoskeletal changes after herpes simplex virus type 1 infection in human trabecular meshwork cells.
Infections
Cytokine profiles, signalling pathways and effects of fluticasone propionate in respiratory syncytial virus-infected human foetal lung fibroblasts.
Infections
Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome.
Infections
Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.
Infections
Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1.
Infections
Data showing differential expression of Monocyte chemoattractant protein-1 in response to symptomatic and asymptomatic T. vaginalis infection.
Infections
Defense against influenza A virus infection: essential role of the chemokine system.
Infections
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
Infections
Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
Infections
Detection of serum MCP-1 and TGF-?1 in polymyositis/dermatomyositis patients and its significance.
Infections
Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Infections
Differences in pig respiratory tract and peripheral blood immune responses to Actinobacillus pleuropneumoniae.
Infections
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration.
Infections
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
Infections
Differential expression of chemokines by human retinal pigment epithelial cells infected with cytomegalovirus.
Infections
Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections.
Infections
Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.
Infections
Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells.
Infections
Differential regulation of chemokine secretion in tuberculous and staphylococcal osteomyelitis.
Infections
Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.
Infections
Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery.
Infections
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Infections
Dual-Specificity Phosphatase 12 Targets p38 MAP Kinase to Regulate Macrophage Response to Intracellular Bacterial Infection.
Infections
Dynamics of transcription of immunomodulatory genes in endothelial cells infected with different coccidian parasites.
Infections
Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.
Infections
Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study.
Infections
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.
Infections
Effect of 10 pharmacologic probes on mRNA levels of inducible nitric oxide synthetase and selected inflammatory cytokines in a rat model of acute otitis media.
Infections
Effect of Bisphenol A on non-specific immunodefenses against non-pathogenic Escherichia coli.
Infections
Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection.
Infections
Effect of fetal calf serum on cytokine release by bone marrow-derived macrophages during infection with intracellular bacteria.
Infections
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.
Infections
Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures.
Infections
Exposure to urban air particulates alters the macrophage-mediated inflammatory response to respiratory viral infection.
Infections
Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-kappaB.
Infections
Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae.
Infections
Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis.
Infections
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Infections
Gamma Interferon and Interleukin-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas aeruginosa Infection.
Infections
Gastric lesions and immune responses caused by long-term infection with Helicobacter heilmannii in C57BL/6 mice.
Infections
Glial Cell-Elicited Activation of Brain Microvasculature in Response to Brucella abortus Infection Requires ASC Inflammasome-Dependent IL-1? Production.
Infections
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
Infections
GS-9620 inhibits enterovirus 71 replication mainly through the NF-?B and PI3K-AKT signaling pathways.
Infections
Heme Oxygenase-1 and Carbon Monoxide Promote Burkholderia pseudomallei Infection.
Infections
HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines.
Infections
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Infections
Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).
Infections
Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1.
Infections
Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes.
Infections
Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-kappaB pathway.
Infections
Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells.
Infections
Human intestinal epithelial cell cytokine mRNA responses mediated by NF-kappaB are modulated by the motility and adhesion process of Vibrio cholerae.
Infections
Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
Infections
Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I:C), or zymosan.
Infections
Identification of defective early immune responses to Burkholderia pseudomallei infection in a diet-induced murine model of type 2 diabetes.
Infections
Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial pneumonia.
Infections
IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.
Infections
Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems.
Infections
Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.
Infections
Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model.
Infections
Impaired cytokine expression, neutrophil infiltration, and bacterial clearance in response to urinary tract infection in diabetic mice.
Infections
Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice.
Infections
In situ cytokines (IL-4, IL-10, IL-12, IFN-?) and chemokines (MCP-1, MIP-1?) gene expression in human Leishmania (Leishmania) Mexicana infection.
Infections
Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis.
Infections
Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.
Infections
Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Infections
Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB.
Infections
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.
Infections
Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli.
Infections
Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression.
Infections
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro.
Infections
Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis.
Infections
Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice.
Infections
Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells.
Infections
Infection with Leishmania major induces a cellular stress response in macrophages.
Infections
Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans.
Infections
Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.
Infections
Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury.
Infections
Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
Infections
Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation.
Infections
Inhibitory effect of polysaccharide of Sargassum weizhouense on PCV2 induced inflammation in mice by suppressing histone acetylation.
Infections
Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection.
Infections
Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.
Infections
Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice.
Infections
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.
Infections
JNK regulates MCP-1 expression in adenovirus type 19-infected human corneal fibroblasts.
Infections
Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells.
Infections
Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis.
Infections
Legionella pneumophila Type II Secretion Dampens the Cytokine Response of Infected Macrophages and Epithelia.
Infections
Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Infections
Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses.
Infections
Lipoteichoic acid of Enterococcus faecalis induces the expression of chemokines via TLR2 and PAFR signaling pathways.
Infections
Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections.
Infections
Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes.
Infections
Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice.
Infections
Macrophages of different tissue origin exhibit distinct inflammatory responses to mycobacterial infection.
Infections
Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
Infections
Mathematical Modeling of the Biomarker Milieu to Characterize Preterm Birth and Predict Adverse Neonatal Outcomes.
Infections
Mayaro Virus Replication Restriction and Induction of Muscular Inflammation in Mice Are Dependent on Age, Type-I Interferon Response, and Adaptive Immunity.
Infections
MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis.
Infections
Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells.
Infections
Mechanisms of Porphyromonas gingivalis-induced monocyte chemoattractant protein-1 expression in endothelial cells.
Infections
Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.
Infections
Melatonin and Leishmania amazonensis Infection Altered miR-294, miR-30e, and miR-302d Impacting on Tnf, Mcp-1, and Nos2 Expression.
Infections
Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.
Infections
Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammation.
Infections
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Infections
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Infections
Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.
Infections
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.
Infections
Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines.
Infections
Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia.
Infections
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
Infections
Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.
Infections
Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.
Infections
Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response.
Infections
mRNA expression of cytokines and chemokines in the normal gastric surface mucous epithelial cell line GSM06 during bacterial infection with Helicobacter felis.
Infections
Mumps virus induces innate immune responses in mouse ovarian granulosa cells through the activation of Toll-like receptor 2 and retinoic acid-inducible gene I.
Infections
Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice.
Infections
MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection.
Infections
Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway.
Infections
Negative regulation of lung inflammation and immunopathology by TNF-? during acute influenza infection.
Infections
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.
Infections
Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
Infections
Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model.
Infections
Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1?, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.
Infections
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Infections
Noradrenergic Neurons Regulate Monocyte Trafficking and Mortality during Gram-Negative Peritonitis in Mice.
Infections
Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections.
Infections
Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.
Infections
Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response.
Infections
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy.
Infections
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.
Infections
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
Infections
Platelets Promote Brucella abortus Monocyte Invasion by Establishing Complexes With Monocytes.
Infections
Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice.
Infections
Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction.
Infections
Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines.
Infections
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.
Infections
Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis.
Infections
Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.
Infections
Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge.
Infections
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.
Infections
RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
Infections
Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques.
Infections
Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis.
Infections
Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.
Infections
Respiratory echovirus 30 and coxsackievirus B5 can induce production of RANTES, MCP-1 and IL-8 by human bronchial epithelial cells.
Infections
Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.
Infections
Respiratory syncytial virus infection increases chlorine-induced airway hyperresponsiveness.
Infections
Respiratory Syncytial Virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs.
Infections
Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs.
Infections
Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes.
Infections
Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain Differentially Regulate Endothelial Cell Responses.
Infections
Rickettsia rickettsii infection of human macrovascular and microvascular endothelial cells reveals activation of both common and cell type-specific host response mechanisms.
Infections
Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.
Infections
Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.
Infections
Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-alpha, interleukin-10, and monocyte chemotactic protein-1 by Mycobacterium tuberculosis H37Rv-infected human monocytes.
Infections
Roles Played by Toll-like Receptor-9 in Corneal Endothelial Cells after Herpes Simplex Virus Type 1 Infection.
Infections
Rupintrivir reduces RV-induced TH-2 cytokine IL-4 in precision-cut lung slices (PCLS) of HDM-sensitized mice ex vivo.
Infections
SARS-CoV accessory protein 3b induces AP-1 transcriptional activity through activation of JNK and ERK pathways.
Infections
Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract.
Infections
Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection.
Infections
Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence.
Infections
Serum Monocyte Chemoattractant Protein-1 Predicts Liver Inflammation of Patients with Chronic Hepatitis B.
Infections
Serum of cytomegalovirus-infected mice induces monocyte chemoattractant protein-1 expression by endothelial cells.
Infections
Signaling lymphocyte-activation molecule SLAMF1 augments mycobacteria BCG-induced inflammatory response and facilitates bacterial clearance.
Infections
SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-?B pathway.
Infections
Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis.
Infections
Staphylococcus aureus-mediated blood-brain barrier injury: An in vitro human brain microvascular endothelial cell model.
Infections
Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses.
Infections
Structural analysis of human CCR2b and primate CCR2b by molecular modeling and molecular dynamics simulation.
Infections
Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus.
Infections
Survey of small intestinal and systemic immune responses following murine Arcobacter butzleri infection.
Infections
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
Infections
The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells.
Infections
The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs.
Infections
The feedback loop of "EMMPRIN/NF-?B" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Infections
The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF- ? B Pathway in Mice.
Infections
The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.
Infections
The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage.
Infections
The Role of Alveolar Epithelial Cells in Initiating and Shaping Pulmonary Immune Responses: Communication between Innate and Adaptive Immune Systems.
Infections
The role of Ca(2+) mediated signaling pathways on the effect of taurine against Streptococcus uberis infection.
Infections
The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection.
Infections
The Role of Toll-Like Receptor 5 in the Innate Immune Response to Acute P. aeruginosa Pneumonia.
Infections
The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus.
Infections
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.
Infections
Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.
Infections
Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.
Infections
Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Infections
Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro.
Infections
Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection.
Infections
Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge.
Infections
Trichinella spiralis infection is mediated by MCP-1 and MIP-2, while echinococcus granulosus is strongly mediated by MCP-1, but not MIP-2.
Infections
Trypanosoma cruzi Infection Induces Cellular Stress Response and Senescence-Like Phenotype in Murine Fibroblasts.
Infections
Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.
Infections
Up-regulation of pro-inflammatory factors by HP-PRRSV infection in microglia: Implications for HP-PRRSV neuropathogenesis.
Infections
Upper Urinary Tract Infections Are Associated with RANTES Promoter Polymorphism.
Infections
Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen.
Infections
Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection.
Infections
Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment.
Infections
Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells.
Infections
Virulence of Mycobacterium tuberculosis affects interleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes.
Infections
Vitamin A Modifies the Intestinal Chemokine and Cytokine Responses to Norovirus Infection in Mexican Children.
Infections
Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
Infections
Wnt5a is involved in LOX-1 and TLR4 induced host inflammatory response in peri-implantitis.
Infections
[Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].
Infections
[Expression profiles of microRNA in peripheral blood mononuclear cells and immune factors in pregnant women with hepatitis B virus infection].
Infections
[Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients]
Infections
[Monocyte chemotactic protein-1 gene polymorphism and monocyte chemotactic protein-1 expression in Chongqing Han children with tuberculosis]
Infections
[Tick-borne encephalitis virus (TBEV) enhances the expression of MCP-1, CD68 and NF-?B in infected mouse brain tissue].
Infections
[TLR9 expression and its relationship with MCP-1 and TNF-? in HCV-stimulated BV2 cells].
Infertility
Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis.
Infertility
Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization.
Infertility
The Peritoneal Leptin, MCP-1 and TNF-? in the Pathogenesis of Endometriosis-Associated Infertility.
Inflammatory Bowel Diseases
Association of chemokine and chemokine receptor polymorphisms with activity degree of IBD in Tunisian patients.
Inflammatory Bowel Diseases
Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease.
Inflammatory Bowel Diseases
Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa.
Inflammatory Bowel Diseases
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.
Inflammatory Bowel Diseases
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa.
Inflammatory Bowel Diseases
Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease.
Inflammatory Bowel Diseases
The -2518 A/G MCP-1 polymorphism as a risk factor of inflammatory bowel disease.
Inflammatory Bowel Diseases
The -A2518G Polymorphism in the MCP-1 Gene and Inflammatory Bowel Disease Risk_ A Meta-Analysis.
Inflammatory Bowel Diseases
The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease.
Inflammatory Bowel Diseases
The Role of Inflammatory Cytokines as Intermediates in the Pathway from Increased Adiposity to Disease.
Inflammatory Bowel Diseases
Tissue cytokine and chemokine expression in inflammatory bowel disease.
Influenza, Human
Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
Influenza, Human
Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection.
Influenza, Human
Antibody and inflammatory response-mediated severity of pandemic 2009 (pH1N1) influenza virus.
Influenza, Human
CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.
Influenza, Human
Defense against influenza A virus infection: essential role of the chemokine system.
Influenza, Human
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus.
Influenza, Human
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.
Influenza, Human
Dual regulatory effect of plant extracts of Forsythia suspense on RANTES and MCP-1 secretion in influenza A virus-infected human bronchial epithelial cells.
Influenza, Human
Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.
Influenza, Human
GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma.
Influenza, Human
Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.
Influenza, Human
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.
Influenza, Human
Lariciresinol-4-O-?-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response.
Influenza, Human
MCP-1 Antibody Treatment Enhances Damage and Impedes Repair of the Alveolar Epithelium in Influenza Pneumonitis.
Influenza, Human
Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.
Influenza, Human
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Influenza, Human
Negative regulation of lung inflammation and immunopathology by TNF-? during acute influenza infection.
Influenza, Human
Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine.
Influenza, Human
Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques.
Influenza, Human
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.
Influenza, Human
Studies on the Bioactive Flavonoids Isolated from Pithecellobium clypearia Benth.
Insulin Resistance
12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice.
Insulin Resistance
A possible association between the -2518 A>G MCP-1 polymorphism and insulin resistance in school children.
Insulin Resistance
An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.
Insulin Resistance
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
Insulin Resistance
Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue.
Insulin Resistance
Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.
Insulin Resistance
Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice.
Insulin Resistance
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.
Insulin Resistance
Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers.
Insulin Resistance
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Insulin Resistance
Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children.
Insulin Resistance
Chemokine and free fatty acid levels in insulin-resistant state of successful pregnancy: a preliminary observation.
Insulin Resistance
Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women.
Insulin Resistance
Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1?, and TNF? levels in type 2 diabetes and insulin resistance.
Insulin Resistance
Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation?
Insulin Resistance
Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle.
Insulin Resistance
Early Regression of Carotid Intima-Media Thickness after Bariatric Surgery and Its Relation to Serum Leptin Reduction.
Insulin Resistance
Effect of a High-fat Diet on 24-Hour Pattern of Circulating Adipocytokines in Rats.
Insulin Resistance
Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
Insulin Resistance
Effect of ARB on expression of CD68 and MCP-1 in adipose tissue of rats on long-term high fat diet.
Insulin Resistance
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages.
Insulin Resistance
Expression of chemokine receptors in insulin-resistant human skeletal muscle cells.
Insulin Resistance
Freeze-dried strawberry and blueberry attenuates diet-induced obesity and insulin resistance in rats by inhibiting adipogenesis and lipogenesis.
Insulin Resistance
From excess adiposity to insulin resistance: The role of free fatty acids.
Insulin Resistance
Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
Insulin Resistance
GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr
Insulin Resistance
Growth hormone (GH) differentially regulates NF-kB activity in preadipocytes and macrophages: implications for GH's role in adipose tissue homeostasis in obesity.
Insulin Resistance
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Insulin Resistance
High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
Insulin Resistance
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.
Insulin Resistance
High-Fat Diets Containing Different Amounts of n3 and n6 Polyunsaturated Fatty Acids Modulate Inflammatory Cytokine Production in Mice.
Insulin Resistance
Hyperbaric oxygen therapy increases insulin sensitivity in overweight men with and without type 2 diabetes.
Insulin Resistance
Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1 release in mature 3T3-L1 adipocytes: Possible regulatory mechanism through endogenous ER stress and AMPK-related pathways.
Insulin Resistance
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Insulin Resistance
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.
Insulin Resistance
Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?
Insulin Resistance
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes.
Insulin Resistance
JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice.
Insulin Resistance
L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose.
Insulin Resistance
L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats.
Insulin Resistance
Loss of PPAR gamma in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue.
Insulin Resistance
Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis.
Insulin Resistance
Macrophage chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected].
Insulin Resistance
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
Insulin Resistance
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Insulin Resistance
Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity.
Insulin Resistance
Moderate Exercise Suppresses NF-?B Signaling and Activates the SIRT1-AMPK-PGC1? Axis to Attenuate Muscle Loss in Diabetic db/db Mice.
Insulin Resistance
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Insulin Resistance
Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population.
Insulin Resistance
Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Insulin Resistance
Monocyte chemoattractant protein-1 promoter -2518 polymorphism is associated with post-challenge insulin and glucose levels in non-diabetic Japanese subjects.
Insulin Resistance
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Insulin Resistance
Moringa oleifera Lam. leaf extracts reverse metabolic syndrome in Sprague Dawley rats fed high-fructose high fat diet for 60-days.
Insulin Resistance
Muscle-specific inflammation induced by MCP-1 overexpression does not affect whole-body insulin sensitivity in mice.
Insulin Resistance
Obstructive sleep apnea is associated with lower adiponectin and higher cholesterol levels independently of traditional factors and other sleep disorders in middle-aged adults: the ELSA-Brasil cohort.
Insulin Resistance
Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance.
Insulin Resistance
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
Insulin Resistance
Plasma monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome and associated with adiposity, but unaffected by pioglitazone treatment.
Insulin Resistance
PM2.5 aggravates diabetes via the systemically activated IL-6-mediated STAT3/SOCS3 pathway in rats' liver.
Insulin Resistance
Pro-inflammatory gene expression profile in obese adults with high plasma GIP levels.
Insulin Resistance
Prophylactic role of vitamin K supplementation on vascular inflammation in type 2 diabetes by regulating the NF-?B/Nrf2 pathway via activating Gla proteins.
Insulin Resistance
Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-induced Obese Mice.
Insulin Resistance
Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
Insulin Resistance
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Insulin Resistance
Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats.
Insulin Resistance
Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
Insulin Resistance
Stress Augments Insulin Resistance and Prothrombotic State: Role of Visceral Adipose-Derived Monocyte Chemoattractant Protein-1.
Insulin Resistance
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
Insulin Resistance
Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice.
Insulin Resistance
The effect of hypolipidemic treatment on monocyte cytokine release in different age groups of patients with type 2 diabetes and atherogenic dyslipidemia.
Insulin Resistance
The inflammatory status score including IL-6, TNF-?, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Insulin Resistance
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Insulin Resistance
Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression.
Insulin Resistance
Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance.
Insulin Resistance
Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension.
Insulin Resistance
Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome.
Insulin Resistance
Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for the metabolic syndrome.
Insulin Resistance
[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]
Insulin Resistance
[The impacts of testosterone on insulin sensitivity and chronic low-grade].
Insulinoma
IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells.
Insulinoma
The Novel Mechanisms Concerning the Inhibitions of Palmitate-Induced Proinflammatory Factor Releases and Endogenous Cellular Stress with Astaxanthin on MIN6 ?-Cells.
Intermittent Claudication
Platelet monocyte aggregates and monocyte chemoattractant protein-1 are not inhibited by aspirin in critical limb ischaemia.
Intervertebral Disc Degeneration
Effects of IL-1?, IL-20, and BMP-2 on Intervertebral Disc Inflammation under Hypoxia.
Intervertebral Disc Degeneration
Extracellular osmolarity regulates matrix homeostasis in the intervertebral disc and articular cartilage: evolving role of TonEBP.
Intervertebral Disc Degeneration
Sirt1 suppresses MCP-1 production during the intervertebral disc degeneration by inactivating AP-1 subunits c-Fos/c-Jun.
Intervertebral Disc Displacement
A potential role of thymic stromal lymphopoietin in the recruitment of macrophages to mouse intervertebral disc cells via monocyte chemotactic protein 1 induction: implications for herniated discs.
Intervertebral Disc Displacement
Low-intensity pulsed ultrasound stimulation enhances TIMP-1 in nucleus pulposus cells and MCP-1 in macrophages in the rat.
Intervertebral Disc Displacement
Nucleus pulposus cells derived IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation.
Intracranial Aneurysm
Effect of dietary ? carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E(-/-) mice.
Intracranial Aneurysm
Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells.
Intracranial Aneurysm
Expression of NF-?B, MCP-1 and MMP-9 in a Cerebral Aneurysm Rabbit Model.
Intracranial Aneurysm
Ratio of IL-8 in CSF versus Serum Is Elevated in Patients with Unruptured Brain Aneurysm.
Intracranial Aneurysm
Role of inflammatory responses in the pathogenesis of human cerebral aneurysm.
Intracranial Aneurysm
Serum Levels of Monocyte Chemoattractant Protein-1 Correlate with Poor Clinical Grades in Cerebral Aneurysms.
Intracranial Aneurysm
Sustained expression of MCP-1 by low wall shear stress loading concomitant with turbulent flow on endothelial cells of intracranial aneurysm.
Intracranial Aneurysm
Sustained expression of MCP-1 induced low wall shear stress loading in conjunction with turbulent flow on endothelial cells of intracranial aneurysm.
Intracranial Aneurysm
The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-?B, MCP-1 and MMP-9.
Iron Deficiencies
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.
Iron Overload
Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Ischemic Stroke
Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes.
Ischemic Stroke
Association of monocyte chemoattractant protein-1 -2518A>G polymorphism with occurrence, severity, and outcome in ischemic stroke.
Ischemic Stroke
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Ischemic Stroke
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
Ischemic Stroke
Lack of association between MCP-1 -2518A/G polymorphism and ischemic stroke: From a case-control study to an updated meta-analysis.
Ischemic Stroke
Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.
Ischemic Stroke
Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities.
Ischemic Stroke
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.
Ischemic Stroke
Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex.
Ischemic Stroke
Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
Ischemic Stroke
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Ischemic Stroke
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
Ischemic Stroke
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: The PRIME Study.
Ischemic Stroke
Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.
Ischemic Stroke
The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.
Ischemic Stroke
Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India.
Joint Diseases
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Joint Diseases
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
Joint Diseases
The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.
Keloid
Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids.
Keloid
[Microvessel counts and the expressions of chemotactic factors in the pathological scar tissues]
Keratitis
Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10.
Keratitis
Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
Keratitis
MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis.
Ketosis
High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
Kidney Calculi
Calcium oxalate monohydrate crystals stimulate monocyte chemoattractant protein-1 and transforming growth factor ?1 expression in human renal epithelial cells.
Kidney Calculi
Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals.
Kidney Calculi
Urinary extracellular vesicles associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.
Kidney Diseases
Comparison of serum monocide chemoattractant protein levels with immunosuppressive therapy protocols in patients with renal transplantation.
Kidney Diseases
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.
Kidney Diseases
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study.
Kidney Diseases
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
Kidney Diseases
Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease.
Kidney Diseases
Urinary monocyte chemotactic protein-1 (MCP-1) in leprosy patients: increased risk for kidney damage.
Kidney Diseases, Cystic
Renal CD14 expression correlates with the progression of cystic kidney disease.
Kidney Failure, Chronic
Association between Monocyte Chemoattractant Protein-1 -2518 (A/G) Single Nucleotide Polymorphism and Chronic Periodontitis in End-stage Renal Disease Patients - A Case-control Study.
Kidney Failure, Chronic
Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure.
Kidney Failure, Chronic
Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease.
Kidney Failure, Chronic
MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease.
Kidney Failure, Chronic
Monocyte chemoattractant protein-1 (MCP-1) g.-2518A>G polymorphism and susceptibility to type 2 diabetes (T2D) and end stage renal disease (ESRD) in the North-West Indian population of Punjab.
Kidney Failure, Chronic
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
Kidney Failure, Chronic
Monocyte chemoattractant protein-1 is associated with silent cerebral infarction in patients on hemodialysis.
Kidney Failure, Chronic
RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure.
Kidney Failure, Chronic
The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis.
Kidney Failure, Chronic
Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms.
Latent Infection
Combined Analysis of IFN-?, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Latent Infection
Discriminating between latent and active tuberculosis with multiple biomarker responses.
Latent Tuberculosis
Discriminating between latent and active tuberculosis with multiple biomarker responses.
Latent Tuberculosis
Evaluation of the Diagnostic Efficacy of Monocyte Parameters and MCP-1 to Distinguishing Active Tuberculosis from Latent Tuberculosis.
Leg Ulcer
Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice.
Leiomyoma
Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus.
Leiomyoma
Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis.
Leiomyoma
Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata.
Leiomyoma
Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis.
Leishmaniasis
Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages.
Leishmaniasis, Cutaneous
Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis.
Leprosy
New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
Leprosy
Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls.
Leprosy
Urinary monocyte chemotactic protein-1 (MCP-1) in leprosy patients: increased risk for kidney damage.
Leprosy, Paucibacillary
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
Leprosy, Tuberculoid
CXCL10, MCP-1, and other immunologic markers involved in neural leprosy.
Leprosy, Tuberculoid
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
Leptospirosis
Chemokines expression during Leptospira interrogans serovar Copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice.
Leptospirosis
Importance of KIM-1 and MCP-1 in Determining the Leptospirosis-Associated AKI: A Sri Lankan Study.
Leukemia
9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells.
Leukemia
Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli.
Leukemia
Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target.
Leukemia
Expression of human monocyte chemoattractant protein-1 in the yeast Pichia pastoris.
Leukemia
Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-kappaB-independent mechanism.
Leukemia
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid.
Leukemia
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Leukemia
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Leukemia
Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716.
Leukemia
The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis.
Leukemia
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.
Leukemia
Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK/PPAR-? pathway.
Leukemia
[Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells]
Leukemia, Feline
Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.
Leukemia, Feline
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Leukemia, Monocytic, Acute
Urolithin A attenuates ox-LDL-induced endothelial dysfunction partly by modulating microRNA-27 and ERK/PPAR-? pathway.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells]
Leukemia, Myeloid, Acute
LINC01255 combined with BMI1 to regulate human mesenchymal stromal senescence and acute myeloid leukemia cell proliferation through repressing transcription of MCP-1.
Leukemia-Lymphoma, Adult T-Cell
Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
Leukocytosis
Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
Leukocytosis
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Leukocytosis
Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.
Leukocytosis
Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-?B and p38 MAPK.
Leukocytosis
Tobacco smoking and acute exercise on immune-inflammatory responses among relative short and longer smoking histories.
Leukoencephalopathies
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Leukoencephalopathy, Progressive Multifocal
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Lichen Planus, Oral
An association of the MCP-1 and CCR2 gene polymorphisms with oral lichen planus.
Listeriosis
IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis.
Listeriosis
LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation.
Listeriosis
Neutrophils sequestered in the liver suppress the proinflammatory response of Kupffer cells to systemic bacterial infection.
Liver Cirrhosis
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.
Liver Cirrhosis
Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice.
Liver Cirrhosis
Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide.
Liver Cirrhosis
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Liver Cirrhosis
Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.
Liver Cirrhosis
Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice.
Liver Cirrhosis
The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection.
Liver Cirrhosis
The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.
Liver Cirrhosis, Alcoholic
Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis.
Liver Diseases
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Liver Diseases
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.
Liver Diseases
CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.
Liver Diseases
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Liver Diseases
Diagnostic and Prognostic Values of Monocyte Chemotactic Protein-1 in Ascitic Fluid of Patients with Spontaneous Bacterial Peritonitis.
Liver Diseases
Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
Liver Diseases
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.
Liver Diseases
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
Liver Diseases
Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery.
Liver Diseases
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Liver Diseases
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Liver Diseases
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.
Liver Diseases
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Liver Diseases
Sphingosine 1-phosphate/microRNA-1249-5p/MCP-1 axis is involved in macrophage-associated inflammation in fatty liver injury in mice.
Liver Diseases
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
Liver Diseases, Alcoholic
22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXR?.
Liver Diseases, Alcoholic
Hepatocyte-specific hypoxia-inducible factor-1? is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
Liver Diseases, Alcoholic
Increased monocyte MCP-1 production in acute alcoholic hepatitis.
Liver Diseases, Alcoholic
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Liver Diseases, Alcoholic
Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
Liver Failure, Acute
MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: A pilot study.
Liver Failure, Acute
Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease.
Liver Failure, Acute
Secreted Ectodomain of SIGLEC-9 and MCP-1 Synergistically Improve Acute Liver Failure in Rats by Altering Macrophage Polarity.
Liver Neoplasms
Correlation between inflammatory cytokines and liver cancer stem cell markers in DEN-induced liver cancer rats.
Liver Neoplasms, Experimental
Cachexia--induced cerebellar degeneration: involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease.
Lung Diseases
Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.
Lung Diseases
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Lung Diseases
Doxycycline decreases monocyte chemoattractant protein-1 in human lung epithelial cells.
Lung Diseases
Evaluation of a whole-blood chemiluminescent immunoassay of IFN-?, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Lung Diseases
Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases.
Lung Diseases
In vivo hydroquinone exposure impairs MCP-1 secretion and monocyte recruitment into the inflamed lung.
Lung Diseases
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Lung Diseases
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Lung Diseases
The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants.
Lung Diseases, Interstitial
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Lung Diseases, Interstitial
High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia.
Lung Diseases, Interstitial
[Relationship between the level of MCP-1 expression in sera of RA patients and ILD]
Lung Diseases, Interstitial
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Lung Injury
A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
Lung Injury
Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1.
Lung Injury
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury.
Lung Injury
Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1.
Lung Injury
Bis-N-norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis.
Lung Injury
Brain death-induced lung injury is complement dependent, with a primary role for the classical/lectin pathway.
Lung Injury
Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-?B activation and oxidative stress mediators.
Lung Injury
CD38 deficiency up-regulated IL-1? and MCP-1 through TLR4/ERK/NF-?B pathway in sepsis pulmonary injury.
Lung Injury
Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models.
Lung Injury
Divergent Effects of Neutrophils on Fas-Induced Pulmonary Inflammation, Apoptosis, and Lung Damage.
Lung Injury
Effect of acute inflammatory lung injury on the expression of monocyte chemoattractant protein-1 (MCP-1) in rat pulmonary alveolar macrophages.
Lung Injury
Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.
Lung Injury
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-?B in mice.
Lung Injury
Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury.
Lung Injury
Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP.
Lung Injury
Immunity-Related Protein Expression and Pathological Lung Damage in Mice Poststimulation with Ambient Particulate Matter from Live Bird Markets.
Lung Injury
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
Lung Injury
Intraperitoneal blood exacerbates the remote inflammatory response to murine peritonitis.
Lung Injury
Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1.
Lung Injury
Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia.
Lung Injury
Non-Myeloid Cells are Major Contributors to Innate Immune Responses via Production of Monocyte Chemoattractant Protein-1/CCL2.
Lung Injury
Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C).
Lung Injury
PDX regulates inflammatory cell infiltration via resident macrophage in LPS-induced lung injury.
Lung Injury
Pivotal Role of 5-Lipoxygenase Pathway in Lung Injury After Experimental Sepsis.
Lung Injury
Protein kinase C modulates the pulmonary inflammatory response in acute pancreatitis.
Lung Injury
Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of carbon black.
Lung Injury
Rat donor lung quality deteriorates more after fast than slow brain death induction.
Lung Injury
Recovery from oxidant-mediated lung injury: response of metallothionein, MIP-2, and MCP-1 to nitrogen dioxide, oxygen, and ozone exposures.
Lung Injury
Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta.
Lung Injury
Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats.
Lung Injury
San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs.
Lung Injury
Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
Lung Neoplasms
?-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-?B/HIF-1? signaling pathway.
Lung Neoplasms
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Lung Neoplasms
Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.
Lung Neoplasms
Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
Lung Neoplasms
Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance.
Lung Neoplasms
Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-?B and inhibition of monocyte chemoattractant protein-1 in urethane induced lung tumor model.
Lung Neoplasms
Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases.
Lung Neoplasms
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Lung Neoplasms
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Lung Neoplasms
Knockdown of 14-kDa phosphohistidine phosphatase expression suppresses lung cancer cell growth in vivo possibly through inhibition of NF-?B signaling pathway.
Lung Neoplasms
Lung Cancer Cell-Derived Secretome Mediates Paraneoplastic Inflammation and Fibrosis in Kidney in Mice.
Lung Neoplasms
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Lung Neoplasms
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Lung Neoplasms
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.
Lung Neoplasms
Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China.
Lung Neoplasms
Relationship between genetic polymorphisms in MCP-1, CCR-2, and non-small-cell lung cancer in the Han nationality of Northern China.
Lung Neoplasms
The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.
Lung Neoplasms
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Lupus Erythematosus, Systemic
A functional SNP MCP-1 (-2518A/G) predispose to renal disorder in Indian Systemic Lupus Erythematosus patients.
Lupus Erythematosus, Systemic
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Lupus Erythematosus, Systemic
Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells.
Lupus Erythematosus, Systemic
Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection.
Lupus Erythematosus, Systemic
MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus.
Lupus Erythematosus, Systemic
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.
Lupus Erythematosus, Systemic
Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Lupus Erythematosus, Systemic
Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.
Lupus Erythematosus, Systemic
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.
Lupus Erythematosus, Systemic
[Expression of monocyte chemoattractant protein-1 and lupus nephritis]
Lupus Nephritis
Absence of association between the MCP-1 gene polymorphism and histological phenotype of lupus nephritis.
Lupus Nephritis
Analysis of urinary TGF-?1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis.
Lupus Nephritis
Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Lupus Nephritis
Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis.
Lupus Nephritis
Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
Lupus Nephritis
Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
Lupus Nephritis
Correlations of Urinary Biomarkers, TNF-Like Weak Inducer of Apoptosis (TWEAK), Osteoprotegerin (OPG), Monocyte Chemoattractant Protein-1 (MCP-1), and IL-8 with Lupus Nephritis.
Lupus Nephritis
Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Lupus Nephritis
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Lupus Nephritis
Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
Lupus Nephritis
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Lupus Nephritis
Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
Lupus Nephritis
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
Lupus Nephritis
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
Lupus Nephritis
The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study.
Lupus Nephritis
The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
Lupus Nephritis
Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
Lupus Nephritis
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Lupus Nephritis
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Mediates p38 Mitogen-Activated Protein Kinase Activation and Signal Transduction in Peripheral Blood Mononuclear Cells from Patients with Lupus Nephritis.
Lupus Nephritis
Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Lupus Nephritis
Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis.
Lupus Nephritis
Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
Lupus Nephritis
Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
Lupus Nephritis
Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Lupus Nephritis
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
Lupus Nephritis
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.
Lupus Vasculitis, Central Nervous System
Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection.
Lyme Disease
Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro.
Lymphatic Metastasis
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Lymphatic Metastasis
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Lymphatic Metastasis
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Lymphatic Metastasis
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Lymphoma
Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Lymphoma
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma.
Lymphoma
Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.
Lymphoma
Primary central nervous system lymphoma secretes monocyte chemoattractant protein 1.
Lymphoma
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Lymphoma
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Lymphoma
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Lymphoma, B-Cell
Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer's disease-induced in ovarictomized rats.
Lymphoma, B-Cell
Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Lymphoma, B-Cell
Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma.
Lymphoma, B-Cell
Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma.
Lymphoma, B-Cell
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Lymphoma, Large B-Cell, Diffuse
Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma.
Lymphoma, Large B-Cell, Diffuse
Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937.
Lymphoma, Large B-Cell, Diffuse
Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Lymphoma, Non-Hodgkin
Cytotoxicity of rabbit macrophage peptides MCP-1 and MCP-2 for mouse tumor cells.
Lymphoma, Non-Hodgkin
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Lymphoma, T-Cell
Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Lymphopenia
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Macular Degeneration
Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration.
Macular Degeneration
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Macular Degeneration
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Macular Degeneration
Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD).
Macular Degeneration
Single nucleotide polymorphisms in MCP-1 and its receptor are associated with the risk of age related macular degeneration.
Macular Edema
Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.
Macular Edema
Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration.
Malaria
Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2.
Malaria
Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain.
Malaria
Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria.
Malaria
Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.
Malaria
Events associated with susceptibility to invasive Salmonella enterica serovar Typhi in BALB/c mice previously infected with Plasmodium berghei ANKA.
Malaria
Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand.
Malaria
Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
Malaria, Cerebral
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria.
Malaria, Cerebral
Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand.
Malaria, Vivax
Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region.
Malnutrition
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Mastocytoma
Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1.
Measles
Induction of beta-family chemokines mRNA in human embryonic astrocytes by inflammatory cytokines and measles virus protein.
Measles
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Melanoma
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Melanoma
An Autocrine Wnt5a Loop Promotes NF-?B Pathway Activation and Cytokine/Chemokine Secretion in Melanoma.
Melanoma
Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
Melanoma
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.
Melanoma
Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy.
Melanoma
Endogenous PGE(2) induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma.
Melanoma
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Melanoma
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
Melanoma
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Melanoma
Inhibition of proliferation and migration of melanoma cells by ketoconazole and Ganoderma immunomodulatory proteins.
Melanoma
Long-Term Local Injection of RAGE-Aptamer Suppresses the Growth of Malignant Melanoma in Nude Mice.
Melanoma
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.
Melanoma
Measurement of 45 cytokine, chemokine and growth factors in established cell culture supernatants and autologous serum from advanced melanoma patients.
Melanoma
Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
Melanoma
Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Melanoma
RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice.
Melanoma
Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis.
Melanoma
Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma.
Melanoma
Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Melanoma
Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.
Melanoma
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.
Melanoma
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.
Melanoma
Therapeutic Targeting of Melanoma Cells Using Neural Stem Cells Expressing Carboxylesterase, a CPT-11 Activating Enzyme.
Melanoma
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.
Melanoma, Experimental
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Melanoma, Experimental
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Melanoma, Experimental
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Melioidosis
Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.
Meningioma
Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells and monocytes in meningioma.
Meningitis
Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis.
Meningitis
Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients.
Meningitis, Bacterial
Selected Biomarkers Correlate with the Origin and Severity of Sepsis.
Meningitis, Cryptococcal
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Meningitis, Pneumococcal
Myeloid-Related Protein 8/14 Participates in the Progression of Experimental Pneumococcal Meningitis by Augmentation of Inflammation.
Meningitis, Viral
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1.
Meningoencephalitis
No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.
Mesothelioma
Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
Mesothelioma
Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Metabolic Diseases
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Metabolic Syndrome
Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study.
Metabolic Syndrome
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Metabolic Syndrome
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Metabolic Syndrome
Correlation between PAI-1, leptin and ferritin with HOMA in HIV/AIDS patients.
Metabolic Syndrome
Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome.
Metabolic Syndrome
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis.
Metabolic Syndrome
Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.
Metabolic Syndrome
Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1 release in mature 3T3-L1 adipocytes: Possible regulatory mechanism through endogenous ER stress and AMPK-related pathways.
Metabolic Syndrome
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.
Metabolic Syndrome
Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects.
Metabolic Syndrome
Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention.
Metabolic Syndrome
Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease.
Metabolic Syndrome
Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome.
Metabolic Syndrome
Moringa oleifera Lam. leaf extracts reverse metabolic syndrome in Sprague Dawley rats fed high-fructose high fat diet for 60-days.
Metabolic Syndrome
Phytochemical characterization of Tabernanthe iboga root bark and its effects on dysfunctional metabolism and cognitive performance in high-fat-fed C57BL/6J mice.
Metabolic Syndrome
Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Metabolic Syndrome
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations.
Metabolic Syndrome
The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats.
Metabolic Syndrome
Therapeutic Lifestyle Modification Program Reduces Plasma Levels of the Chemokines CRP and MCP-1 inSubjects With Metabolic Syndrome.
Metabolic Syndrome
[Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
Metabolic Syndrome
[Left ventricular mass, forced baseline spirometry and adipocytokine profiles in obese children with and without metabolic syndrome.]
Microcephaly
Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week.
Microvascular Angina
Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X?
Migraine Disorders
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Migraine Disorders
Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
Migraine Disorders
Possible association between dysfunction of vitamin D binding protein (GC Globulin) and migraine attacks.
Migraine with Aura
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Miller Fisher Syndrome
Detection of MCP-1 and IL-8 in the serum and cerebrospinal fluid of a child with Miller Fisher syndrome.
Mouth Diseases
Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.
Mouth Neoplasms
Anti-IL-20 monoclonal antibody alleviates inflammation in oral cancer and suppresses tumor growth.
Mouth Neoplasms
Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.
Mouth Neoplasms
[Investigation of the effect of nuclear factor ?B on inflammatory cell recruitment phenotype of oral cancer associated macrophage].
Movement Disorders
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Movement Disorders
Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation.
Mucocutaneous Lymph Node Syndrome
Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy.
Mucocutaneous Lymph Node Syndrome
Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.
Mucositis
Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal Mucositis.
Mucositis
Radiation-induced damage in different segments of the rat intestine after external beam irradiation of the liver.
Multiple Myeloma
Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.
Multiple Myeloma
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
Multiple Sclerosis
CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone).
Multiple Sclerosis
Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions.
Multiple Sclerosis
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease.
Multiple Sclerosis
MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.
Multiple Sclerosis
No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.
Multiple Sclerosis
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies.
Multiple Sclerosis
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
Multiple Sclerosis
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Multiple Sclerosis
Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection.
Multiple Sclerosis
[Chemokines MIP-1 and MCP-1 and patients with multiple sclerosis treated with interferon beta-1a]
Multiple Sclerosis, Relapsing-Remitting
Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis.
Muscle Weakness
Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.
Muscular Atrophy
Local Cyclical Compression Modulates Macrophage Function In Situ and Alleviates Immobilization-Induced Muscle Atrophy.
Musculoskeletal Pain
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat.
Myalgia
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat.
Myasthenia Gravis, Autoimmune, Experimental
Chemokine production by rat myocytes exposed to interferon-gamma.
Myocardial Infarction
Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese.
Myocardial Infarction
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Myocardial Infarction
Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients.
Myocardial Infarction
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
Myocardial Infarction
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
Myocardial Infarction
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
Myocardial Infarction
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Myocardial Infarction
Chemokines and left ventricular function in patients with acute myocardial infarction.
Myocardial Infarction
Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction.
Myocardial Infarction
Clinical diagnostic value of combined detection of IMA, D-D and MCP-1 in acute myocardial infarction.
Myocardial Infarction
Coronary collaterals: the role of MCP-1 during the early phase of acute myocardial infarction.
Myocardial Infarction
Dobutamine inhibits monocyte chemoattractant protein-1 production and chemotaxis in human monocytes.
Myocardial Infarction
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Myocardial Infarction
Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.
Myocardial Infarction
Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1.
Myocardial Infarction
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Myocardial Infarction
Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size.
Myocardial Infarction
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Myocardial Infarction
MiR-124 Regulates the Inflammation and Apoptosis in Myocardial Infarction Rats by Targeting STAT3.
Myocardial Infarction
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Myocardial Infarction
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia.
Myocardial Infarction
Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardium.
Myocardial Infarction
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
Myocardial Infarction
Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.
Myocardial Infarction
Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction.
Myocardial Infarction
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
Myocardial Infarction
Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Myocardial Infarction
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Myocardial Infarction
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Myocardial Infarction
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
Myocardial Infarction
Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarction.
Myocardial Infarction
Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction.
Myocardial Infarction
Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Myocardial Infarction
Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Myocardial Infarction
The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population.
Myocardial Infarction
The MCP-1 -2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population.
Myocardial Infarction
Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Myocardial Infarction
[Temporal changes and interaction of serum cytokines in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention].
Myocardial Ischemia
Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension.
Myocardial Ischemia
Blockade of the monocyte chemoattractant protein-1 receptor pathway ameliorates myocardial injury in animal models of ischemia and reperfusion.
Myocardial Ischemia
Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death.
Myocardial Ischemia
MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects.
Myocardial Ischemia
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Myocardial Ischemia
Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70.
Myocardial Ischemia
The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.
Myocardial Ischemia
The MCP-1 -2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population.
Myocardial Ischemia
[Prospects of buccal epithelium application for noninvasive diagnosis of coronary heart disease in people of different age.]
Myocarditis
Coxsackievirus b3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
Myocarditis
Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis.
Myocarditis
Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Myocarditis
Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1.
Myocarditis
Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.
Myocarditis
Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1.
Myocarditis
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Myocarditis
Interleukin-17-induced expression of monocyte chemoattractant protein-1 in cardiac myocytes requires nuclear factor ?B through the phosphorylation of p65.
Myocarditis
Kruppel-like factor 10 protects against acute viral myocarditis by negatively regulating cardiac MCP-1 expression.
Myocarditis
Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimental autoimmune myocarditis in rats.
Myocarditis
Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux.
Myocarditis
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Myocarditis
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
Myoma
The Peritoneal Leptin, MCP-1 and TNF-? in the Pathogenesis of Endometriosis-Associated Infertility.
Myositis
Clinical Features and Cytokine Profile in Myositis Patients with Anti-EJ Autoantibodies Detected by a Novel Immunoprecipitation Assay.
Myositis
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Myxoma
Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
Narcolepsy
Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: A case-control study.
Nasal Polyps
IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.
Nasal Polyps
Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies.
Nasal Polyps
[Expression of monocyte chemotactic protein 1 and vascular endothelial growth factor in nasal polyps]
Nasopharyngeal Carcinoma
Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
Nematode Infections
Disruption of CD40-CD40 ligand pathway inhibits the development of intestinal muscle hypercontractility and protective immunity in nematode infection.
Neoplasm Metastasis
Activation of the NF-¿B pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
Neoplasm Metastasis
Appearance of peanut agglutinin in the blood circulation after peanut ingestion promotes endothelial secretion of metastasis-promoting cytokines.
Neoplasm Metastasis
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Neoplasm Metastasis
Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.
Neoplasm Metastasis
Cytokine Production by Tumor Bioptate at Different Pathological Prognostic Stages in Breast Cancer.
Neoplasm Metastasis
Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases.
Neoplasm Metastasis
Determination of angiogenic factors in serum by protein array in patients with renal cell carcinoma.
Neoplasm Metastasis
Effects of protein kinase Cdelta and phospholipase C-gamma1 on monocyte chemoattractant protein-1 expression in taxol-induced breast cancer cell death.
Neoplasm Metastasis
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Neoplasm Metastasis
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Neoplasm Metastasis
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Neoplasm Metastasis
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
Neoplasm Metastasis
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.
Neoplasm Metastasis
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
Neoplasm Metastasis
MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
Neoplasm Metastasis
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
Neoplasm Metastasis
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Neoplasm Metastasis
Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.
Neoplasm Metastasis
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
Neoplasm Metastasis
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Neoplasm Metastasis
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Neoplasm Metastasis
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Neoplasm Metastasis
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Neoplasm Metastasis
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
Neoplasm Metastasis
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Neoplasm Metastasis
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Neoplasm Metastasis
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Neoplasm Metastasis
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.
Neoplasm Metastasis
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Neoplasm Metastasis
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Neoplasm Metastasis
Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
Neoplasm Metastasis
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Neoplasm Metastasis
Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
Neoplasm Metastasis
The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites model.
Neoplasm Metastasis
TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts.
Neoplasm Metastasis
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.
Neoplasm Metastasis
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.
Neoplasm Micrometastasis
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Neoplasms
5-Fluoruracil blocked giant cell tumor progression by suppressing osteoclastogenesis through NF-kappaB signals and blocking angiogenesis.
Neoplasms
9-Hydroxycanthin-6-one isolated from stem bark of Ailanthus altissima induces ovarian cancer cell apoptosis and inhibits the activation of tumor-associated macrophages.
Neoplasms
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Neoplasms
A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages.
Neoplasms
A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation.
Neoplasms
A metalloporphyrin antioxidant alters cytokine responses after irradiation in a prostate tumor model.
Neoplasms
A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells.
Neoplasms
Abciximab combined with half-dose reteplase has beneficial effects on inflammatory myocardial response in patients with myocardial infarction.
Neoplasms
Ablation of Galectin-12 Inhibits Atherosclerosis through Enhancement of M2 Macrophage Polarization.
Neoplasms
Absence of Glia Maturation Factor Protects Dopaminergic Neurons and Improves Motor Behavior in Mouse Model of Parkinsonism.
Neoplasms
AcCystatin, an immunoregulatory molecule from Angiostrongylus cantonensis, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma.
Neoplasms
Acidic stress-ER stress axis for blunted activation of NF-?B in mesothelial cells exposed to peritoneal dialysis fluid.
Neoplasms
Activation of adventitial fibroblasts in the early stage of the aortic transplant vasculopathy in rat.
Neoplasms
Activation of the NF-¿B pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.
Neoplasms
Activation PDGFR-?/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin.
Neoplasms
Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Neoplasms
Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling.
Neoplasms
Adipose tissue IL-8 is increased in normal weight women after menopause and reduced after gastric bypass surgery in obese women.
Neoplasms
Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
Neoplasms
Age-Associated Proinflammatory Secretory Phenotype in Vascular Smooth Muscle Cells From the Non-human Primate Macaca mulatta: Reversal by Resveratrol Treatment.
Neoplasms
Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice.
Neoplasms
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Neoplasms
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
Neoplasms
Airway mucosal immune-suppression in neonates of mothers receiving A(H1N1)pnd09 vaccination during pregnancy.
Neoplasms
Almond Skin Polyphenol Extract Inhibits Inflammation and Promotes Lipolysis in Differentiated 3T3-L1 Adipocytes.
Neoplasms
Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer's disease-induced in ovarictomized rats.
Neoplasms
Alteration in the responsiveness to tumour necrosis factor-alpha is crucial for maximal expression of monocyte chemoattractant protein-1 in human neutrophils.
Neoplasms
Alteration of a macrophages inflammatory protein-related protein-2 (MRP-2) response by high fat and cholesterol diet in mice.
Neoplasms
Altered adhesive properties of cord blood endothelial outgrowth cells expressing IL-1ra.
Neoplasms
Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy.
Neoplasms
Aluminium, carbonyls and cytokines in human nipple aspirate fluids: Possible relationship between inflammation, oxidative stress and breast cancer microenvironment.
Neoplasms
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Neoplasms
Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo.
Neoplasms
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.
Neoplasms
An aqueous extract of Nomura's jellyfish ameliorates inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells and a zebrafish model of inflammation.
Neoplasms
An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.
Neoplasms
Androgen-androgen receptor system improves chronic inflammatory conditions by suppressing monocyte chemoattractant protein-1 gene expression in adipocytes via transcriptional regulation.
Neoplasms
Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells.
Neoplasms
Anti-Folate Receptor-? IgE but not IgG Recruits Macrophages to Attack Tumors via TNF?/MCP-1 Signaling.
Neoplasms
Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice.
Neoplasms
Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib.
Neoplasms
Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes.
Neoplasms
Appearance of peanut agglutinin in the blood circulation after peanut ingestion promotes endothelial secretion of metastasis-promoting cytokines.
Neoplasms
Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
Neoplasms
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.
Neoplasms
Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
Neoplasms
Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production.
Neoplasms
Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients.
Neoplasms
Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.
Neoplasms
Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy.
Neoplasms
Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma.
Neoplasms
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: A meta-analysis.
Neoplasms
Association of sustained supraphysiologic hyperinsulinemia and inflammatory signaling within the digital lamellae in light-breed horses.
Neoplasms
Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West India.
Neoplasms
Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis.
Neoplasms
Astragalus polysaccharide induces anti-inflammatory effects dependent on AMPK activity in palmitate-treated RAW264.7 cells.
Neoplasms
ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.
Neoplasms
Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Neoplasms
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile.
Neoplasms
Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment.
Neoplasms
Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice.
Neoplasms
Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis.
Neoplasms
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL.
Neoplasms
Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota-A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
Neoplasms
Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
Neoplasms
Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
Neoplasms
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Neoplasms
c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells.
Neoplasms
Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients.
Neoplasms
Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.
Neoplasms
Cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanoma.
Neoplasms
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1.
Neoplasms
Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype.
Neoplasms
Carvedilol prevents pancreatic ?-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-?B, COX-2, iNOS and oxidative stress.
Neoplasms
Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1.
Neoplasms
Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Neoplasms
Cerebrospinal fluid IL-6, TNF-? and MCP-1 in children with acute lymphoblastic leukaemia during chemotherapy.
Neoplasms
Changes in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.
Neoplasms
Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection.
Neoplasms
Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines.
Neoplasms
Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression.
Neoplasms
Chemotherapy induces macrophage chemoattractant protein-1 production in ovarian cancer.
Neoplasms
Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.
Neoplasms
Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Neoplasms
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Neoplasms
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.
Neoplasms
Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients.
Neoplasms
Coadministration of the cyanobacterial lipopolysaccharide antagonist CyP with antibiotic inhibits cytokine production by an in vitro meningitis model infected with Neisseria meningitidis.
Neoplasms
Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis.
Neoplasms
Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Neoplasms
Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance.
Neoplasms
Comparative study of cytokine content in the plasma and wound exudate from children with severe burns.
Neoplasms
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Neoplasms
Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli.
Neoplasms
Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees.
Neoplasms
Copper induces--and copper chelation by tetrathiomolybdate inhibits--endothelial activation in vitro.
Neoplasms
Correlations between Tear Cytokines, Chemokines, and Soluble Receptors and Clinical Severity of Dry Eye Disease.
Neoplasms
COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells.
Neoplasms
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Neoplasms
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.
Neoplasms
Curcumin affects ox-LDL-induced IL-6, TNF-?, MCP-1 secretion and cholesterol efflux in THP-1 cells by suppressing the TLR4/NF-?B/miR33a signaling pathway.
Neoplasms
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Neoplasms
Cytokine Production by Tumor Bioptate at Different Pathological Prognostic Stages in Breast Cancer.
Neoplasms
Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes.
Neoplasms
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
Neoplasms
Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies.
Neoplasms
Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.
Neoplasms
Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts.
Neoplasms
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.
Neoplasms
Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation.
Neoplasms
Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines.
Neoplasms
Decellularization protocol-dependent damage-associated molecular patterns in rat uterus scaffolds differentially affect the immune response after transplantation.
Neoplasms
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Neoplasms
Deficiency of ??T cells protects against abdominal aortic aneurysms by regulating phosphoinositide 3-kinase/AKT signaling.
Neoplasms
Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-?B and inhibition of monocyte chemoattractant protein-1 in urethane induced lung tumor model.
Neoplasms
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Neoplasms
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
Neoplasms
Dextromethorphan - A widely-used cough suppressant - Induces local anaphylaxis via MRGPRX2 on mast cells.
Neoplasms
Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation.
Neoplasms
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors.
Neoplasms
Differential effects of staurosporine and its analogues on chemokine release by promyelocytic leukemia cell line NB-4.
Neoplasms
Differential Immune Activating, Anti-Inflammatory, and Regenerative Properties of the Aqueous, Ethanol, and Solid Fractions of a Medicinal Mushroom Blend.
Neoplasms
Differential impact of familial hypercholesterolemia and combined hyperlipidemia on vascular wall and network remodeling in mice.
Neoplasms
Dihydroxystilbenes prevent azoxymethane/dextran sulfate sodium-induced colon cancer by inhibiting colon cytokines, a chemokine, and programmed cell death-1 in C57BL/6J mice.
Neoplasms
Dipeptidyl Peptidase-4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation.
Neoplasms
Direct contact between human peripheral blood mononuclear cells and renal fibroblasts facilitates the expression of monocyte chemoattractant protein-1.
Neoplasms
Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Neoplasms
Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.
Neoplasms
Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Neoplasms
Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.
Neoplasms
Early and late neuropathological features of meningoencephalitis associated with Maraba virus infection.
Neoplasms
Early Inflammatory Reactions in Atherosclerosis Are Induced by Tyrosine Kinase Proline-Rich Tyrosine Kinase/Reactive Oxygen Species-Mediated Release of Tumor Necrosis Factor-{alpha} and Subsequent Activation of the p21Cip1/Ets-1/p300 System.
Neoplasms
Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
Neoplasms
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
Neoplasms
EcTI impairs survival and proliferation pathways in triple-negative breast cancer by modulating cell-glycosaminoglycans and inflammatory cytokines.
Neoplasms
Effect of digital hypothermia on lamellar inflammatory signaling in the euglycemic hyperinsulinemic clamp laminitis model.
Neoplasms
Effect of glucocorticoid pretreatment on oxidative liver injury and survival in jaundiced rats with endotoxin cholangitis.
Neoplasms
Effect of High Glucose Concentration on Human Preadipocytes and Their Response to Macrophage-Conditioned Medium.
Neoplasms
Effect of IL-1 beta and TNF-alpha on the expression of monocyte chemotactic protein-1 in endometriotic cells.
Neoplasms
Effect of Kumatakenin Isolated From Cloves on the Apoptosis of Cancer Cells and the Alternative Activation of Tumor-Associated Macrophages.
Neoplasms
Effect of nicotine on placental inflammation and apoptosis in preeclampsia-like model.
Neoplasms
Effect of sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells.
Neoplasms
Effects of calcitriol and its analogues on interaction of MCP-1 and monocyte derived dendritic cells in vitro.
Neoplasms
Effects of enriched environment on COX-2, leptin and eicosanoids in a mouse model of breast cancer.
Neoplasms
Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions.
Neoplasms
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Neoplasms
Effects of Voluntary Running and Soy Supplementation on Diet-Induced Metabolic Disturbance and Inflammation in Mice.
Neoplasms
Egg-Derived Peptide IRW Inhibits TNF-?-Induced Inflammatory Response and Oxidative Stress in Endothelial Cells.
Neoplasms
Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures.
Neoplasms
Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Neoplasms
Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Neoplasms
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Neoplasms
Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice.
Neoplasms
Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Neoplasms
Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1.
Neoplasms
Establishment of inflammatory model induced by Pseudorabies virus infection in mice.
Neoplasms
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.
Neoplasms
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.
Neoplasms
Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation.
Neoplasms
Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
Neoplasms
Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.
Neoplasms
Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma.
Neoplasms
Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils.
Neoplasms
Expression and regulation of the CC-chemokine monocyte chemoattractant protein-1 in rat testicular cells in primary culture.
Neoplasms
Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis.
Neoplasms
Expression of chemotaxis- and angiogenesis-related factors in human monocytes following interaction with colon cancer cells is suppressed by low-dose lipopolysaccharide.
Neoplasms
Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis.
Neoplasms
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: Involvement of ATP and P2X(7) receptor.
Neoplasms
Expression of macrophage inflammatory protein-1? and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X? receptor.
Neoplasms
Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues.
Neoplasms
Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators.
Neoplasms
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Neoplasms
Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain.
Neoplasms
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Neoplasms
Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes.
Neoplasms
Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin.
Neoplasms
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.
Neoplasms
Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
Neoplasms
Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.
Neoplasms
Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases.
Neoplasms
Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes.
Neoplasms
Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells.
Neoplasms
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Neoplasms
Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells.
Neoplasms
Gax gene transfer inhibits vascular remodeling induced by adventitial inflammation in rabbits.
Neoplasms
Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
Neoplasms
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Neoplasms
Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.
Neoplasms
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
Neoplasms
Germinated Brown Rice Attenuates Atherosclerosis and Vascular Inflammation in Low-Density Lipoprotein Receptor-Knockout Mice.
Neoplasms
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Neoplasms
Glucosyl Hesperidin Has an Anti-diabetic Effect in High-Fat Diet-Induced Obese Mice.
Neoplasms
GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
Neoplasms
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1 h68.
Neoplasms
Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture.
Neoplasms
Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells.
Neoplasms
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Neoplasms
Heat-Processed Scutellariae Radix Protects Hepatic Inflammation through the Amelioration of Oxidative Stress in Lipopolysaccharide-Induced Mice.
Neoplasms
Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes.
Neoplasms
Hepatitis B virus X protein modulates renal tubular epithelial cell-induced T-cell and macrophage responses.
Neoplasms
Hepatoprotective, Antihyperlipidemic, and Anti-inflammatory Activity of Moringa oleifera in Diabetic-induced Damage in Male Wistar Rats.
Neoplasms
High dose gabapentin does not alter tumor growth in mice but reduces arginase activity and increases superoxide dismutase, IL-6 and MCP-1 levels in Ehrlich ascites.
Neoplasms
High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice.
Neoplasms
High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes.
Neoplasms
Highly oxidized low-density lipoprotein mediates activation of monocytes but does not confer interleukin-1? secretion nor interleukin-15 transpresentation function.
Neoplasms
Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment.
Neoplasms
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
Neoplasms
Host and environmental factors influencing respiratory secretion of pro-wheezing biomarkers in preterm children.
Neoplasms
Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Neoplasms
Host-derived MCP-1 and MIP-1? regulate protective anti-tumor immunity to localized and metastatic B16 melanoma.
Neoplasms
hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.
Neoplasms
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro.
Neoplasms
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Neoplasms
Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays.
Neoplasms
Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches.
Neoplasms
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.
Neoplasms
Human Truncated Tau is Using a Different Mechanism from Amyloid-beta to Damage the Blood-Brain Barrier.
Neoplasms
Hyperglycemic Condition Causes Pro-Inflammatory and Permeability Alterations Associated with Monocyte Recruitment and Deregulated NF?B/PPAR? Pathways on Cerebral Endothelial Cells: Evidence for Polyphenols Uptake and Protective Effect.
Neoplasms
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors.
Neoplasms
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
Neoplasms
IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor.
Neoplasms
IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
Neoplasms
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype.
Neoplasms
IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
Neoplasms
IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo.
Neoplasms
IL-20 may contribute to the pathogenesis of human intervertebral disc herniation.
Neoplasms
IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells.
Neoplasms
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.
Neoplasms
IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines.
Neoplasms
IL-7, IL-18, MCP-1, MIP1-?, and OPG as biomarkers for pain treatment response in patients with cancer.
Neoplasms
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.
Neoplasms
Immolina, a high-molecular-weight polysaccharide fraction of spirulina, enhances chemokine expression in human monocytic THP-1 cells.
Neoplasms
Immune activation and chronic inflammation: Is there an additional effect of HIV in a geriatric population?
Neoplasms
Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinoma.
Neoplasms
Immune Mediators of Protective and Pathogenic Immune Responses in Patients with Mild and Fatal Human Monocytotropic Ehrlichiosis.
Neoplasms
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer.
Neoplasms
Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
Neoplasms
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.
Neoplasms
Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.
Neoplasms
Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
Neoplasms
Improvement of antigen binding ability of human antibodies by light chain shifting.
Neoplasms
In situ increased chemokine expression in human cervical intraepithelial neoplasia.
Neoplasms
In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway.
Neoplasms
Increase of inflammatory markers after indoor renovation activities: the LISA birth cohort study.
Neoplasms
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Neoplasms
Increased monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha can mediate macrophage infiltration in gliomas.
Neoplasms
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma.
Neoplasms
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Neoplasms
Increased susceptibility of hyperthyroid rats to ozone: early events and mechanisms.
Neoplasms
Induction and secretion of the chemokines interleukin-8 and monocyte chemotactic protein-1 in human immature leukemia cell lines.
Neoplasms
Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells.
Neoplasms
Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells.
Neoplasms
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression.
Neoplasms
Induction of monocyte chemoattractant protein-1 by Mycoplasma hominis in respiratory epithelial cells.
Neoplasms
Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells.
Neoplasms
Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
Neoplasms
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Neoplasms
Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum.
Neoplasms
Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta.
Neoplasms
Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters.
Neoplasms
Inhibition of In-Stent Stenosis by Oral Administration of Bindarit in Porcine Coronary Arteries.
Neoplasms
Inhibition of monocyte chemoattractant protein-1 by Krüppel-like factor 5 small interfering RNA in the tumor necrosis factor- alpha-activated human umbilical vein endothelial cells.
Neoplasms
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Neoplasms
Inhibition of proliferation and migration of melanoma cells by ketoconazole and Ganoderma immunomodulatory proteins.
Neoplasms
Inhibitory effect of Malvidin on TNF-?-induced inflammatory response in endothelial cells.
Neoplasms
Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts.
Neoplasms
Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells.
Neoplasms
Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells.
Neoplasms
Inhibitory Effects of ?-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy.
Neoplasms
Innate immune molecule surfactant protein D attenuates sepsis-induced acute kidney injury through modulating apoptosis and NF?B-mediated inflammation.
Neoplasms
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour.
Neoplasms
Interaction of differentiated human adipocytes with macrophages leads to trogocytosis and selective IL-6 secretion.
Neoplasms
Interference with MCP-1 gene expression by vector generated triple helix-forming RNA oligonucleotides.
Neoplasms
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells.
Neoplasms
Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts.
Neoplasms
Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.
Neoplasms
Interleukin-17D mediates tumor rejection through recruitment of natural killer cells.
Neoplasms
Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha.
Neoplasms
Interleukin-8 secretion of cortical tubular epithelial cells is directed to the basolateral environment and is not enhanced by apical exposure to Escherichia coli.
Neoplasms
Intra-amniotic LPS modulates expression of antimicrobial peptides in the fetal sheep lung.
Neoplasms
INTRAOCULAR ACTIVATION OF ANGIOGENIC AND INFLAMMATORY PATHWAYS IN UVEAL MELANOMA.
Neoplasms
Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis.
Neoplasms
Intratumoral VEGF and FGF1 administration alters tumor growth, vascular density, oxygenation, and expression of MCP-1 and interleukins.
Neoplasms
Ischemic Stroke May Activate Bone Marrow Mononuclear Cells to Enhance Recovery After Stroke.
Neoplasms
JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
Neoplasms
Knockdown of 14-kDa phosphohistidine phosphatase expression suppresses lung cancer cell growth in vivo possibly through inhibition of NF-?B signaling pathway.
Neoplasms
Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).
Neoplasms
Knockout of ccr2 alleviates photoreceptor cell death in a model of retinitis pigmentosa.
Neoplasms
Laminar Inflammation Responses in the Oligofructose Overload Induced Model of Bovine Laminitis.
Neoplasms
Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).
Neoplasms
Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes.
Neoplasms
Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimental autoimmune myocarditis in rats.
Neoplasms
Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer.
Neoplasms
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
Neoplasms
Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways.
Neoplasms
Localized immunosuppressive environment in the foreign body response to implanted biomaterials.
Neoplasms
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Neoplasms
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.
Neoplasms
Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production.
Neoplasms
Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NF?B-TLR signaling pathway.
Neoplasms
Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells.
Neoplasms
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
Neoplasms
Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease.
Neoplasms
MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells.
Neoplasms
MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo.
Neoplasms
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
Neoplasms
MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression.
Neoplasms
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
Neoplasms
MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
Neoplasms
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
Neoplasms
MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1? in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis.
Neoplasms
Measurement of CD4+ and CD8+ T-Lymphocyte Cytokine Secretion and Gene Expression Changes in p-Phenylenediamine Allergic Patients and Tolerant Individuals.
Neoplasms
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation.
Neoplasms
Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma.
Neoplasms
miR-218 regulates diabetic nephropathy via targeting IKK-? and modulating NK-?B-mediated inflammation.
Neoplasms
Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model.
Neoplasms
Mitochondrial reactive oxygen species regulate fungal protease-induced inflammatory responses.
Neoplasms
Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine.
Neoplasms
Modulation of Toll-like receptor-mediated innate immunity in bovine intestinal epithelial cells by lactic acid bacteria isolated from feedlot cattle.
Neoplasms
Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells.
Neoplasms
Molecular basis of lateral force spectroscopy nano-diagnostics: computational unbinding of autism related chemokine MCP-1 from IgG antibody.
Neoplasms
Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines.
Neoplasms
Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
Neoplasms
Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids.
Neoplasms
Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease.
Neoplasms
Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Neoplasms
Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.
Neoplasms
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Neoplasms
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
Neoplasms
Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung.
Neoplasms
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Neoplasms
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Neoplasms
Monocyte Chemoattractant Protein-1 and Large Artery Structure and Function in Young Individuals: The African-PREDICT Study.
Neoplasms
Monocyte chemoattractant protein-1 derived from biliary innate immunity contributes to hepatic fibrogenesis.
Neoplasms
Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes.
Neoplasms
Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.
Neoplasms
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
Neoplasms
Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas.
Neoplasms
Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
Neoplasms
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Neoplasms
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Neoplasms
Monocyte Chemoattractant Protein-1 in Dogs Affected with Neoplasia or Inflammation.
Neoplasms
Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Neoplasms
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.
Neoplasms
Monocyte chemoattractant protein-1 polymorphism interaction with spirulina immunomodulatory effects in healthy Korean elderly: A 16 week, double-blind randomized clinical trial.
Neoplasms
Monocyte chemoattractant protein-1 stimulates tumor necrosis and recruitment of macrophages into tumors in tumor-bearing nude mice: increased granulocyte and macrophage progenitors in murine bone marrow.
Neoplasms
Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Neoplasms
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
Neoplasms
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
Neoplasms
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Neoplasms
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
Neoplasms
Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Neoplasms
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet.
Neoplasms
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Neoplasms
Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells.
Neoplasms
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.
Neoplasms
Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2.
Neoplasms
Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas.
Neoplasms
Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemia.
Neoplasms
Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.
Neoplasms
Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.
Neoplasms
Mouse interleukin-20 receptor 1a targets renal epithelial cells and is associated with renal calcium deposition.
Neoplasms
Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology.
Neoplasms
Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells.
Neoplasms
Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
Neoplasms
Mycophenolic acid regulates spleen tyrosine kinase to repress tumour necrosis factor-alpha-induced monocyte chemotatic protein-1 production in cultured human aortic endothelial cells.
Neoplasms
n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-?B-dependent mechanisms.
Neoplasms
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Neoplasms
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Neoplasms
Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity.
Neoplasms
NF-?Bp65 and Expression of Its Pro-Inflammatory Target Genes Are Upregulated in the Subcutaneous Adipose Tissue of Cachectic Cancer Patients.
Neoplasms
No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Neoplasms
Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
Neoplasms
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.
Neoplasms
Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.
Neoplasms
Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes.
Neoplasms
Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
Neoplasms
Optimal amount of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy against hepatocellular carcinoma by M1 macrophage activation.
Neoplasms
Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor-alpha and interferon-gamma.
Neoplasms
Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Neoplasms
Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-?1.
Neoplasms
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Neoplasms
Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Neoplasms
Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk.
Neoplasms
Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM).
Neoplasms
PDGF-BB enhances monocyte chemoattractant protein-1 mRNA stability in smooth muscle cells by downregulating ribonuclease activity.
Neoplasms
Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Neoplasms
Peroxisome proliferator-activated receptor gamma coactivator-1?/HSF1 axis effectively alleviates lipopolysaccharide-induced acute lung injury via suppressing oxidative stress and inflammatory response.
Neoplasms
Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).
Neoplasms
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Neoplasms
Pituitary Adenylate Cyclase-Activating Polypeptide Deficiency Enhances Oxazolone-Induced Allergic Contact Dermatitis in Mice.
Neoplasms
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension.
Neoplasms
Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.
Neoplasms
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas.
Neoplasms
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Neoplasms
Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase.
Neoplasms
Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells.
Neoplasms
Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions.
Neoplasms
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy.
Neoplasms
Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts.
Neoplasms
Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells.
Neoplasms
Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma: relation to the origin of histiocyte-like cells.
Neoplasms
Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma.
Neoplasms
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Neoplasms
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Neoplasms
Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Neoplasms
Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro.
Neoplasms
Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an m1 phenotype in retinal microglia.
Neoplasms
Protective Effects of Luteolin on Lipopolysaccharide-Induced Acute Renal Injury in Mice.
Neoplasms
Protective role of Akt2 in Salmonella enterica serovar typhimurium-induced gastroenterocolitis.
Neoplasms
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
Neoplasms
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Neoplasms
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
Neoplasms
Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.
Neoplasms
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation.
Neoplasms
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Neoplasms
Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells.
Neoplasms
Reduced immune responses to purified protein derivative and Candida albicans in oral lichen planus.
Neoplasms
Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines.
Neoplasms
Regulation of cytokine expression by Schwann cells in response to ?2-macroglobulin binding to LRP1.
Neoplasms
Regulation of Granulocyte Colony-Stimulating Factor and Its Receptor in Skeletal Muscle is Dependent Upon the Type of Inflammatory Stimulus.
Neoplasms
Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue.
Neoplasms
Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells.
Neoplasms
Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta.
Neoplasms
Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer.
Neoplasms
Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines.
Neoplasms
Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines.
Neoplasms
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.
Neoplasms
Relationship between MCP1 (-2518A>G) gene variants and ovarian cancer in Turkish population.
Neoplasms
Relationship between the Monocyte Chemo-attractant Protein-1 gene rs1024611 A>G Polymorphism and Cancer Susceptibility: A Meta-analysis Involving 14,617 Subjects.
Neoplasms
RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
Neoplasms
Relationships of Single Nucleotide Polymorphisms of Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 With Susceptibility and Clinicopathologic Characteristics of Neoplasia of Uterine Cervix in Taiwan Women.
Neoplasms
Renoprotective Effect of Oridonin in a Mouse Model of Acute Kidney Injury via Suppression of Macrophage Involved Inflammation.
Neoplasms
Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor Immunity.
Neoplasms
Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.
Neoplasms
Response of VEGF to activation of viral receptors and TNF? in human mesangial cells.
Neoplasms
Retinal neuronal MCP-1 induced by AGEs stimulates TNF-? expression in rat microglia via p38, ERK, and NF-?B pathways.
Neoplasms
Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.
Neoplasms
Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.
Neoplasms
Rho-kinase mediates TNF-?-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells.
Neoplasms
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Neoplasms
Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain.
Neoplasms
Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction.
Neoplasms
Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
Neoplasms
Serum amyloid P and a DC-SIGN ligand inhibit high fat diet-induced adipose tissue and liver inflammation and steatosis in mice.
Neoplasms
Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer.
Neoplasms
Serum Inflammatory Factor Profiles in the Pathogenesis of High-Altitude Polycythemia and Mechanisms of Acclimation to High Altitudes.
Neoplasms
Serum monocyte chemoattractant protein-1 in patients with postoperative infectious complications from gastrointestinal surgery for cancer.
Neoplasms
Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study.
Neoplasms
Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential.
Neoplasms
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Neoplasms
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Neoplasms
Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.
Neoplasms
Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
Neoplasms
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma.
Neoplasms
Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
Neoplasms
Size matters: TLR4-mediated effects of ?-(1,5)-linear arabino-oligosaccharides in macrophage-like cells depend on their degree of polymerization.
Neoplasms
Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor.
Neoplasms
Standard versus video-assisted thyroidectomy: objective postoperative pain evaluation.
Neoplasms
Staphylococcal enterotoxin M induced inflammation and impairment of bovine mammary epithelial cells.
Neoplasms
Statins' Withdrawal Induces Atherosclerotic Plaque Destabilization in Animal Model-A "Rebound" Stimulation of Inflammation.
Neoplasms
Statistical prediction of the type of gastric aspiration lung injury based on early cytokine/chemokine profiles.
Neoplasms
Stimulation through CD40 on mouse and human renal cell carcinomas triggers cytokine production, leukocyte recruitment, and antitumor responses that can be independent of host CD40 expression.
Neoplasms
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers.
Neoplasms
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Neoplasms
Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response.
Neoplasms
Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells and monocytes in meningioma.
Neoplasms
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
Neoplasms
Synergistic antitumor interaction of human monocyte chemotactant protein-1 gene transfer and modulator for tumor-infiltrating macrophages.
Neoplasms
Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
Neoplasms
Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines.
Neoplasms
Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.
Neoplasms
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.
Neoplasms
Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management.
Neoplasms
Tec kinases regulate actin assembly and cytokine expression in LPS-stimulated human neutrophils via JNK activation.
Neoplasms
Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-{gamma} in Macrophages.
Neoplasms
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
Neoplasms
Thalidomide Controls Adipose Tissue Inflammation Associated with High-Fat Diet-Induced Obesity in Mice.
Neoplasms
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis.
Neoplasms
The anti-adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants.
Neoplasms
The Chemical Composition of Brazilian Green Propolis and Its Protective Effects on Mouse Aortic Endothelial Cells against Inflammatory Injury.
Neoplasms
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Neoplasms
The effect of COX-2 inhibitor, nimesulide, on angiogenetic factors in primary endometrial carcinoma cell culture.
Neoplasms
The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.
Neoplasms
The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines.
Neoplasms
The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
Neoplasms
The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - A mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
Neoplasms
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Neoplasms
The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.
Neoplasms
The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth.
Neoplasms
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.
Neoplasms
The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments.
Neoplasms
The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma.
Neoplasms
The Role of Macrophages in the Biological Reaction to Wear Debris from Artificial Joints.
Neoplasms
The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.
Neoplasms
The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis.
Neoplasms
The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites model.
Neoplasms
The transcriptional factor PREB mediates MCP-1 transcription induced by cytokines in human vascular endothelial cells.
Neoplasms
Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.
Neoplasms
Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells.
Neoplasms
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients.
Neoplasms
TNF-alpha stimulation of MCP-1 expression is mediated by the Akt/PKB signal transduction pathway in vascular endothelial cells.
Neoplasms
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
Neoplasms
Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.
Neoplasms
trans-Retinoic acid blocks platelet-derived growth factor-BB-induced expression of the murine monocyte chemoattractant-1 gene by blocking the assembly of a promoter proximal Sp1 binding site.
Neoplasms
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.
Neoplasms
Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1.
Neoplasms
Truncation of the lipopolysaccharide outer core affects susceptibility to antimicrobial peptides and virulence of Actinobacillus pleuropneumoniae serotype 1.
Neoplasms
Tumor microenvironments direct the recruitment and expansion of human Th17 cells.
Neoplasms
Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1.
Neoplasms
Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment.
Neoplasms
Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.
Neoplasms
Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.
Neoplasms
Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors.
Neoplasms
Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Neoplasms
Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.
Neoplasms
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.
Neoplasms
USF1 promotes the development of knee osteoarthritis by activating the NF-?B signaling pathway.
Neoplasms
Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma.
Neoplasms
Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor.
Neoplasms
Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis.
Neoplasms
Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.
Neoplasms
Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus.
Neoplasms
Yin zi huang, an injectable multicomponent chinese herbal medicine, is a potent inhibitor of T-cell activation.
Neoplasms
Yin-yang effect of tumour cells in breast cancer: from mechanism of crosstalk between tumour-associated macrophages and cancer-associated adipocytes.
Neoplasms
Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Neoplasms
[Antiangiogenic and anti-immunosuppressive therapeutic strategies in human head and neck squamous cell carcinoma (HNSCC)]
Neoplasms
[Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].
Neoplasms
[Determination of monocyte chemotactic protein-1 in cultured endometriotic cells]
Neoplasms
[Ginger extracts improve renal injury of high fructose-fed SD rats by inhibiting the expression of proinflammatory cytokines].
Neoplasms
[Role of MCP-1 chemokine in the response of monocytes of patients with superficial tumors of the bladder treated with BCG immunotherapy]
Nephritis
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Nephritis
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Nephritis
Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Nephritis
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
Nephritis
Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis.
Nephritis
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Nephritis
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Nephritis
Evaluation of TGF-?1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
Nephritis
High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.
Nephritis
Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Nephritis
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Nephritis
Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice.
Nephritis
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.
Nephritis
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Nephritis
Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury.
Nephritis
Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Nephritis
Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
Nephritis
RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.
Nephritis
Relationship between MCP-1 promoter -2518 A/G gene polymorphism (rs1024611) and systemic lupus erythematosus/lupus nephritis.
Nephritis
Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis.
Nephritis
Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis.
Nephritis
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.
Nephritis
Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Nephritis
[Effects of bushen huoxue recipe on urinary levels of albumin, IL-6, TGF-beta1 and MCP-1 in chronic nephritis patients of shen-deficiency blood-stasis syndrome].
Nephritis, Interstitial
1,25-dihydroxyvitamin D3 differentially regulates IL-1alpha-stimulated IL-8 and MCP-1 mRNA expression and chemokine secretion by human primary proximal tubular epithelial cells.
Nephritis, Interstitial
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment.
Nephrolithiasis
Calcium oxalate monohydrate crystals stimulate monocyte chemoattractant protein-1 and transforming growth factor ?1 expression in human renal epithelial cells.
Nephrolithiasis
Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.
Nephrolithiasis
Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.
Nephrolithiasis
Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo.
Nephrolithiasis
Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells.
Nephrolithiasis
Urinary MCP-1?HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.
Nephrosclerosis
Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.
Nephrosis
Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome.
Nephrosis
Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.
Nephrosis
Transient and sequential expression of chemokine mRNA in glomeruli in puromycin aminonucleoside nephrosis.
Nephrosis, Lipoid
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.
Nephrotic Syndrome
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.
Nephrotic Syndrome
[The role of Cubilin in albumin-induced MCP-1, RANTES expression by renal tubular epithelial cells]
Nephrotic Syndrome
[Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]
Nervous System Diseases
Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.
Nervous System Diseases
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression.
Nervous System Diseases
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
Nervous System Diseases
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.
Neuralgia
Curcumin Inhibits Monocyte Chemoattractant Protein-1 Expression in TNF-? induced Astrocytes Through AMPK Pathway.
Neuralgia
Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain.
Neuralgia
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Neuralgia
Granulocyte Colony Stimulating Factor (GCSF) Can Attenuate Neuropathic Pain by Suppressing Monocyte Chemoattractant Protein-1 (MCP-1) Expression, through Upregulating the Early MicroRNA-122 Expression in the Dorsal Root Ganglia.
Neuralgia
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
Neuralgia
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons.
Neuralgia
Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats.
Neuralgia
Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury.
Neuralgia
Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury.
Neuritis
Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Neuritis, Autoimmune, Experimental
Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Neurocysticercosis
CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response.
Neurodegenerative Diseases
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
Neurodegenerative Diseases
[Chemokines as mediators for intercellular communication in the brain]
Neuroectodermal Tumors, Primitive
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Neurogenic Inflammation
Role of substance P and calcitonin gene-related peptide in the regulation of interleukin-8 and monocyte chemotactic protein-1 expression in human dental pulp.
Neuroinflammatory Diseases
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.
Neuroinflammatory Diseases
Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion.
Neuroinflammatory Diseases
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's disease.
Neuroinflammatory Diseases
Chemokines regulate the migration of neural progenitors to sites of neuroinflammation.
Neuroinflammatory Diseases
Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
Neuroinflammatory Diseases
Dexmedetomidine Attenuates Lipopolysaccharide Induced MCP-1 Expression in Primary Astrocyte.
Neuroinflammatory Diseases
Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS.
Neuroinflammatory Diseases
Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration.
Neuroinflammatory Diseases
Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.
Neuroinflammatory Diseases
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.
Neuroinflammatory Diseases
Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain".
Neuroinflammatory Diseases
Neuroinflammatory Markers in the Serum of Prepubertal Children with Down Syndrome.
Neuroinflammatory Diseases
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.
Neuroinflammatory Diseases
P7C3 Suppresses Neuroinflammation and Protects Retinal Ganglion Cells of Rats from Optic Nerve Crush.
Neuroinflammatory Diseases
Protective Effect of the MCP-1 Gene Haplotype against Schizophrenia.
Neuroinflammatory Diseases
Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain.
Neuroinflammatory Diseases
Stimulator of IFN genes mediates neuroinflammatory injury by suppressing AMPK signal in experimental subarachnoid hemorrhage.
Neuroinflammatory Diseases
Targeting monocyte chemoattractant protein-1 signalling in disease.
Neuroinflammatory Diseases
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.
Neuroinflammatory Diseases
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).
Neurologic Manifestations
Relationship between Cardiac Troponin and Thrombo-Inflammatory Molecules in Prediction of Outcome after Acute Ischemic Stroke.
Neurologic Manifestations
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Non-alcoholic Fatty Liver Disease
Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
Non-alcoholic Fatty Liver Disease
Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers.
Non-alcoholic Fatty Liver Disease
Cell-specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP-1 in high-fat diet-induced mice NAFLD.
Non-alcoholic Fatty Liver Disease
Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Non-alcoholic Fatty Liver Disease
Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
Non-alcoholic Fatty Liver Disease
Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice.
Non-alcoholic Fatty Liver Disease
IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Non-alcoholic Fatty Liver Disease
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Non-alcoholic Fatty Liver Disease
Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice.
Non-alcoholic Fatty Liver Disease
[Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease].
Non-alcoholic Fatty Liver Disease
[Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].
Obesity
A combination of circulating chemokines as biomarkers of obesity-induced insulin resistance at puberty.
Obesity
Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation.
Obesity
Adhesion molecules and chemokines; relation to anthropometric, body composition, biochemical and dietary variables.
Obesity
Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue.
Obesity
Adipose Tissues Characteristics of Normal, Obesity, and Type 2 Diabetes in Uygurs Population.
Obesity
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-{kappa}B-dependent pathway in rat preadipocytes.
Obesity
Arginase inhibition ameliorates adipose tissue inflammation in mice with diet-induced obesity.
Obesity
Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis.
Obesity
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Obesity
Association of Monocyte Chemotactic Protein-1 and Dickkopf-1 with Body Composition and Physical Performance in Community-Dwelling Older Adults in Singapore.
Obesity
Association of salivary C-reactive protein with the obesity measures and markers in children.
Obesity
Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.
Obesity
Bariatric surgery improves clinical outcomes and adiposity biomarkers but not inflammatory cytokines SAA and MCP-1 after a six-month follow-up.
Obesity
Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women.
Obesity
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Obesity
Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women.
Obesity
Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant.
Obesity
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Obesity
Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice.
Obesity
Effect of ARB on expression of CD68 and MCP-1 in adipose tissue of rats on long-term high fat diet.
Obesity
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Obesity
Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.
Obesity
Effects of Voluntary Running and Soy Supplementation on Diet-Induced Metabolic Disturbance and Inflammation in Mice.
Obesity
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
Obesity
GLP-1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in Mice.
Obesity
Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro.
Obesity
High-fat diet increases the level of circulating Monocyte Chemoattractant Protein-1 in Wistar rats, independent of obesity.
Obesity
Hypoxic adipocytes induce macrophages to release inflammatory cytokines that render skeletal muscle cells insulin resistant.
Obesity
Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss.
Obesity
Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.
Obesity
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes.
Obesity
JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
Obesity
Lipopolysaccharide and palmitic acid synergistically induced MCP-1 production via MAPK-meditated TLR4 signaling pathway in RAW264.7 cells.
Obesity
Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.
Obesity
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
Obesity
Melatonin Supplementation Attenuates the Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice Induced by A High-Fat Diet.
Obesity
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Obesity
Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity.
Obesity
Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
Obesity
Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin.
Obesity
Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.
Obesity
Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.
Obesity
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Obesity
Monocyte chemotactic protein-1 plays a role in ovarian dysfunction related to high-fat diet-induced obesity.
Obesity
Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes.
Obesity
ONO-1301, a Sustained-Release Prostacyclin Analog, Ameliorates the Renal Alterations in a Mouse Type 2 Diabetes Model Possibly Through Its Protective Effects on Mesangial Cells.
Obesity
RANTES RELEASE BY HUMAN ADIPOSE TISSUE IN VIVO AND EVIDENCE FOR DEPOT SPECIFIC DIFFERENCES.
Obesity
Resveratrol Delivery from Porous Poly(lactide-co-glycolide) Scaffolds Promotes an Anti-inflammatory Environment within Visceral Adipose Tissue.
Obesity
Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity.
Obesity
Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy.
Obesity
Role of MCP-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the FVB/N strain.
Obesity
Salivary Amylase Gene Copy Number Is Associated with the Obesity and Inflammatory Markers in Children.
Obesity
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
Obesity
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Obesity
The DNA methylation of TNF-aplha, MCP-1, and adiponectin in visceral adipose tissue is related to type 2 diabetes in Xinjiang Uygur population.
Obesity
The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity.
Obesity
The Immunophenotyping Changes of Peripheral CD4+ T Lymphocytes and Inflammatory Markers of Class III Obesity Subjects After Laparoscopic Gastric Sleeve Surgery - A Follow-Up Study.
Obesity
The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
Obesity
Therapeutic strategies of plant-derived compounds for diabetes via regulation of monocyte chemoattractant protein-1.
Obesity
[Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy].
Obesity
[Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases]
Obesity
[Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
Obesity
[Effects of serum from the obesity patients with diabetic mellitus on TLR4/NF-?B pathway in human THP-1 monocytes].
Obesity
[Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes]
Obesity, Abdominal
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Obesity, Abdominal
[Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
Obesity, Morbid
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Obstetric Labor, Premature
Blood protein profiles of infants born before 28th weeks differ by pregnancy complication.
Obstetric Labor, Premature
Modulation of monocyte chemotactic protein-1 expression during lipopolysaccharide-induced preterm delivery in the pregnant mouse.
Obstetric Labor, Premature
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
Oligodendroglioma
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma.
Opportunistic Infections
Blocking CXCL1-dependent neutrophil recruitment prevents immune damage and reduces pulmonary bacterial infection after inhalation injury.
Optic Nerve Diseases
Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration.
Optic Nerve Injuries
Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury.
Orchitis
Monocyte chemoattractant protein-1 (MCP-1/CCL2) in experimental autoimmune orchitis.
Osteoarthritis
Correlation between osteoarthritis and monocyte chemotactic protein-1 expression: a meta-analysis.
Osteoarthritis
Elevated Synovial Fluid Concentration of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Dogs with Osteoarthritis of the Stifle.
Osteoarthritis
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Osteoarthritis
Evaluation of serum MMP-2 and MMP-3, synovial fluid IL-8, MCP-1, and KC concentrations as biomarkers of stifle osteoarthritis associated with naturally occurring cranial cruciate ligament rupture in dogs.
Osteoarthritis
Extracellular osmolarity regulates matrix homeostasis in the intervertebral disc and articular cartilage: evolving role of TonEBP.
Osteoarthritis
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis.
Osteoarthritis
Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production.
Osteoarthritis
Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Osteoarthritis
Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium.
Osteoarthritis
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4.
Osteoarthritis
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
Osteolysis
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL.
Osteolysis
Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays.
Osteolysis
Monocyte Chemoattractant Protein 1 Expression in Synovial Fluid of Patients With Total Hip Arthroplasty.
Osteolysis
Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles.
Osteomyelitis
Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue.
Osteomyelitis
The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis.
Osteonecrosis
Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation.
Osteophyte
A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats.
Osteoporosis
[Bone marrow-derived mesenchymal stem cells from estrogen deficiency induced osteoporosis mice regulate T cell migration and apoptosis through expressing MCP-1].
Osteoporosis
[Effects of ER? gene overexpression on bone mineral density and calcium and phosphorus metabolism inovariectomized osteoporosis mice].
Osteosarcoma
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL.
Osteosarcoma
Expression of different chemokines by human osteosarcoma cells in response to tumor necrosis factor-alpha.
Osteosarcoma
Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Osteosarcoma
Human monocyte chemotactic protein-2: cDNA cloning and regulated expression of mRNA in mesenchymal cells.
Osteosarcoma
Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form.
Osteosarcoma
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Osteosarcoma
Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma.
Osteosarcoma
Possible involvement of PI3K-dependent pathways in the increased VEGF120 release from osteoblastic cells preloaded with palmitate in vitro.
Osteosarcoma
Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells.
Osteosarcoma
Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and ?-catenin expression and increases susceptibility to chemotherapeutic agents.
Osteosarcoma
TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration.
Osteosarcoma
Titanium particles induce the immediate early stress responsive chemokines IL-8 and MCP-1 in osteoblasts.
Otitis
Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.
Ovarian Hyperstimulation Syndrome
Inflammatory Response Patterns in ICSI Patients: A Comparative Study Between Chronic Anovulating and Normally Ovulating Women.
Ovarian Neoplasms
9-Hydroxycanthin-6-one isolated from stem bark of Ailanthus altissima induces ovarian cancer cell apoptosis and inhibits the activation of tumor-associated macrophages.
Ovarian Neoplasms
Anti-Folate Receptor-? IgE but not IgG Recruits Macrophages to Attack Tumors via TNF?/MCP-1 Signaling.
Ovarian Neoplasms
Chemotherapy induces macrophage chemoattractant protein-1 production in ovarian cancer.
Ovarian Neoplasms
Cytokine elevations in acute coronary syndrome and ovarian cancer: a mechanism for the up-regulation of the acute phase proteins in these different disease etiologies.
Ovarian Neoplasms
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.
Ovarian Neoplasms
Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.
Ovarian Neoplasms
Effect of Kumatakenin Isolated From Cloves on the Apoptosis of Cancer Cells and the Alternative Activation of Tumor-Associated Macrophages.
Ovarian Neoplasms
Functional polymorphisms in monocyte chemoattractant protein-1 are associated with increased susceptibility to ovarian cancer.
Ovarian Neoplasms
Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.
Ovarian Neoplasms
Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors.
Ovarian Neoplasms
Kaempferia parviflora extract inhibits TNF-?-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-?B signaling.
Ovarian Neoplasms
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
Ovarian Neoplasms
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Ovarian Neoplasms
Oldhamianoside inhibits the growth of ovarian cancer both in vitro and in vivo via adjusting inflammation and angiogenesis signals.
Ovarian Neoplasms
Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Ovarian Neoplasms
Relationship between MCP1 (-2518A>G) gene variants and ovarian cancer in Turkish population.
Ovarian Neoplasms
Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer.
Ovarian Neoplasms
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.
Overweight
Adipose tissue-derived cytokines and their correlations with clinical characteristics in Vietnamese patients with type 2 diabetes mellitus.
Overweight
Associations of dietary inflammatory index, serum levels of MCP-1 and body composition in Iranian overweight and obese women: a cross-sectional study.
Overweight
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Overweight
Forskolin Inhibits Lipopolysaccharide-Induced Modulation of MCP-1 and GPR120 in 3T3-L1 Adipocytes through an Inhibition of NF?B.
Overweight
Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.
Overweight
Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation.
Overweight
Serum and follicular fluid monocyte chemotactic protein-1 levels are elevated in obese women and are associated with poorer clinical pregnancy rate after in vitro fertilization: a pilot study.
Overweight
The effect of a 10-week high-intensity interval training and ginger consumption on inflammatory indices contributing to atherosclerosis in overweight women.
p-type cu2+ transporter deficiency
Production of LPS-induced inflammatory mediators in murine peritoneal macrophages: neocuproine as a broad inhibitor and ATP7A as a selective regulator.
Pancreatitis
Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges.
Pancreatitis
Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats.
Pancreatitis
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis.
Pancreatitis
CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.
Pancreatitis
Chemokines MCP-1 and RANTES in isolated rat pancreatic acinar cells treated with CCK and ethanol in vitro.
Pancreatitis
Clinical significance of dynamic detection for serum levels of MCP-1, TNF-? and IL-8 in patients with acute pancreatitis.
Pancreatitis
Dexamethasone down-regulates the inflammatory mediators but fails to reduce the tissue injury in the lung of acute pancreatitis rat models.
Pancreatitis
Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1.
Pancreatitis
Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis?
Pancreatitis
MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation.
Pancreatitis
Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome.
Pancreatitis
Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator.
Pancreatitis
Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis.
Pancreatitis
Repeated Stimulation of Toll-Like Receptor 2 and Dectin-1 Induces Chronic Pancreatitis in Mice Through the Participation of Acquired Immunity.
Pancreatitis
Sensing of Commensal Organisms by the Intracellular Sensor NOD1 Mediates Experimental Pancreatitis.
Pancreatitis
Serum Concentration of Inflammatory Cytokines in Dogs with Suspected Acute Pancreatitis.
Pancreatitis
Substance P treatment stimulates chemokine synthesis in pancreatic acinar cells via the activation of NF-kappaB.
Pancreatitis
Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis.
Pancreatitis
[Effects of N-acetylcysteine on mRNA expression of monocyte chemotactic protein and macrophage inflammatory protein 2 in acute necrotizing pancreatits: experiment with rats]
Pancreatitis
[Relationship between genetic polymorphism of MCP-1 and acute pancreatitis in Han population of Suzhou in China.]
Pancreatitis, Acute Necrotizing
[Effects of N-acetylcysteine on mRNA expression of monocyte chemotactic protein and macrophage inflammatory protein 2 in acute necrotizing pancreatits: experiment with rats]
Pancreatitis, Chronic
Alcohol modulates circulating levels of interleukin-6 and monocyte chemoattractant protein-1 in chronic pancreatitis.
Pancreatitis, Chronic
Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatitis, Chronic
Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis?
Pancreatitis, Chronic
Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR, and SPINK-1 in the Setting of Acute, Acute Recurrent, and Chronic Pancreatitis.
Pancreatitis, Chronic
Differential expression of chemokines in normal pancreas and in chronic pancreatitis.
Pancreatitis, Chronic
Polymorphisms of the MCP-1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis.
Pancreatitis, Chronic
The MCP-1 -2518 A/G polymorphism is not a susceptibility factor for chronic pancreatitis.
Pancreatitis, Chronic
The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats.
Panuveitis
Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent uveitic cataracts.
Papillomavirus Infections
Cytokine expression profiles in cervical mucus from patients with cervical cancer and its precursor lesions.
Paralysis
MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AN IMMUNE PARALYSIS PHENOTYPE IN PEDIATRIC SEPSIS.
Parasitemia
Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria.
Parasitemia
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Parasitemia
Serum Cytokines as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure.
Parasitic Diseases
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.
Parasitic Diseases
Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
Parasitic Diseases
Trichinella spiralis infection is mediated by MCP-1 and MIP-2, while echinococcus granulosus is strongly mediated by MCP-1, but not MIP-2.
Parathyroid Neoplasms
Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism.
Parkinson Disease
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.
Parkinson Disease
MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort.
Parkinson Disease
The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation.
Parkinsonian Disorders
Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.
Pelvic Inflammatory Disease
Significantly Elevated Concentration of Plasma Monocyte Chemotactic Protein 1 of Patients With Pelvic Inflammatory Disease.
Penile Induration
Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease.
Peri-Implantitis
Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis.
Peri-Implantitis
Cytokine Levels and Human Herpesviruses in Saliva from Clinical Periodontal Healthy Subjects with Peri-Implantitis: A Case-Control Study.
Periapical Periodontitis
The expression of MCP-1 and CCR2 in induced rats periapical lesions.
Periodontal Diseases
Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects.
Periodontal Diseases
Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease.
Periodontal Diseases
Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues.
Periodontal Diseases
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Periodontal Diseases
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease.
Periodontal Diseases
Monocyte-derived RANTES is intrinsically elevated in periodontal disease while MCP-1 levels are related to inflammation and are inversely correlated with IL-12 levels.
Periodontal Diseases
Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases.
Periodontal Diseases
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Periodontal Diseases
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Periodontitis
Anti-cardiolipin from periodontitis patients induces MCP-1 production by human umbilical vein endothelial cells.
Periodontitis
Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts.
Periodontitis
Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis.
Periodontitis
Expression profile of macrophage migration inhibitory factor in periodontitis.
Periodontitis
Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis.
Periodontitis
Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.
Periodontitis
HIF-1? activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization.
Periodontitis
Host Modulation in Rheumatoid Arthritis Patients with TNF Blockers Significantly Decreases Biochemical Parameters in Periodontitis.
Periodontitis
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Periodontitis
Increased Levels of Serum and Gingival Crevicular Fluid Monocyte Chemoattractant Protein-1 in Smokers With Periodontitis.
Periodontitis
Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.
Periodontitis
Long-term effect of full-mouth tooth extraction on the responsiveness of peripheral blood monocytes.
Periodontitis
Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis.
Periodontitis
The effect of experimental periodontitis, experimental diabetes and their combination on the serum levels of adiponectin, leptin, IL-6, IL-18, MCP-1, RANTES and sICAM-1 in rats.
Periodontitis
The secretion of cytokines by peripheral blood mononuclear cells of patients with periodontitis and healthy controls when exposed to H2S.
Periodontitis
Treponema denticola induces interleukin-8 and macrophage chemoattractant protein 1 production in human umbilical vein epithelial cells.
Periodontitis
[Infiltration of monocytes/macrophages and expression of monocyte chemoattractant protein-1 in gingival tissues from patients with rapidly progressive periodontitis]
Periodontitis
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Peripheral Arterial Disease
Association between Plasma Monocyte Chemoattractant Protein-1 Levels and the Extent of Atherosclerotic Peripheral Artery Disease.
Peripheral Arterial Disease
Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1.
Peripheral Arterial Disease
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Peripheral Arterial Disease
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
Peripheral Nerve Injuries
Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.
Peripheral Nerve Injuries
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons.
Peripheral Nerve Injuries
Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury.
Peripheral Nervous System Diseases
Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Peritoneal Fibrosis
NFAT5 contributes to osmolality-induced MCP-1 expression in mesothelial cells.
Peritoneal Fibrosis
Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells.
Peritoneal Fibrosis
Smad7 inhibits TGF-?1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells.
Peritonitis
5?-Reduced Glucocorticoids Exhibit Dissociated Anti-Inflammatory and Metabolic Effects.
Peritonitis
Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation.
Peritonitis
Dietary alpha-linked galacto-oligosaccharide suppresses ovalbumin-induced allergic peritonitis in BALB/c mice.
Peritonitis
Distinct regulation of IL-8 and MCP-1 by LPS and interferon-gamma-treated human peritoneal macrophages.
Peritonitis
Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.
Peritonitis
Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4.
Peritonitis
Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Peritonitis
Granulocyte macrophage-colony stimulating factor stimulates secretion of chemoattractive cytokines by peritoneal macrophages of CAPD patients.
Peritonitis
Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients.
Peritonitis
Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis.
Peritonitis
Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation.
Peritonitis
Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages.
Peritonitis
MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
Peritonitis
Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge.
Peritonitis
N-Acetylglucosamine Reduces Inflammatory Response during Acute Peritonitis in Uremic Rats.
Peritonitis
Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1.
Peritonitis
Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
Peritonitis
Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition.
Peritonitis
Protective effect of a novel antibody against TLR2 on zymosan-induced acute peritonitis in NF-?B transgenic mice.
Peritonitis
Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
Peritonitis
Repositioning of the ?-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome.
Peritonitis
Synthetic 4-Hydroxy Auxarconjugatin B, a Novel Autophagy Inducer, Attenuates Gouty Inflammation by Inhibiting the NLRP3 Inflammasome.
Peritonitis
Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1.
Persistent Infection
Chronic Trypanosoma cruzi infection potentiates adipose tissue macrophage polarization toward an anti-inflammatory M2 phenotype and contributes to diabetes progression in a diet-induced obesity mode.
Persistent Infection
Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats.
Persistent Infection
Treponema denticola induces interleukin-8 and macrophage chemoattractant protein 1 production in human umbilical vein epithelial cells.
plasmin deficiency
Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice.
Pleural Diseases
A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Pleural Effusion
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
Pleural Effusion
Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.
Pleural Effusion
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Pleural Effusion
Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.
Pleural Effusion
Tissue Plasminogen Activator Potently Stimulates Pleural Effusion via an MCP-1 Dependent Mechanism.
Pleural Effusion
[Role of C-C chemokines in the determination of pleural effusion etiology]
Pleural Effusion, Malignant
Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids.
Pleural Effusion, Malignant
[Role of C-C chemokines in the determination of pleural effusion etiology]
Pleurisy
Role of MCP-1 in pleural effusion development in a carrageenan-induced murine model of pleurisy.
Pneumoconiosis
Blood Levels of IL-I?, IL-6, IL-8, TNF-?, and MCP-1 in Pneumoconiosis Patients Exposed to Inorganic Dusts.
Pneumoconiosis
MCP-1 secretion in lung from nonsmoking patients with coal worker's pneumoconiosis.
Pneumoconiosis
Serum Levels of TGF-?1 and MCP-1 as Biomarkers for Progressive Coal Workers' Pneumoconiosis in Retired Coal Workers: A Three-year Follow-up Study.
Pneumonia
Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1.
Pneumonia
Aging increases the expression of lung CINCs and MCP-1 in senile patients with pneumonia.
Pneumonia
Antecedent acute kidney injury worsens subsequent endotoxin-induced lung inflammation in a 2-hit mouse model.
Pneumonia
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.
Pneumonia
Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae.
Pneumonia
Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.
Pneumonia
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Pneumonia
Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.
Pneumonia
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-?B in mice.
Pneumonia
Induction of monocyte chemoattractant protein-1 (MCP-1) production by Pseudomonas nitrite reductase in human pulmonary type II epithelial-like cells.
Pneumonia
Inhalation of welding fumes reduced sperm counts and high fat diet reduced testosterone levels; differential effects in Sprague Dawley and Brown Norway rats.
Pneumonia
Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury.
Pneumonia
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.
Pneumonia
Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice.
Pneumonia
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.
Pneumonia
Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-?B activation.
Pneumonia
MCP-1 Antibody Treatment Enhances Damage and Impedes Repair of the Alveolar Epithelium in Influenza Pneumonitis.
Pneumonia
Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammation.
Pneumonia
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.
Pneumonia
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Pneumonia
Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator.
Pneumonia
Serum MCP-1 and NGAL Play an Important Role in the Acute Inflammatory Event of Chronic Obstructive Pulmonary Disease.
Pneumonia
Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP-1, CXCL10, and viral RNA in the lungs of rhesus macaques.
Pneumonia
Tityus serrulatus scorpion venom improves survival and lung inflammation in lethal sepsis induced by CLP in mice.
Pneumonia
[Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats]
Pneumonia
[Effect of aging on pulmonary ICAM-1 and MCP-1 expressions in rats with lipopolysaccharide- induced acute lung injury.]
Pneumonia
[Effect of Cryptoporus polysaccharide on lipopolysaccharide-induced production of monocyte chemoattractant protein-1 in human alveolar epithelial cells]
Pneumonia, Pneumococcal
Age-related changes in the levels and kinetics of pulmonary cytokine and chemokine responses to Streptococcuspneumoniae in mouse pneumonia models.
Pneumonia, Pneumococcal
Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumonia.
Pneumoperitoneum
[Immediate peritoneal response to contamination during laparoscopic surgery in an experimental rat model.]
Polycystic Kidney Diseases
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Polycystic Kidney Diseases
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.
Polycystic Kidney Diseases
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.
Polycystic Kidney Diseases
PPAR? agonists in polycystic kidney disease with frequent development of cardiovascular disorders.
Polycystic Kidney Diseases
Renal CD14 expression correlates with the progression of cystic kidney disease.
Polycystic Kidney, Autosomal Dominant
Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease.
Polycystic Kidney, Autosomal Dominant
Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Polycystic Kidney, Autosomal Dominant
Co-Inheritance of Autosomal Dominant Polycystic Kidney Disease and Naevoid Basal Cell Carcinoma Syndrome: Effects on Renal Progression.
Polycystic Kidney, Autosomal Dominant
Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function.
Polycystic Kidney, Autosomal Dominant
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.
Polycystic Kidney, Autosomal Dominant
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Polycystic Kidney, Autosomal Dominant
Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD.
Polycystic Kidney, Autosomal Dominant
Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor ?B-induced inflammation.
Polycystic Kidney, Autosomal Dominant
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
Polycystic Kidney, Autosomal Dominant
Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.
Polycystic Kidney, Autosomal Dominant
Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
Polycystic Ovary Syndrome
Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.
Polymyalgia Rheumatica
Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF.
Porcine Reproductive and Respiratory Syndrome
Endometriotic Mesenchymal Stem Cells Exhibit Distinct Immune-Phenotype#
Post-Cardiac Arrest Syndrome
[Dachengqi decoction reduces the serum levels of mast cell tryptase and inflammatory cytokines in rabbits with post-cardiac arrest syndrome].
Post-Traumatic Headache
Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.
Pouchitis
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.
Pre-Eclampsia
Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with preeclampsia.
Pre-Eclampsia
Blood protein profiles of infants born before 28th weeks differ by pregnancy complication.
Pre-Eclampsia
Combined use of serum MCP-1/IL-10 ratio and uterine artery Doppler index significantly improves the prediction of preeclampsia.
Pre-Eclampsia
Maternal serum leptin, adiponectin, resistin and monocyte chemoattractant protein-1 levels in different types of diabetes mellitus.
Pre-Eclampsia
PP028. Serum cytokine profile in relation to the clinical features and laboratory parameters in women with preeclampsia.
Pre-Eclampsia
Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia.
Pre-Eclampsia
Thrombin impairs the angiogenic activity of extravillous trophoblast cells via monocyte chemotactic protein-1 (MCP-1): A possible link with preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Premature Birth
A MCP-1 promoter polymorphism at G-2518A is associated with spontaneous preterm birth.
Premature Birth
Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation.
Premature Birth
Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor.
Premature Birth
Preventive and therapeutic effect of N-Acetyl-l-cysteine on infection-associated preterm labor in mice.
Pressure Ulcer
The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer.
Primary Graft Dysfunction
Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Primary Myelofibrosis
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.
Prion Diseases
MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease.
Prostatic Hyperplasia
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
Prostatic Neoplasms
Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
Prostatic Neoplasms
Association of Polymorphisms in MCP-1, CCR2, and CCR5 Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer.
Prostatic Neoplasms
Elevated IL-8, TNF-?, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.
Prostatic Neoplasms
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.
Prostatic Neoplasms
Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study.
Prostatic Neoplasms
Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array.
Prostatic Neoplasms
Impact of the Tumor Microenvironment on the Expression of Inflammatory Mediators in Cancer Cells.
Prostatic Neoplasms
Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
Prostatic Neoplasms
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.
Prostatic Neoplasms
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Prostatic Neoplasms
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
Prostatic Neoplasms
N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
Prostatic Neoplasms
Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles.
Prostatic Neoplasms
PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
Prostatic Neoplasms
Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer.
Prostatitis
[Immune mechanisms of the active ingredients of Chinese medicinal herbs for chronic prostatitis].
Prostatitis
[Influence of Kudou Shencha decotion on INF-gamma, ICAM-1, MCP-1 levels of prostate tissue homogenate in immunity prostatitis model rats].
protein-tyrosine-phosphatase deficiency
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.
Proteinuria
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Proteinuria
Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
Proteinuria
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.
Proteinuria
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice.
Proteinuria
Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria.
Proteinuria
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
Proteinuria
Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.
Proteinuria
Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis.
Proteinuria
Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
Proteinuria
Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
Proteinuria
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Proteinuria
Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice.
Proteinuria
Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Proteinuria
Elevated plasma levels of interleukin 1 beta, tumour necrosis factor alpha and monocyte chemotactic protein 1 are associated with pregnancy toxaemia in ewes.
Proteinuria
Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Proteinuria
Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Proteinuria
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Proteinuria
Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in paediatric lupus nephritis.
Proteinuria
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
Proteinuria
Increased Serum MCP-1 Levels in Systemic Vasculitis Patients with Renal Involvement.
Proteinuria
Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
Proteinuria
Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein.
Proteinuria
Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells.
Proteinuria
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Proteinuria
KLF6 Acetylation Promotes Sublytic C5b-9-Induced Production of MCP-1 and RANTES in Experimental Mesangial Proliferative Glomerulonephritis.
Proteinuria
LPS Induces Preeclampsia-Like Phenotype in Rats and HTR8/SVneo Cells Dysfunction Through TLR4/p38 MAPK Pathway.
Proteinuria
MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis.
Proteinuria
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice.
Proteinuria
Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Proteinuria
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
Proteinuria
NIACIN AMELIORATES OXIDATIVE STRESS, INFLAMMATION, PROTEINURIA, AND HYPERTENSION IN RATS WITH CHRONIC RENAL FAILURE.
Proteinuria
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
Proteinuria
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.
Proteinuria
Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.
Proteinuria
RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.
Proteinuria
Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD.
Proteinuria
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Proteinuria
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.
Proteinuria
Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.
Proteinuria
Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis.
Proteinuria
Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis.
Proteinuria
Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
Proteinuria
Serum interferon-? and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy.
Proteinuria
Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Proteinuria
Study on the Regulation of Compound siRNA Nanoparticles on the Rat Model of Kidney Injury Induced by Sepsis by Inhibiting the Expression of NF-?B and P65.
Proteinuria
Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats.
Proteinuria
T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
Proteinuria
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.
Proteinuria
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
Proteinuria
Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis.
Proteinuria
TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
Proteinuria
Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Proteinuria
Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
Proteinuria
Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Proteinuria
Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
Proteinuria
[The role of Cubilin in albumin-induced MCP-1, RANTES expression by renal tubular epithelial cells]
Proteinuria
[The role of monocyte chemotactic peptide (MCP-1) in chronic renal allograft rejection]
Pruritus
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models.
Pseudolymphoma
The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.
Psoriasis
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.
Psoriasis
CC and CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman's therapy.
Psoriasis
Circulating levels of chemokines in patients with psoriasis vulgaris and their association with disease severity: A case-control study from North India.
Psoriasis
Effect of NB-UVB on levels of MCP-1 and CCR6 mRNA in patients with psoriasis vulgaris.
Psoriasis
Effect of pharmacological intervention on MIP-1?, MIP-1? and MCP-1 expression in patients with psoriasis vulgaris.
Psoriasis
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Psoriasis
The -2518 A/G MCP-1 and -403 G/A RANTES promoter gene polymorphisms are associated with psoriasis vulgaris.
Psoriasis
Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
Psoriasis
Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease.
Pulmonary Alveolar Proteinosis
Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis.
Pulmonary Disease, Chronic Obstructive
Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
Pulmonary Disease, Chronic Obstructive
CC-chemokine receptors in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Pulmonary Disease, Chronic Obstructive
Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.
Pulmonary Disease, Chronic Obstructive
Circulating monocytes from healthy individuals and COPD patients.
Pulmonary Disease, Chronic Obstructive
Comparative analysis of MCP-1 and TF in elderly patients with acute exacerbations of COPD and its clinical significance.
Pulmonary Disease, Chronic Obstructive
COPD rat model is more susceptible to cold stress and PM2.5 exposure and the underlying mechanism.
Pulmonary Disease, Chronic Obstructive
Correlation between serum biomarkers and BODE index in patients with stable COPD.
Pulmonary Disease, Chronic Obstructive
Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model.
Pulmonary Disease, Chronic Obstructive
Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs.
Pulmonary Disease, Chronic Obstructive
Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
Pulmonary Disease, Chronic Obstructive
MCP1 -2518 polymorphism and chronic obstructive pulmonary disease in Taiwanese men.
Pulmonary Disease, Chronic Obstructive
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking.
Pulmonary Disease, Chronic Obstructive
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD.
Pulmonary Disease, Chronic Obstructive
Regulation of DNA methylation signatures on NF-?B and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro.
Pulmonary Disease, Chronic Obstructive
Resveratrol Impairs the Release of Steroid-resistant Cytokines from Bacterial Endotoxin-Exposed Alveolar Macrophages in COPD.
Pulmonary Disease, Chronic Obstructive
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension.
Pulmonary Disease, Chronic Obstructive
Serum MCP-1 and NGAL Play an Important Role in the Acute Inflammatory Event of Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Pulmonary Disease, Chronic Obstructive
The Association of Monocyte Chemotactic Protein-1 and CC Chemokine Receptor 2 Gene Variants with Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
The Expression of IL-6, TNF-?, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
Pulmonary Disease, Chronic Obstructive
[Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease]
Pulmonary Disease, Chronic Obstructive
[The protective effects of vitamin E on lung injury caused by high temperature and PM2.5 in COPD rats].
Pulmonary Edema
Association of IL-8 and MCP-1 with the development of reexpansion pulmonary edema in rabbits.
Pulmonary Edema
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-?B in mice.
Pulmonary Edema
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.
Pulmonary Embolism
N-Acetylcysteine potentiates the haemodynamic-improving effect of sildenafil in a rabbit model of acute pulmonary thromboembolism via the p38 MAPK pathway.
Pulmonary Embolism
Protective effect of breviscapine in acute pulmonary embolism rats via regulation of MCP-1 and IL-13.
Pulmonary Embolism
[The effect of low molecular heparin and urokinase on MCP-1 of acute experimental pulmonary embolism in rabbits].
Pulmonary Eosinophilia
Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion.
Pulmonary Fibrosis
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.
Pulmonary Fibrosis
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Pulmonary Fibrosis
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Pulmonary Fibrosis
Elevated levels of MCP-1, MIP-alpha and MIP-1beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis.
Pulmonary Fibrosis
Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury.
Pulmonary Fibrosis
Longitudinal micro-computed tomography-derived biomarkers quantify non-resolving lung fibrosis in a silicosis mouse model.
Pulmonary Fibrosis
Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.
Pulmonary Fibrosis
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Purpura
Evaluation of TGF-?1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
Purpura
Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.
Purpura, Thrombocytopenic, Idiopathic
IP-10 and MCP-1 gene polymorphisms in Chinese patients with chronic immune thrombocytopenia.
Pyelonephritis
Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice.
Q Fever
Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
Rectal Neoplasms
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
Renal Insufficiency
Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
Renal Insufficiency
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Renal Insufficiency
Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus.
Renal Insufficiency
Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure.
Renal Insufficiency
Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
Renal Insufficiency
MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.
Renal Insufficiency
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.
Renal Insufficiency
Monocyte adhesion molecule expression in interstitial inflammation in patients with renal failure.
Renal Insufficiency
Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Renal Insufficiency
Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.
Renal Insufficiency
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Renal Insufficiency
[Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]
Renal Insufficiency, Chronic
Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease.
Renal Insufficiency, Chronic
Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Renal Insufficiency, Chronic
Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
Renal Insufficiency, Chronic
Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.
Renal Insufficiency, Chronic
Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.
Renal Insufficiency, Chronic
Expression and clinical significance of MCP-1 in serum of patients with chronic kidney disease undergoing maintenance hemodialysis.
Renal Insufficiency, Chronic
High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population.
Renal Insufficiency, Chronic
Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-?B, p53, ERK, and JNK in proximal tubular cells.
Renal Insufficiency, Chronic
MCP-1 and soluble TWEAK levels are independently associated with coronary artery disease severity in patients with chronic kidney disease.
Renal Insufficiency, Chronic
Metformin inhibits TGF-beta 1-induced MCP-1 expression through BAMBI-mediated suppression of MEK/ERK1/2 signaling.
Renal Insufficiency, Chronic
Renal TLR4 mRNA Expression Correlates with Inflammatory Marker MCP-1 and Profibrotic Molecule TGF-?(1) in Patients with Chronic Kidney Disease.
Renal Insufficiency, Chronic
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease.
Renal Insufficiency, Chronic
Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
Renal Insufficiency, Chronic
Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.
Reperfusion Injury
Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury.
Reperfusion Injury
IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines.
Reperfusion Injury
Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failure.
Reperfusion Injury
Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney.
Reperfusion Injury
Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
Reperfusion Injury
Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.
Reperfusion Injury
The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer.
Reperfusion Injury
The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation.
Reperfusion Injury
Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation.
Reperfusion Injury
[Dynamic changes of serum MCP-1 and MIP-2 chemokines after renal transplantation in rats]
Reperfusion Injury
[Effect of prostaglandin E1 on monocyte chemotactic protein-1 expression in Kupffer cells of rats with hepatic ischemia-reperfusion injury]
Reperfusion Injury
[Effects of ischemic reperfusion on the expression of cell adhesion molecules and monocyte chemotactic protein-1 and the protective role of MgSO4]
Respiratory Distress Syndrome
High concentrations of GRO-alpha and MCP-1 in bronchoalveolar fluid of infants with respiratory distress syndrome after surfactant.
Respiratory Distress Syndrome
Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia.
Respiratory Insufficiency
Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.
Respiratory Insufficiency
Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome.
Respiratory Insufficiency
The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review.
Retinal Detachment
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Retinal Detachment
Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.
Retinal Detachment
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Retinal Detachment
Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
Retinal Detachment
Retinal detachment-induced Müller glial cell swelling activates TRPV4 ion channels and triggers photoreceptor death at body temperature.
Retinal Detachment
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Retinal Detachment
[Effects of mechanical stress on expressions of monocyte chemoattractant protein-1 and interleukin-8 of cultured human retinal pigment epithelial cells]
Retinal Diseases
Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression.
Retinal Neovascularization
Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation.
Retinal Neovascularization
MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy.
Retinal Neovascularization
Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization.
Retinal Perforations
Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Retinal Perforations
Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Retinal Perforations
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Retinal Perforations
Role of inflammation in previously untreated macular edema with branch retinal vein occlusion.
Retinal Telangiectasis
Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease.
Retinal Vasculitis
Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis.
Retroviridae Infections
MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Rhinitis, Allergic
Cetirizine, a second-generation H1 antagonist, modulates Rantes and MCP-1 levels in allergic rhinitis.
Rhinitis, Allergic
Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa.
Rocky Mountain Spotted Fever
Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-kappaB.
Sarcoidosis
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Sarcoidosis
Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.
Sarcoidosis
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Sarcoidosis
Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.
Sarcoidosis
Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Sarcoidosis
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Sarcoidosis
Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.
Sarcoidosis
High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia.
Sarcoidosis
Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis.
Sarcoidosis
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
Sarcoidosis
The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Löfgren's syndrome.
Sarcoidosis
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Sarcoidosis, Pulmonary
Chemokines in the bronchoalveolar lavage fluid of patients with sarcoidosis.
Sarcoidosis, Pulmonary
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Sarcoma
A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells.
Sarcoma
Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.
Sarcoma
Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
Sarcoma, Kaposi
A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells.
Sarcoma, Synovial
The small molecule NSM00191 specifically represses the TNF-?/NF-?B axis in foot and ankle rheumatoid arthritis.
Sarcopenia
Association of Monocyte Chemotactic Protein-1 and Dickkopf-1 with Body Composition and Physical Performance in Community-Dwelling Older Adults in Singapore.
Schistosomiasis
Nitric oxide interaction with IL-10, MIP-1alpha, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis.
Schistosomiasis mansoni
Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation.
Scleroderma, Systemic
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Scleroderma, Systemic
Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis.
Scleroderma, Systemic
MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis.
Scleroderma, Systemic
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Scleroderma, Systemic
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.
Scleroderma, Systemic
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis.
Scleroderma, Systemic
The CTLA-4 and MCP-1 polymorphisms and susceptibility to systemic sclerosis: a meta-analysis.
Scleroderma, Systemic
The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Scrub Typhus
[Differences in immune damage between patients with severe fever with thrombocytopenia syndrome and patients with tsutsugamushi disease].
Seizures
Characterization of monocyte chemoattractant protein-1 expression following a kainate model of status epilepticus.
Seizures
Monocyte Chemoattractant Protein (MCP)-1 in Rotavirus-Associated White Matter Injury in Newborns.
Seizures
Pyrrolidine dithiocarbamate (PDTC) inhibits the overexpression of MCP-1 and attenuates microglial activation in the hippocampus of a pilocarpine-induced status epilepticus rat model.
Seizures, Febrile
Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis.
Sepsis
A Novel Role for Programmed Cell Death Receptor Ligand-1 (PD-L1) in Sepsis-Induced Intestinal Dysfunction.
Sepsis
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Sepsis
Adipocytokine Profile Reveals Resistin Forming A Prognostic-Related Cytokine Network In The Acute Phase of Sepsis.
Sepsis
Adiponectin Deficiency Promotes the Production of Inflammatory Mediators While Severely Exacerbating Hepatic Injury in Mice with Polymicrobial Sepsis.
Sepsis
Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges.
Sepsis
Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis.
Sepsis
Buprenorphine Markedly Elevates a Panel of Surrogate Markers in a Murine Model of Sepsis.
Sepsis
CD38 deficiency up-regulated IL-1? and MCP-1 through TLR4/ERK/NF-?B pathway in sepsis pulmonary injury.
Sepsis
Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patients.
Sepsis
Cytokine and nitric oxide levels in patients with sepsis--temporal evolvement and relation to platelet mitochondrial respiratory function.
Sepsis
Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology.
Sepsis
Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: A prospective observational study.
Sepsis
Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.
Sepsis
Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.
Sepsis
Innate immune molecule surfactant protein D attenuates sepsis-induced acute kidney injury through modulating apoptosis and NF?B-mediated inflammation.
Sepsis
LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway.
Sepsis
Mathematical Modeling of the Biomarker Milieu to Characterize Preterm Birth and Predict Adverse Neonatal Outcomes.
Sepsis
MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AN IMMUNE PARALYSIS PHENOTYPE IN PEDIATRIC SEPSIS.
Sepsis
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.
Sepsis
Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons.
Sepsis
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
Sepsis
Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort Study.
Sepsis
Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination.
Sepsis
Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era.
Sepsis
Sepsis Activates the TLR4/MyD88 Pathway in Schwann Cells to Promote Infiltration of Macrophages, Thereby Impeding Neuromuscular Function.
Sepsis
Sepsis is associated with reduced spontaneous neutrophil migration velocity in human adults.
Sepsis
Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs.
Sepsis
The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions.
Sepsis
Zymomonas mobilis culture protects against sepsis by modulating the inflammatory response, alleviating bacterial burden and suppressing splenocyte apoptosis.
Sepsis
[Changes in renal cell apoptosis and inflammatory cytokines in early stage of sepsis in rats.]
Sepsis
[Heparin inhibits lipopolysaccharide-induced adhesion of monocytes to endothelial cells].
Sepsis
[High mobility group box-1 stimulates proinflammatory cytokine production in endothelial cells via MAP kinases]
Sepsis
[The effect of necrostatin-1 on expression of liver monocyte chemotactic protein-1 in septic rats].
Severe Acute Respiratory Syndrome
Future perspective: biologic agents in patients with severe COVID-19.
Severe Dengue
Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease.
Severe Dengue
Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017.
Sexually Transmitted Diseases
Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: A pilot study.
Sexually Transmitted Diseases
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive.
Shock, Cardiogenic
Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach.
Shock, Septic
Cytokine and nitric oxide levels in patients with sepsis--temporal evolvement and relation to platelet mitochondrial respiratory function.
Shock, Septic
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
Shock, Septic
Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection.
Shock, Septic
Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression.
Shock, Septic
Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model.
Shock, Septic
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis.
Shock, Septic
Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock.
Shock, Septic
Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era.
Sialorrhea
Leptin and NGF in saliva of patients with diabetes mellitus type 2: A pilot study.
Silicosis
Role of human pulmonary fibroblast-derived MCP-1 in cell activation and migration in experimental silicosis.
Silicosis
[Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by the regulation of MCP-1 and ED-1 expression on rats with silicosis]
Silicosis
[The discriminant analysis of the silicosis's induction on cytokines in phlegm and combined multi-markers].
Skin Diseases
Effects of Schisandra chinensis Turcz. fruit on contact dermatitis induced by dinitrofluorobenzene in mice.
Skin Diseases
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak. A review of the literature.
Skin Diseases
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
Skin Diseases
Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin.
Sleep Apnea, Obstructive
Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.
Sleep Apnea, Obstructive
Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome.
Sleep Apnea, Obstructive
Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome.
Sleep Apnea, Obstructive
[Correlation study between the levels of serum MCP-1,SAA and cognitive function in patients with COPD-OSAHS].
Sleep Initiation and Maintenance Disorders
Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
Smooth Muscle Tumor
[Study of the mechanism of mast cell increase in cellular leiomyoma of uterus]
Spinal Cord Injuries
Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat.
Spinal Cord Injuries
Effects of hyperbaric oxygen therapy on RAGE and MCP-1 expression in rats with spinal cord injury.
Spinal Cord Injuries
Involvement of glial cell line-derived neurotrophic factor in activation processes of rodent macrophages.
Spinal Cord Injuries
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.
Spinal Cord Injuries
miRNA-544a Regulates the Inflammation of Spinal Cord Injury by Inhibiting the Expression of NEUROD4.
Spinal Cord Injuries
Monocyte chemoattractant protein-1 level in serum of patients with acute spinal cord injury.
Spinal Cord Injuries
Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.
Spinal Cord Injuries
Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma.
Spinal Cord Injuries
Protective Effects of SIRT6 Against Inflammation, Oxidative Stress, and Cell Apoptosis in Spinal Cord Injury.
Spinal Cord Injuries
Secreted ectodomain of sialic Acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity.
Spinal Cord Injuries
[Macrophages promote the migration of neural stem cells into mouse spinal cord injury site].
Spinal Dysraphism
Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor.
Spondylitis, Ankylosing
Serum Monocyte Chemotactic Protein-1 Concentrations Distinguish Patients With Ankylosing Spondylitis From Patients With Mechanical Low Back Pain.
Squamous Cell Carcinoma of Head and Neck
An association of the MCP-1 and CCR2 gene polymorphisms with oral lichen planus.
Squamous Cell Carcinoma of Head and Neck
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Squamous Cell Carcinoma of Head and Neck
Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
Squamous Cell Carcinoma of Head and Neck
Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40.
Squamous Cell Carcinoma of Head and Neck
Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Squamous Cell Carcinoma of Head and Neck
MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids.
Squamous Cell Carcinoma of Head and Neck
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
ST Elevation Myocardial Infarction
Abciximab combined with half-dose reteplase has beneficial effects on inflammatory myocardial response in patients with myocardial infarction.
ST Elevation Myocardial Infarction
Chemokines and left ventricular function in patients with acute myocardial infarction.
ST Elevation Myocardial Infarction
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.
ST Elevation Myocardial Infarction
Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction.
ST Elevation Myocardial Infarction
Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Staphylococcal Infections
Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection.
Starvation
[Inhibition of MCP-1 mRNA expression by propylene glycol mannate sulfate in hyperlipidemic rat aorta]
Status Epilepticus
Pyrrolidine dithiocarbamate (PDTC) inhibits the overexpression of MCP-1 and attenuates microglial activation in the hippocampus of a pilocarpine-induced status epilepticus rat model.
Still's Disease, Adult-Onset
Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease.
Stomach Neoplasms
Circulating blood levels of IL-6, IFN-?, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Stomach Neoplasms
COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells.
Stomach Neoplasms
Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.
Stomach Neoplasms
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.
Stomach Ulcer
The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients.
Stomatitis, Denture
Decreased production of proinflammatory cytokines by monocytes from individuals presenting Candida-associated denture stomatitis.
Stroke
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro.
Stroke
Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes.
Stroke
CD40 Ligand and MCP-1 as Predictors of Cardiovascular Events in Diabetic Patients with Stroke.
Stroke
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
Stroke
Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.
Stroke
Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke.
Stroke
Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats.
Stroke
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Stroke
Inflammatory responses mediate brain-heart interaction after ischemic stroke in adult mice.
Stroke
Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke.
Stroke
Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.
Stroke
MIP-1alpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke.
Stroke
Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities.
Stroke
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.
Stroke
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.
Stroke
Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1? and G-CSF after transient focal ischemia in mice.
Stroke
Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
Stroke
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Stroke
Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.
Stroke
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Stroke
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Stroke
Sex differences in stroke outcome correspond to rapid and severe changes in gut permeability in adult Sprague-Dawley rats.
Stroke
Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia.
Stroke
The Neurovascular Protective Effect of S14G-Humanin in a Murine MCAO Model and Brain Endothelial Cells.
Stroke
The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Subarachnoid Hemorrhage
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage.
Surgical Wound Infection
Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery.
Synovitis
Anti-TNF-? therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.
Synovitis
Diet-induced obesity leads to behavioral indicators of pain preceding structural joint damage in wild-type mice.
Synovitis
Evaluation of serum MMP-2 and MMP-3, synovial fluid IL-8, MCP-1, and KC concentrations as biomarkers of stifle osteoarthritis associated with naturally occurring cranial cruciate ligament rupture in dogs.
Synovitis
Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Synovitis
Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis.
Synovitis
Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
Synovitis
Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.
Syphilis
Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men.
Syphilis
The immunological response to syphilis differs by HIV status; a prospective observational cohort study.
Systemic Vasculitis
Increased Serum MCP-1 Levels in Systemic Vasculitis Patients with Renal Involvement.
Tauopathies
The stress-responsive gene GDPGP1/mcp-1 regulates neuronal glycogen metabolism and survival.
Tension-Type Headache
Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration.
Tension-Type Headache
Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke.
Thrombocytopenia
Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study.
Thrombocytopenia
Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE.
Thrombocytopenia
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
Thrombosis
15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension.
Thrombosis
Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi.
Thrombosis
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T.
Thrombosis
Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi.
Thrombosis
Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
Thrombosis
Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
Thrombosis
Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
Thrombosis
Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects.
Thrombosis
The relationship between inflammation and venous thrombosis. A systematic review of clinical studies.
Thrombosis
Thrombolysis of deep vein thrombosis and inhibiting chemotaxis of macrophage by MCP-1 blockage.
Thrombosis
Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Thyroid Cancer, Papillary
The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
Thyroid Diseases
Abnormal Iodine Nutrition-Induced ER Stress Upregulates MCP-1 Expression Through P38/MAPK Signaling Pathway in Thyroid Cells.
Thyroid Diseases
Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Thyroiditis
Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes.
Thyroiditis
Vitamin D deficiency, insulin resistance and thyroid dysfunction in obese patients: is inflammation the common link?
Thyroiditis, Autoimmune
Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis.
Tics
Regulatory effects of Ningdong granule on microglia-mediated neuroinflammation in a rat model of Tourette's syndrome.
Tooth Loss
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Tourette Syndrome
Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases.
Transfusion Reaction
Monocyte chemoattractant protein production in red cell incompatibility.
Trichinellosis
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo.
Trichinellosis
Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
Trichomonas Infections
Data showing differential expression of Monocyte chemoattractant protein-1 in response to symptomatic and asymptomatic T. vaginalis infection.
Trichosporonosis
Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis.
Triple Negative Breast Neoplasms
Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity.
Triple Negative Breast Neoplasms
Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model.
Triple Negative Breast Neoplasms
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
Trypanosomiasis, African
Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen.
Tuberculoma
Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis.
Tuberculosis
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
Tuberculosis
Association of MCP-1 -2518A/G and -362G/C variants and tuberculosis susceptibility: A meta-analysis.
Tuberculosis
Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.
Tuberculosis
Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.
Tuberculosis
CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosis.
Tuberculosis
Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.
Tuberculosis
Combined Analysis of IFN-?, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Tuberculosis
Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Tuberculosis
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
Tuberculosis
Discriminating between latent and active tuberculosis with multiple biomarker responses.
Tuberculosis
Early Secreted Antigenic Target of 6 kDa of Mycobacterium tuberculosis Stimulates Macrophage Chemoattractant Protein-1 Production by Macrophages and Its Regulation by p38 Mitogen-Activated Protein Kinases and Interleukin-4.
Tuberculosis
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.
Tuberculosis
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Tuberculosis
Evaluation of the Diagnostic Efficacy of Monocyte Parameters and MCP-1 to Distinguishing Active Tuberculosis from Latent Tuberculosis.
Tuberculosis
Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis.
Tuberculosis
Genetic association meta-analysis: a new classification to assess ethnicity using the association of MCP-1 -2518 polymorphism and tuberculosis susceptibility as a model.
Tuberculosis
Impact of tuberculosis on HIV-1 replication, diversity, and disease progression.
Tuberculosis
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.
Tuberculosis
Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.
Tuberculosis
Macrophages of different tissue origin exhibit distinct inflammatory responses to mycobacterial infection.
Tuberculosis
MCP-1 -2518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients.
Tuberculosis
MCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis.
Tuberculosis
Mycobacterium tuberculosis Rv0652 stimulates production of TNF and MCP-1 in macrophages through the TLR4 pathway.
Tuberculosis
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
Tuberculosis
Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1?, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.
Tuberculosis
Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression.
Tuberculosis
Plasma Level of IL-4 Differs in Patients Infected with Different Modern Lineages of M. tuberculosis.
Tuberculosis
Restoration of impaired free radical generation and proinflammatory cytokines by MCP-1 in mycobacterial pathogenesis.
Tuberculosis
Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-alpha, interleukin-10, and monocyte chemotactic protein-1 by Mycobacterium tuberculosis H37Rv-infected human monocytes.
Tuberculosis
Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma.
Tuberculosis
The -2518A/G Polymorphism in the MCP-1 Gene and Tuberculosis Risk: A Meta-Analysis.
Tuberculosis
The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis.
Tuberculosis
TLR stimulation of human neutrophils lead to increased release of MCP-1, MIP-1?, IL-1?, IL-8 and TNF during tuberculosis.
Tuberculosis, Pleural
Evaluation of a whole-blood chemiluminescent immunoassay of IFN-?, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Tuberculosis, Pleural
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
Tuberculosis, Pleural
[Study of the expression profile of immunogenesis associated genes in tuberculosis by microarray]
Tuberculosis, Pulmonary
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
Tuberculosis, Pulmonary
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.
Tuberculosis, Pulmonary
Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients.
Tuberculosis, Pulmonary
Evaluation of a whole-blood chemiluminescent immunoassay of IFN-?, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Tuberculosis, Pulmonary
Genetic association meta-analysis: a new classification to assess ethnicity using the association of MCP-1 -2518 polymorphism and tuberculosis susceptibility as a model.
Tuberculosis, Pulmonary
Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.
Tuberculosis, Pulmonary
MCP-1 -2518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients.
Tuberculosis, Pulmonary
MCP-1 gene polymorphisms in North Chinese patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa.
Tuberculosis, Pulmonary
Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1?, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains.
Tuberculosis, Pulmonary
The association between the -2518A/G polymorphism in the MCP-1 gene and the risk of pulmonary tuberculosis in Sichuan Chinese population.
Tuberculosis, Pulmonary
The MCP-1 (CCL2) -2518 GG genotype is associated with protection against pulmonary tuberculosis in Moroccan patients.
Tuberculosis, Pulmonary
TLR stimulation of human neutrophils lead to increased release of MCP-1, MIP-1?, IL-1?, IL-8 and TNF during tuberculosis.
Tuberculosis, Pulmonary
[Concentration of selected cytokines associated with monocytes/macrophages in serum of patients with different clinical stages of pulmonary tuberculosis]
Tuberculosis, Pulmonary
[The relationship between monocyte chemoattactant protein-1 gene polymorphisms and the susceptibility to pulmonary tuberculosis]
Tuberculosis, Spinal
Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population.
Tuberculosis, Spinal
Monocyte chemoattractant protein-1 in spinal tuberculosis: -362G/C genetic variant and protein levels in Chinese patients.
Tuberculosis, Spinal
Monocyte chemotactic protein-1 -2518 gene polymorphism and susceptibility to spinal tuberculosis.
Tuberculosis, Spinal
Roles of monocyte chemotactic protein 1 and nuclear factor-?B in immune response to spinal tuberculosis in a New Zealand white rabbit model.
Tuberous Sclerosis
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
Uremia
Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury.
Ureteral Obstruction
The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice.
Ureteral Obstruction
Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.
Urethral Obstruction
Expression of NGF, MCP-1, uroplakin III, and NOS in bladder urothelium after partial urethral obstruction in rats.
Urinary Bladder Neoplasms
Malignancy of bladder cancer cells is enhanced by tumor-associated fibroblasts through a multifaceted cytokine-chemokine loop.
Urinary Bladder Neoplasms
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy.
Urinary Bladder Neoplasms
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer.
Urinary Bladder, Overactive
Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder.
Urinary Bladder, Overactive
Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients.
Urinary Incontinence
Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder.
Urinary Tract Infections
Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections.
Urinary Tract Infections
Upper Urinary Tract Infections Are Associated with RANTES Promoter Polymorphism.
Urogenital Neoplasms
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Urticaria
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
Uterine Cervical Neoplasms
hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.
Uterine Cervical Neoplasms
Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas.
Uterine Cervical Neoplasms
Relationships of Single Nucleotide Polymorphisms of Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 With Susceptibility and Clinicopathologic Characteristics of Neoplasia of Uterine Cervix in Taiwan Women.
Uterine Cervical Neoplasms
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.
Uterine Cervical Neoplasms
[miR-520a-3p regulates the signaling pathway of cytokine secretion in cervical cancer].
Uveitis
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
Uveitis
Aqueous humor levels of asymmetric dimethylarginine (ADMA) are positively associated with monocyte chemoattractant protein-1 (MCP-1) in patients with uveitis.
Uveitis
Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat.
Uveitis
Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Uveitis
Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.
Uveitis
Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitis.
Uveitis
The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients.
Uveitis, Anterior
Chemokine and adhesion molecule profiles in aqueous humor of clinically quiescent uveitic cataracts.
Uveitis, Anterior
Cytokine profile and cytoskeletal changes after herpes simplex virus type 1 infection in human trabecular meshwork cells.
Uveitis, Anterior
Effect of berberine on monocyte chemotactic protein-1 and cytokine-induced neutrophil chemoattractant-1 expression in rat lipopolysaccharide-induced uveitis.
Uveitis, Anterior
Role of MCP-1 and IL-8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells.
Uveitis, Anterior
Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis.
Uveomeningoencephalitic Syndrome
A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis.
Uveomeningoencephalitic Syndrome
Monocyte chemoattractant protein (MCP)-1 -2518 A/G SNP in Chinese Han patients with VKH syndrome.
Vaccinia
The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site.
Vascular Calcification
Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model.
Vascular Diseases
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Vascular Diseases
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.
Vascular Diseases
Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty.
Vascular Diseases
Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.
Vascular Diseases
Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1.
Vascular Diseases
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Vascular Diseases
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Vascular Diseases
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Vascular Diseases
[Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia]
Vascular Malformations
Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations.
Vascular Malformations
Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.
Vascular System Injuries
3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells.
Vascular System Injuries
Attenuation of Monocyte Chemoattractant Protein-1 Expression Via Inhibition of Nuclear Factor-kappaB Activity in Inflammatory Vascular Injury.
Vascular System Injuries
C-Reactive Protein Can Influence the Proliferation, Apoptosis, and Monocyte Chemotactic Protein-1 Production of Human Umbilical Vein Endothelial Cells.
Vascular System Injuries
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
Vascular System Injuries
IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.
Vascular System Injuries
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury.
Vascular System Injuries
Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women.
Vascular System Injuries
Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
Vascular System Injuries
Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cells.
Vascular System Injuries
Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction.
Vascular System Injuries
Roscovitine attenuates intimal hyperplasia via inhibiting NF-?B and STAT3 activation induced by TNF-? in vascular smooth muscle cells.
Vascular System Injuries
Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells.
Vasculitis
Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Vasculitis
Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.
Vasculitis
Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Vasculitis
Intracellular glutathione redox status modulates MCP-1 expression in pulmonary granulomatous vasculitis.
Vasculitis
Levistilide A Ameliorates NLRP3 Expression Involving the Syk-p38/JNK Pathway and Peripheral Obliterans in Rats.
Vasculitis
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Vasculitis
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
Vasculitis
Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene.
Vasculitis
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: A meta-analysis.
Vasculitis
Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis.
Vasculitis
Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1.
Vasculitis
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat.
Vasculitis
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Vasospasm, Intracranial
Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Vasospasm, Intracranial
Potential role of poly (ADP-ribose) polymerase in delayed cerebral vasospasm following subarachnoid hemorrhage in rats.
Venous Thromboembolism
The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: A case-control study.
Venous Thrombosis
The relationship between inflammation and venous thrombosis. A systematic review of clinical studies.
Venous Thrombosis
Thrombolysis of deep vein thrombosis and inhibiting chemotaxis of macrophage by MCP-1 blockage.
Ventricular Dysfunction, Left
Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.
Ventricular Dysfunction, Left
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Ventricular Dysfunction, Left
Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
Ventricular Dysfunction, Left
Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure.
Ventricular Dysfunction, Left
Relationship between circulating levels of monocyte chemoattractant protein-1 and systolic dysfunction in patients with hypertrophic cardiomyopathy.
Vesico-Ureteral Reflux
Urinary biomarkers of latent inflammation and fibrosis in children with vesicoureteral reflux.
Vesico-Ureteral Reflux
Urinary excretion of EGF and MCP-1 in children with vesicoureteral reflux.
Vesicular Stomatitis
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.
Vesicular Stomatitis
Expression Kinetics of RANTES and MCP-1 in the Brain of Deer Mice (Peromyscus maniculatus) Infected with Vesicular Stomatitis New Jersey Virus.
Vesicular Stomatitis
Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes.
Viremia
Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
Virus Diseases
Age-related changes in the inflammatory responses to viral infections in the central nervous system during childhood.
Virus Diseases
Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Virus Diseases
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease.
Virus Diseases
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.
Virus Diseases
Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.
Virus Diseases
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus.
Virus Diseases
Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.
Virus Diseases
Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.
Virus Diseases
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Virus Diseases
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.
Virus Diseases
Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.
Virus Diseases
Phagocytosis of Mycobacterium tuberculosis or particulate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression.
Virus Diseases
Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections.
Virus Diseases
Role of MCP-1 and IL-8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells.
Virus Diseases
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.
Virus Diseases
The -2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection.
Virus Diseases
The Expression of IL-6, TNF-?, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Virus Diseases
The role of cytokines in the immune response to influenza A virus infection.
Virus Diseases
Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.
Virus Diseases
Zika Virus Infects Newborn Monocytes Without Triggering a Substantial Cytokine Response.
Virus Diseases
[Evaluation of soluble platelet cell adhesion molecule sPECAM-1 and chemokine MCP-1 (CCL2) concentration in CSF of patients with tick-borne encephalitis]
Vitamin D Deficiency
Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial.
Vitamin D Deficiency
Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
Vitamin D Deficiency
Vitamin D deficiency, insulin resistance and thyroid dysfunction in obese patients: is inflammation the common link?
Vitreoretinopathy, Proliferative
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Vitreoretinopathy, Proliferative
Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.
Vitreoretinopathy, Proliferative
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Vitreous Hemorrhage
The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
Whooping Cough
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.
Whooping Cough
Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells.
Whooping Cough
Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell.
Whooping Cough
G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro.
Whooping Cough
IFNgamma induces functional chemokine receptor expression in human mesangial cells.
Whooping Cough
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3.
Whooping Cough
Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1.
Whooping Cough
Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
Whooping Cough
Lysophosphatidylcholine- and MCP-1-induced chemotaxis of monocytes requires potassium channel activity.
Whooping Cough
MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.
Whooping Cough
MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression.
Whooping Cough
MCP-1 receptor binding affinity is up-regulated by pre-stimulation with MCP-1 in an actin polymerization-dependent manner.
Whooping Cough
Migration responses of human monocytic cell lines to alpha- and beta-chemokines.
Whooping Cough
Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.
Whooping Cough
Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response.
Whooping Cough
Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.
Whooping Cough
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells.
Whooping Cough
Oestrogen exerts anti-inflammation via p38 MAPK/NF-?B cascade in adipocytes.
Whooping Cough
Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice.
Whooping Cough
Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.
Whooping Cough
Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells.
Whooping Cough
Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes.
Whooping Cough
Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.
Whooping Cough
The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.
Whooping Cough
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.
Wound Infection
Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age.
Xanthomatosis
Ursane triterpenoids inhibit atherosclerosis and xanthoma in LDL receptor knockout mice.
Yersinia Infections
Yersinia enterocolitica invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine network in Yersinia infections.
html completed